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Complex Regional Pain Syndrome (CRPS) is a severe chronic pain condition that typically 
develops after a trauma such as bone fracture or surgery. CRPS pain is typically confined 
to the injured limb and exceeds the intensity and duration that can be expected from the 
initiating trauma.  
 
The neurophysiological basis of pain in CRPS is unknown and there are no effective 
therapies or diagnostic tests available. Plasma exchange has been shown to alleviate pain 
in long-standing CRPS patients in a small trial, indicating involvement of humoral factors.  
 
The aim of my project was to determine the neurophysiological mechanisms responsible 
for pain and hypersensitivity experienced by CRPS patients using a translational mouse 
model. In this model, a paw incision is used as a minor experimental trauma in 
combination with passive transfer of IgG purified from CRPS patients or healthy control 
subjects.  
 
Administration of IgG from CRPS patients, but not from healthy control subjects, 
exacerbated and prolonged the mechanical and thermal hypersensitivities produced by a 
paw incision, but did not alter tactile sensitivity to stimulation with von Frey filaments. 
Passive transfer of CRPS thus recapitulated the sensory profile observed in quantitative 
sensory testing studies of patients.  
 
Electrophysiological studies of skin-nerve preparations identified an increased ectopic 
impulse frequency in CRPS-IgG treated mice, indicative of spontaneous pain or 
paraesthesias. Single-unit recordings in the same preparations revealed an increased 
evoked impulse rate in mechano-nociceptors, whereas low threshold mechanosensitive 
afferents appeared functionally intact. Single-unit recordings were made in saphenous 
afferents innervating the hairy, dorsal paw skin, to reduce the impact of post-surgical 
sensitization. The observed sensitization of nociceptors innervating the hairy skin is 
consistent with the limb-confined pain typical of CRPS.  
 
Overnight incubation of isolated DRG neurons with CRPS-IgG, enhanced the Ca2+-response 
produced by a low concentration of K+ in a subpopulation of neurons, suggesting that 
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autoantibodies directly increased neuronal excitability. Immunohistochemical analysis 
revealed the presence of human IgG in glabrous skin of CRPS and HC-IgG injected mice, 
with a more pronounced staining or deposit around the incision.  
Together, these observations suggest that CRPS autoantibodies may act by binding to 
novel epitopes presented in the post-traumatic environment and that binding may 
stimulate release of mediators that diffuse locally. Alternatively, the trauma may trigger 
CRPS by facilitating extravascularization of autoantibodies, exposing peripheral tissues 
and nerves to higher local titers. In conclusion, my results demonstrate that passively 
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The five senses distinguished and defined by Aristotle (384-322 BC) in De Anima, book II, 
are taste, vision, touch, olfaction and hearing. Humans use them to respond to stimuli 
coming from the outside world and from the surrounding environment. They play a critical 
and primitive role in the living survival, particularly when danger needs to be detected. 
 
Changes in the external and internal environment are detected and the information 
conveyed to the central nervous system by peripheral sensory neurons. 
Different forms of noxious and innocuous mechanosensation such as touch, vibration, 
pressure but also thermosensation are all processed by the somatosensory nervous 
system. 
Spinal sensory neurons that participate in somatosensation have their cell bodies located 
in the dorsal root ganglia and project both to the spinal cord and to peripheral target 
organs. They are termed primary sensory neuron and are the only peripheral afferent 
neurons carrying sensory information to the spinal cord. By stimulation of its receptive 
field in the innervated target organ, e.g. the skin, the information is conducted to the 
spinal cord where the neuron forms synapses with second order neurons. The second 
order neuron is located within the spinal cord or brainstem and relays information to a 
third order neuron within the brain.  
 Primary afferent neurons 
 
 
Figure 1–1 Pseudo-unipolar neuron.  
The pseudo-unipolar sensory neuron has its cell body (soma) located inside the DRG from where an 
axon leaves and splits into two branches, a central branch that goes to the spinal cord level (CNS) to 
form synapses with other neurons, and a peripheral branch that forms the peripheral nerve terminals 
at the peripheral organ levels (i.e. skin, joint, muscle). Modified from Monica Schroeder/Science 
Source. 
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Primary afferent neurons of the somatosensory system have an unusual anatomy, they 
are pseudo-unipolar neurons with a T-junction: a single axon leaves the cell soma, which 
bifurcates and projects to both the spinal cord and the target tissue in the periphery 
(Figure 1–1). The cell body of the primary sensory neuron is contained within the DRG and 
within trigeminal ganglia (TG) when they innervate the head, the face and the neck region. 
1.2.1 Sensory nerve modalities 
The separation of sensory and motor functions in the spinal cord dorsal and ventral roots 
was a fundamental discovery attributed to Charles Bell (1811) and Magendie (1822). The 
idea of specificity of cutaneous sensation was formulated by Müller (1840) who 
established the doctrine of specific nerve energies (Norrsell et al., 1999). Müller suggested 
that the perception of a sense was not linked to how the sensory system was stimulated,  
but instead was explained by the specific activated pathway (Norrsell et al., 1999; Perl, 
2007). 
 
Later, Blix discovered that stimulation of separate localized points on the skin gave rise to 
distinct sensations of pressure, warmth, cold, and pain. His findings thus supported that 
the doctrine of specific nerve energies applies to the different cutaneous senses (Blix, 
1884). Other investigators such as Goldscheider and Donaldson confirmed these 
observations. For instance, a cold spot on the skin would be activated by cold but not by 
heat and an electrical stimulation of the same cold spot would give a cold sensation and 
not a heat sensation (Norrsell et al., 1999). Max von Frey’s observations strongly 
supported this concept who further studied these “spots” by mapping them and 
measuring their density in various places on the body (Norrsell et al., 1999).  
 
It is today known that different primary afferent neurons possess sensitivity to one or 
more specific sensory modalities. Nerve fibres are often classified according to the 
sensory modalities that they transduce and can be broadly categorised as 
mechanoreceptors, thermoreceptors and nociceptors (Zimmermann et al., 2009). 
Transduction of sensory neurons requires activation by different chemical and physical 
stimuli that depolarize the sensory neurons by stimulating cation channels (such as TRP 
channels), inhibiting K+-channels (e.g. two-pore potassium channels (K2P)), and anion 
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channels (e.g. anoctamin 1, a Ca2+-activated Cl- channel (Yang et al., 2008)) and G protein-
coupled receptors (GPCRs) located in the peripheral terminals (Dubin and Patapoutian, 
2010). Some of these channels belong to the transient receptor potential (TRP) channels 
which are sensitive to temperature, osmolality, pH and wide array of endogenous and 
exogenous chemicals and metabolites (Julius, 2013). Acid-sensing ion channels (ASICs) are 
other transduction channels well known for sensing reduction in the extracellular pH 
(García-Añoveros et al., 2001). Finally, PIEZO2, the mechanosensitive ion channel plays a 
crucial role in mechanosensation. PIEZO2 knock out mice exhibit a profound loss of touch 
sensation (Ranade et al., 2014). Constitutive deletion of PIEZO2 leads to perinatal lethality 
(Dublin et al., 2012); an inducible strategy to delete PIEZO2 in adult mice was therefore 
used (Ranade et al., 2014). In humans mutations in PIEZO2 can result in selective loss of 
discriminative touch perception, ataxia and dysmetria (Chesler et al., 2016).  
1.2.2 Primary afferent nerve fibres 
In 1924, Erlanger and Gasser successfully recorded the compound action potential of a 
frog sciatic nerve (Erlanger and Gasser, 1930). After the nerve was stimulated electrically, 
several peaks of voltage were recorded through an oscilloscope. Each peak reflected the 
existence of fibres with different conduction velocities. They classified the fibres 
according to the nerve fibre diameter size and myelination level. The extent of 
myelination of the nerve fibre/axon determines its conduction velocity (Gasser; Purves et 
al., 2001).  
Aα fibres are very large diameter (15-20µm), thickly myelinated neurons that are 
responsible for proprioception in human. Aβ fibres are large diameter (5-15µm), 
myelinated fibres that signal innocuous (non-painful) mechanical stimuli. Aβ fibres have 
a fast conduction velocity which can vary across species and is ~50m/s in humans and 
>10m/s in mice (Knibestöl, 1973; Koltzenburg et al., 1997).  
Aδ fibres are thinly myelinated, medium diameter (1-5µm) neurons and have a slower 
conduction velocity than Aβ fibres. C-fibres are unmyelinated fibres with a slow 
conduction velocity <1.5m/s and are activated by thermal, chemical and mechanical 
stimulus (Figure 1–2). 
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Although, Aδ fibres and unmyelinated C-fibres are commonly described as nociceptors 
based on their responses to noxious stimuli, a proportion of Aδ and C-fibres, the D-hair 
and C-low-threshold mechanoreceptors display responses to innocuous stimuli (light 
touch) (Brown and Iggo, 1967).  
Some recent findings however suggest that both D-hair fibres and CLMRs can influence or 
produce pain (Dawes et al., 2018; Habig et al., 2017; Urien et al., 2017). 
 
 
Figure 1–2 Diagram illustrating the properties of different classes of primary afferent 
nerve fibres.  
Aα and Aβ fibres are large diameter nerve fibres involved in proprioception and respond to light touch. 
Aδ fibres are lightly myelinated fibres and classified as nociceptors (Aδ-nociceptors) or non-
nociceptors (D-hairs). C fibres are unmyelinated small diameter fibres qualified as nociceptors. C-low-
threshold mechanoreceptors are responsive to light touch unlike other C-fibres. Adapted from Julius 
and Basbaum, 2001. 
1.2.3 Nociceptive versus non-nociceptive nerve fibres 
Max von Frey demonstrated that non-damaging mechanical stimulation of certain spots 
on the human skin could induce a pricking, unpleasant sensation while at other spots the 
same stimulation would evoke simply a tactile, non-painful sensation (von Frey, 1894). 
Pressure and pain spots were carefully mapped and were shown to be different from each 
other and from cold and warm spots. A spot-like distribution of mechanically and 
thermally sensitive areas suggested that a specific sensory receptor (organ) existed 
beneath each spot. von Frey therefore suggested that nociception was not only relying on 
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the noxious stimulus, but also on the receptor that had to be a nociceptor/ a ‘pain spot’ 
(von Frey, 1894).  
 
Sherrington, using experimental animals (the dog) conducted several physiological 
experiments by applying different noxious and innocuous mechanical/thermal stimulus 
on various skin spots. He measured the reflex withdrawal of the animals in response to 
various stimuli and proposed the existence of the nociceptive neuron, a primary sensory 
neuron activated by stimuli that threaten or actually damage tissue (Sherrington, 1903, 
1920).  
Perl, Bessou, Brown and Iggo studied unmyelinated cutaneous nerve fibres in the 1960s. 
Perl recorded the activities of cutaneous nerve fibres in cats and primates, and identified 
nerves that were activated by noxious stimuli, but showed little or no activity to innocuous 
stimuli, the C-fibres (Perl, 1968a). These fibres had a higher mechanical threshold for 
activation than myelinated fibres, and some were temperature sensitive (Bessou and Perl, 
1969; Brown and Iggo, 1967; Perl, 1968a). The reduced conduction velocity and higher 
activation threshold distinguished C-fibres from known classes of nociceptive and non-
nociceptive myelinated fibres. 
The different functional classes of sensory afferent nerve fibres have since been 
characterised in detail in the mouse and in the rat (Cain et al., 2001; Koltzenburg et al., 
1997; Leem et al., 1993).  
 
Two major classes of nociceptors have been characterized. The first includes medium 
diameter myelinated (Aδ) afferents that mediate acute, well-localized “first” or fast pain. 
These lightly myelinated fibres conduct action potentials at intermediate velocities 
compared to slow, unmyelinated C- and thickly myelinated non-nociceptive Aβ-fibres. C-
fibres include small diameter nociceptors that convey, the “second”, slow pain 
(Zotterman, 1939). Since C-fibres are slower than Aδ fibres at conducting information, 
they are responsible for the second pain and the Aδ fibres for the first pain when a painful 




Figure 1–3 Fibres conduction velocity and link to the type of pain. 
(A) Compound action potential recording from a peripheral nerve. The more a fibre is myelinated 
(larger its diameter is), the faster an action potential will be generated. Aα/Aβ fibres are thickly 
myelinated fibres which conduction velocities are higher than less myelinated Aδ or non-myelinated 
C-fibres. (B) Aδ and C-fibres account for fast (first) and slow (slow) pain. Modified from Julius and 
Basbaum, 2001 
 
Fibres are differentiated based on their conduction velocities and adaptation properties, 
but in addition, they are associated with specialised endings in the skin that influences 
their adaptation and transduction properties (Iggo and Andres, 1982; Iggo and Muir, 
1969).  
Sensory neurons can be categorized functionally according to their mechanosensitivity as 
low-threshold mechanoreceptors (LTMRs), which respond to innocuous (non-painful) 
mechanical stimulation, and high-threshold mechanoreceptors (HTMRs). HTMRs respond 
to more intense, potentially harmful mechanical stimuli.  
 
Mammalian skin can be divided into glabrous (non-hairy) skin and hairy skin (Figure 1–4). 
The glabrous skin presents four types of mechano-sensory end organs: Pacinian 
corpuscles, Ruffini endings, Meissner corpuscles and Merkel’s discs (Zimmerman et al., 
2014), which play specific roles in mechanical sensation. Merkel cells, for instance, play a 
modulatory role during transmission of mechanical forces onto associated Aβ slowly 
adapting fibre endings via activation of PIEZO2 (Woo et al., 2015). Indeed, Woo et al. 
hypothesized that gentle pressure on the skin or hair deformation opens PIEZO2 in Merkel 
cells, which causes Merkel cell depolarization and subsequent activation of voltage-gated 
calcium channels and neurotransmitter release, which contributes to SA fibre discharge 
(Woo et al., 2015).  
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In contrast with the glabrous skin, fibres endings are longitudinal lanceolate around hair 
follicles in the hairy skin  (Li et al., 2011) (Figure 1–4). 
 
In both glabrous and hairy skin, noxious stimuli are detected by free nerve endings of Aδ 
and C-fibres found in the epidermis (Abraira and Ginty, 2013).  
 
Aδ (AM) and C nociceptive fibres are functionally heterogeneous classes of fibres. Most 
of C-fibres can be activated by noxious mechanical stimulus (M) as well as by heat (H), 
cold (C) and chemicals because they are activated by different modalities, they are termed 
polymodal C-fibres (CMH, CMC, CMHC). Electrical search rather than mechanical search 
for the fibre localization allowed identification of silent fibres which are normally 
insensitive to mechanical and heat stimulus (CMiHi), but becomes sensitive to noxious 
mechanical and heat stimuli after being exposed to inflammatory agents (Meyer et al., 
1991; Schmidt et al., 1995). Prato et al. showed that mechanoinsensitive silent 
nociceptors, characterized by the expression of the nicotinic acetylcholine receptor 
subunit alpha-3 (CHRNA3), were becoming mechanosensitive following a 24h exposure to 
NGF (Prato et al., 2017).  
 
The detection of stimuli by nociceptors is based on membrane signalling molecules which 
convert the stimulus energy into a conformational change, leading to an alteration in ionic 
permeability and depolarization of the nerve terminal. Most transduction molecules are 
ion channels that are directly gated by the stimulus or by intracellular messenger systems 
activated by a variety of chemical substances (Belmonte and Viana, 2007). G-protein-
coupled receptors such as the bradykinin receptor (BK2) are also known to mediate 
nociception. Activation of BK2 by bradykinin, an inflammatory factor, leads to membrane 
depolarization of the sensory neuron via interaction with voltage-gated ion channels 
(Burgess et al., 1989; Wang et al., 2006). Channels such as TRP channels or purinergic 
(P2X2, P2X3 and P2Y1) channels are known to be transduction channels modulating 
neuronal excitability following activation of the channels by their ligand (Treede, 1999). 
TRPV1 is a nonselective cation channel with pronounced permeability for Ca2+ ions. It is 
the main molecular substrate for the ability of polymodal nociceptors to respond to acid, 
heat, and certain pungent chemicals. Other TRP channels (TRPV2, TRPV3, and TRPV4) are 
also gated by temperature, with thresholds ranging from warm to very hot (>52°C) 
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temperatures (Julius, 2013). A recent study showed that acute noxious heat sensing in 
mice was depending on a triad of TRP ion channels: TRPM3, TRPV1, and TRPA1. 
Trpv1−/−Trpm3−/−Trpa1−/− triple knockout mice lacked the acute withdrawal response to 
noxious heat that is necessary to avoid burn injury, while showing normal nociceptive 
responses to cold or mechanical stimuli and a preserved preference for moderate 
temperatures (Vandewauw et al., 2018).  
 
An additional histamine sensitive C-fibre type that mediate itch sensation has been 
identified in the human skin (Schmelz et al., 1997). Histamine mediated itch is well treated 
by antihistamines. Most clinically important and challenging itch is independent of 
histamine. Although histamine induced itch can be blocked by histamine receptor 
antagonists, there are many other itch conditions where such blockers are ineffective to 
stop the itch, as the one arising from renal and liver diseases, atopic dermatitis or caused 
by some agents (e.g. chloroquine, an antimalarial drug) (Liu et al., 2009). Itch when 
extreme or prolongated can become unbearable and make patients refuse treatments as 
it is the case for patients treated for malaria with chloroquine (Mnyika and Kihamia, 
1991). However, Mrgprs, a family of G protein-coupled receptors expressed only in 
peripheral sensory neurons have been shown to function as itch receptors (Liu et al., 
2009). Mrgpr gene lacking mice display significant deficit in chloroquine induced itch but 
not histamine (Liu et al., 2009). 
Mrgprs are expressed almost exclusively in neurons that are positive for tropomyosin 
receptor kinase A (TrkA+), the nerve growth factor (NGF) receptor, and that stained with 
the plant lectin IB4, a marker of nociceptors (Dong et al., 2001).  
 
Beside electrophysiological characterization of the large class of unmyelinated C-fibres, 
recent transcriptomics approaches aimed for their molecular characterization. Usoskin et 
al. thus revealed 11 types of DRG neurons, three distinct low-threshold mechanoreceptive 
neurons, two proprioceptive, and 6 principal types of thermosensitive, itch sensitive, type 
C low-threshold mechanosensitive and nociceptive neurons with markedly different 
molecular and operational properties (Usoskin et al., 2015). The classification Usokin et 
al. did not contradict a polymodal nature of C-fibre nociceptors, but it formally shows that 
discrete transcriptional states in different classes of unmyelinated polymodal neurons 
underlie distinct stimulus response (Usoskin et al., 2015). In vivo GCaMP (a genetically-
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encoded fluorescent Ca2+ indicator) optical imaging approach of sensory neurons was 
used to explore polymodal C-fibres in mice DRGs in response to painful stimuli by Emery 
et al. but also by Chisholm et al. Interestingly, Chisholm et al. demonstrate that the 
majority of primary afferents are polymodal with between 50–80% of thermally sensitive 
DRG neurons also respond to noxious mechanical stimulation (Chisholm et al., 2018) 
which is in contrast with Emery et al. finding demonstrating that neurons responsive to 
both mechanical and heat stimuli are restricted to ~10% of the DRG neurons (Emery et 
al., 2016).  
The current scheme proposes that proprioception, C-LTMR, TrpM8-dependent cold 
detection, some forms of pruritus, and probably acute mechanical pain may be tuned to 
specific neuronal types relatively selectively, whereas other types of sensation are 
encoded by a broader integration of ensembles of neurons with different transcriptional 
states (Usoskin et al., 2015). A similar study using retrograde labelling of gut sensory 
neurons, transcriptomic profiling and unsupervised clustering of 314 colonic sensory 
neurons, revealed seven subtypes of colonic neurons (Hockley et al., 2019). 
 
Further details about the primary sensory nerve fibres electrophysiological properties will 








Figure 1–4 The organisation of cutaneous mechanoreceptors in the skin.  
 (A) The glabrous skin contains nerve terminals which mediate touch by four types of 
mechanoreceptors. Merkel cells make synapse-like associations with enlarge nerve terminals 
branching from a single A fibre. A fibre end organs can be Pacinian corpuscles, Ruffini endings or 
Meissner corpuscles. Each end organ is specialised in sensing a different type of mechanical touch (i.e. 
stretching, stroke, vibration). The glabrous skin also has free nerve endings (A-mechanoreceptor and 
C-fibres). (B) The hairy skin contains hair follicles involved in stimuli transduction.  In the hairy skin 
LTMRs have longitudinal lanceolate endings around the hair follicles. A-LTMRs (D-hair fibres) and C-
LTMRs form lanceolate on zigzag and awl hairs, which are thin hairs. The longest hair type, guard 
hairs, is associated with touch domes at the apex and A-LTMR longitudinal lanceolate endings at 
the base. In contrast, HTMRs free nerve endings have their endings situated in the epidermis layer 
(Abraira and Ginty, 2013).  
1.2.4 Central projections of primary afferent neurons 
Sherrington, who suggested the existence of the nociceptor neuron, proposed a 
distinction between nociception and pain by conducting experiments using a decerebrate 
animal preparation. In these preparations, animal’s brain structures were removed, and 
the brain no longer received direct neuronal input from the spinal cord or brainstem 
trigeminal structures. Woodworth and Sherrington measured the pain behaviour in these 
preparations and suggested the essential contribution of the cortex to the perception of 
pain (Woodworth and Sherrington, 1904).  
Indeed, the sensory neuron innervates the target organ, but also projects to the spinal 
cord to form connections with neurons contained within the spinal cord. Different fibre 
types project to different locations within the dorsal horn (Figure 1–5). The low threshold, 
rapidly conducting Aβ afferents, which respond to light touch, project to deep laminae 
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(III, IV, and V). Aδ nociceptors project to lamina I as well as to deeper dorsal horn (lamina 
V). By contrast, C nociceptors project more superficially to laminae I and II (Basbaum et 
al., 2009).  
Some responses to pain stimuli operate at the spinal cord level without requiring the brain 
input, it is referred as spinal reflex response. Nociceptors can synapse with interneurons 
which in turn synapse onto a motor neuron, all within the spinal cord and activate a motor 
reflex following e.g. an intense heat stimulus (Le Bars et al., 2018).     
 
A more detailed study of C-fibre projection has been conducted and distinct projection 
patterns have been identified. Most peptidergic (CGRP/TrkA-expressing) C-fibres 
terminate within lamina I and the most dorsal part of lamina II, whereas IB4-binding and 
Ret-expressing DRG neurons, sensitive to the glial cell line-derived neurotrophic factor 
(GDNF), project most heavily to the inner aspect of lamina II (Snider and McMahon, 1998). 
These two types of neurons constitute two major classes of nociceptors. 
 
Figure 1–5 Central projection patterns of primary afferent fibres.  
All primary afferent neurons have their cell body within the DRG or TG and axons innervating target 
organs (fibre endings) but each fibre type projects and forms synapses in the spinal cord at various 
level. Peptidergic C-fibre central projections occur at level I and II in the dorsal horn and nonpeptidergic 
C-fibres at level II only. A fibres synapse at level I and IV within the dorsal horn in the spinal cord 
whereas A fibres synapse with neurons at level III, IV and V with the dorsal horn.    
 
 Inhibition of pain transmission 
Patrick Wall and Ronald Melzack were the first to propose the concept of “the gate control 
of pain” in 1965. They suggested that physical pain was not the only result of activation 
of nociceptive fibres, but rather the perception of pain was modulated by interaction 
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between excitatory and inhibitory interneurons in the dorsal horn (Melzack and Wall, 
1965). 
Indeed, pain seems to be lessened when the injured (noxious) area is rubbed (innocuous). 
Fast innocuous signals reach the dorsal horn before noxious signals (both non-nociceptive 
and nociceptive are likely activated by most noxious mechanical stimuli), the fast afferent 
may synapse onto inhibitory interneurons which in turn synapse on projections from 
nociceptors, thereby inhibiting input from to projection neurons (Melzack and Wall, 
1965). A more recent study conducted by Arcourt et al. explores the role of LTMRs and 
nociceptors in pain signalling. Using optogenetics they reveal that tactile sensory input via 
LTMRs has an analgesic effect on A-fibre nociceptors mediated acute pain (Arcourt et al., 
2017). 
 
Prolonged noxious stimuli can induce pain hypersensitivity by central sensitization. 
Central sensitization represents an enhancement in the function of neurons and circuits 
in nociceptive pathways caused by increases in membrane excitability and synaptic 
strength as well as to reduced inhibition (inhibitory neurons). Central sensitization 
produces pain hypersensitivity by changing the sensory response elicited by normal inputs 
(Latremoliere and Woolf, 2009; Woolf, 1983, 2011; Woolf et al., 1988). More recent 
studies used single-cell RNA sequencing to classify neurons and non-neuronal cells 
throughout the nervous system. According to unbiased principle component analysis, the 
dorsal horn contains 15 inhibitory and 15 excitatory subtypes of neurons that can be 
defined by their molecular expression patterns. The existence of these neurons subtype 
were confirmed in situ in the spinal cord (Häring et al., 2018).  
 
The periaqueductal grey (PAG) in the midbrain and the rostral ventromedial medulla 
(RVM) are two important areas of the brain involved in descending inhibitory modulation, 
capable of activating a powerful analgesic effect. Both these centres contain high 
concentrations of opioid receptors and endogenous opioids (Morgan et al., 1992). 
Descending pathways project to the dorsal horn and inhibit pain transmission. These 
regions engage descending noradrenergic and serotonergic systems that can enhance or 
attenuate nociceptive inputs at the spinal level (Ossipov et al., 2014). Loss of descending 
inhibition may explain chronification of pain in certain patient (Ossipov et al., 2014). 
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 Inflammatory, neuropathic and nociplastic pain 
Pain is defined as an unpleasant sensory and emotional experience associated with actual 
or potential tissue damage or described in terms of such damage (International 
Association for the Study of Pain). As defined by the IASP, pain can have different origins 
and is different from nociception. Nociception refers to the peripheral and central 
nervous system (CNS) processing of information about the internal or external 
environment, as generated by the activation of nociceptors (Animals, 2009). IASP defines 
nociception as the neural process of encoding noxious stimuli. The consequences of 
encoding may be autonomic or behavioural (motor withdrawal reflex or more complex 
nocifensive behaviour). Pain sensation is then not necessarily implied (International 
Association for the Study of Pain).  
Also, the terms nociceptive and neuropathic pain are used to differentiate the type of 
pain. Nociceptive pain is described as pain that arises from actual or threatened damage 
to non-neural tissue and is due to the activation of nociceptors with a normally 
functioning somatosensory nervous system, such as the pain arising from a damaged skin 
(e.g. burn), muscle (e.g. strain) or bone (e.g. bone fracture). In contrast, neuropathic pain 
is described as pain caused by a lesion or disease of the somatosensory nervous system. 
Neuropathic pain can be central when the pain is caused by a lesion or disease of the 
central somatosensory nervous system or peripheral (IASP).  
A third and more recent type of pain has been added to the IASP taxonomy in 2017, the 
term “nociplastic pain”. The term has not reached wide acceptance, since it is essentially 
not used in the literature yet. Nociplastic pain refers to pain that arises from altered 
nociception despite no clear evidence of actual or threatened tissue damage causing the 
activation of peripheral nociceptors or evidence for disease or lesion of the 
somatosensory system causing the pain. This term can help describe the pain underlying 
different chronic pain conditions that cannot be covered by the terms "nociceptive pain" 
or "neuropathic pain (e.g. chronic low back pain or irritable bowel syndrome).  
1.4.1 Inflammatory pain 
Pain is frequently a consequence of inflammation, which is a localized reaction that 
produces redness, warmth, swelling as a result of infection (bacterial or viral), irritation 
(UV-light, chemicals, etc), or injury. Surgery, bone fracture, cuts or burns generate 
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inflammatory nociceptive pain that can last for up to 6 months. If the pain persists for 
more than 6 months, it is referred as chronic pain.  
 
Inflammation around the damaged area causes sensitisation of peripheral nerve 
afferents. Nerve endings find themselves exposed to products of tissue damage and 
inflammation, sometimes referred as “inflammatory soup” (Figure 1–6). Important 
mediators or factors of this inflammatory soup include extracellular protons, arachidonic 
acid, lipid metabolites, serotonin, bradykinin, nucleotides and NGF, which may sensitize 
sensory nerve endings by acting at receptors or on ion channels (Figure 1–6) (Julius and 
Basbaum, 2001; Basbaum et al., 2009; Yam et al., 2018).  
 
The inflammatory mediators can be exogenous or endogenous. LPS of gram-negative 
bacteria (endotoxin) acts as an exogenous inflammatory mediator and initiates an 
inflammatory response in infected tissues via binding to the TLR4 receptor and activation 
of monocytes, dendritic cells, macrophages and B cells, which mediate secretion of pro-
inflammatory cytokines (Abbas et al. 2012). Although mostly expressed on immune cells, 
TLR4 receptor is also expressed on human and murine non-immune pancreatic β-cells 
(Garay-Malpartida et al., 2011). Interestingly, LPS has been also shown to trigger strong 
defensive responses in the mice airways. LPS mediates an immediate intracellular Ca2+ in 
airway epithelial cells via a TLR4-independent but TRPV4-dependent mechanism (Alpizar 
et al., 2017). 
In contrast, endogenous mediators of inflammation are not produced from foreign 
exterior factors (e.g. bacteria), but are instead secreted from immune cells (e.g. mast 
cells) or other non-immune cells (e.g. ATP release from keratinocytes (Burrell et al., 2005; 
Moehring et al., 2018)).  
 
Bradykinin and prostaglandin are two examples of endogenous inflammatory mediators, 
often used to study nociception and signalling in vivo and in vitro.  
Bradykinin, physiologically released by mast cells, when applied to primary sensory nerve 
terminals or cultured sensory neurons, produces immediate membrane depolarization as 
well as sensitization to other noxious, or even innocuous stimuli by activating G-protein-
coupled (BK2) receptors that in turn interact with voltage-gated and ligand-gated ion 
channels (Burgess et al., 1989; Wang et al., 2006). 
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Prostaglandin E2 (PGE2) is produced by cyclooxygenase (COX) enzymes and with the 
action of microsomal (mPGES-1, mPGES-2) and cytosolic PGE (cPGES) synthases in 
response to inflammation both in peripheral inflamed tissues and in the spinal cord 
(Zeilhofer, 2005). 
COX-2 is induced in inflammatory cells by pro-inflammatory, cytokines and growth factors 
(Nakanishi and Rosenberg, 2013) and contributes to the synthesis of PGE2 and peripheral 
sensitization by binding to G-protein-coupled receptors (PGE2Rs) (Sugimoto and 
Narumiya, 2007). There are four subtypes of PGE2 receptors, EP1, EP2, EP3 and EP4. All four 
subtypes of PGE2 receptors belong to a large superfamily of G-protein-coupled, seven-
trans-membrane domain receptors (GPCRs) (Kawabata, 2011). EP1 receptors are coupled 
to heterotrimeric Gq/11 protein, and the agonist stimulation of EP1 receptors causes 
activation of phospholipase C, which in turn produces inositol trisphosphate (IP3) and 
diacylglycerol (DG), followed by cytosolic calcium mobilization and activation of protein 
kinase C (PKC) (Kawabata, 2011). EP2 and EP4 receptors are coupled to Gs protein, and the 
agonist stimulation of those receptors activates adenylyl cyclase, which generates cyclic 
AMP (cAMP) (Sugimoto and Narumiya, 2007; Kawabata, 2011). Finally, EP3 receptors are 
coupled to Gi protein (Kawabata, 2011). PGE2 signalling can modulate both excitatory and 
inhibitory neurotransmission by increasing the responsiveness of peripheral nociceptors 
that generate excitatory glutamatergic transmission, and by disinhibition of dorsal horn 
neurons that are relived from inhibitory glycinergic transmission (Zeilhofer, 2005). 
Nonsteroidal anti-inflammatory drugs (NSAIDs) (e.g. aspirin and ibuprofen) inhibit the 
activity of COX enzymes and are administered to reduce pain in patients.   
 
Nociceptive nerve fibres can release neurotransmitters, i.e. substance P, CGRP from their 
peripheral terminals when activated by noxious stimuli (Maggi, 1995). Substance P and 
CGRP release from the peripheral terminal induce vasodilation and plasma extravasation 
(leakage of proteins and fluid from postcapillary venules), as well as activation of many 
non-neuronal cells, including mast cells and neutrophils and vascular tissue. This 
phenomenon is known as neurogenic inflammation. In the central nervous system, loss 
of spinal neurons that possess the substance P receptor (SPR) attenuate pain and 
hyperalgesia produced by capsaicin, inflammation, and nerve injury (Khasabov et al., 




Figure 1–6 Inflammation at site of injury.  
The illustration shows Inflammatory mediators released at the site of tissue injury, which activate 
response in primary afferent nociceptor. Some of the main “inflammatory soup” are shown, including 
peptides (bradykinin), lipids (prostaglandins), neurotransmitters (serotonin (5-HT) and ATP) and 
neurotrophins (NGF). These factors sensitize or excite the terminals of the nociceptor by interacting 
with receptors expressed at the neuron surface. Activation of the nociceptor not only transmit afferent 
messages to CNS (the spinal cord dorsal horn and then the brain), but also initiates the process of 
neurogenic inflammation. This is an efferent function of the nociceptor whereby release of 
neurotransmitters, SP and CGRP, from the peripheral terminal induces vasodilatation and plasma 
extravasation of non-neuronal cells (mast cells and neutrophils). Modified from Julius & Basbaum, 
2001; Yam et al., 2018. 
 
1.4.2 Neuropathic pain – general definition 
The word "neuropathy", used since 1827, refers to nerve dysfunction/damage and 
abnormal nerve activity. Neuropathy can lead to chronic pain or to loss of sensation.  
Neuropathic pain is a direct consequence of a lesion or disease affecting the 
somatosensory system. Neuropathic pain is one of the highly debilitating chronic pain 
conditions, for which, currently, there is no therapeutic treatment. According to a large-
scale European study, 19% of 46,394 participants were suffering from chronic pain (>6 
months) (Breivik et al., 2006) and according to the International Association for the Study 
of Pain (IASP), 7–10% adults suffer from chronic neuropathic pain. Often it is described as 
a shooting, burning, stabbing pain or “pins and needles” feeling. Patients often experience 
spontaneous pain, evoked-pain such as allodynia if non-painful stimuli (e.g. light touch) 
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provoke pain and/or hyperalgesia if a stimulus that normally provokes pain is inducing an 
intensified pain feeling.  
1.4.2.1 Nerve injury 
Nerve damage can occur as a consequence of a traumatic injury or can be initiated by 
particular infections, metabolic diseases, and by certain pharmacological agents (e.g. 
chemotherapy).  
A major consequence of nerve damage is the onset of neuropathic pain characterized by 
allodynia and hypersensitivity in partially denervated regions (Gilron et al., 2015). 
Wallerian degeneration refers to the process by which axons distal to the site of injury are 
broken down and reabsorbed by immune cells. This process is associated with the release 
of inflammatory mediators, many of which act on afferents to modulate ion channel 
properties and afferent excitability (Wu et al., 2001).  
 
Patients with neuropathic pain are naturally heterogeneous in etiology, pathophysiology, 
and clinical appearance (Baron et al., 2017). They exhibit a variety of pain-related sensory 
symptoms and signs (sensory profile), which might indicate different classes of 
neurobiological mechanisms and require different type of approaches for treatment 
(Baron et al., 2017). Using 13 quantitative sensory testing parameters, the authors 
subgrouped a large group of patient with neuropathic pain of different etiologies (Baron 
et al., 2017).  Three distinct subgroups with characteristic sensory profiles were identified 
and replicated. Cluster 1 (sensory loss, 42%) showed a loss of small and large fibre 
function in combination with paradoxical heat sensations. Cluster 2 (thermal 
hyperalgesia, 33%) was characterized by preserved sensory functions in combination with 
heat and cold hyperalgesia and mild dynamic mechanical allodynia. Cluster 3 (mechanical 
hyperalgesia, 24%) was characterized by a loss of small fibre function in combination with 
pinprick hyperalgesia and dynamic mechanical allodynia (Baron et al., 2017).   
 
Various animal models of peripheral nerve injury have been established in order to study 
the underlying mechanism for neuropathic pain. Among them, there is the spared nerve 
injury (SNI) model, a classic partial denervation model (Decosterd and Woolf, 2000a) 
which produces robust mechanical allodynia within one postoperative day that lasts at 
least 28 days (Howard et al., 2005) and that is used extensively to explore the mechanisms 
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responsible for neuropathic pain. In the SNI model the spared nerve injury model, a lesion 
of two of the three terminal branches of the sciatic nerve (tibial and common peroneal 
nerves) is involved, leaving the remaining sural nerve intact (Decosterd and Woolf, 2000). 
The SNI model resulted in early (<24 h), prolonged (>6 months) and robust behavioural 
modifications. The mechanical sensitivity to von Frey hairs and thermal (hot and cold) 
responsiveness was increased in the ipsilateral sural and to a lesser extent saphenous 
territories, without any change in heat thermal thresholds (Decosterd and Woolf, 2000b). 
Many other animal models of nerve injury have been developed. They all differ in the 
anatomical position of the inflicted nerve damage, but also in the symptoms and sensory 
change they cause. Each model has advantages and disadvantages. They are known as the 
partial sciatic nerve injury (PNI) (Seltzer et al., 1990), the spinal nerve ligation (SNL) (Ho 
and Mo, 1992) and the sciatic nerve chronic constriction injury (CCI) (Bennett and Xie, 
1988). 
1.4.2.2 Diabetic peripheral neuropathy (DPN) 
Diabetes is one of the largest global health-care problems of the 21st century. The number 
of people with diabetes worldwide is predicted to double between 2000 and 2030, 
reaching a pandemic level of 366 million people (Hossain et al., 2007; Zimmet et al., 2014). 
Diabetic neuropathy is one of the most common diabetic complication (Vinik et al., 2013). 
It is a leading cause for disability due to subsequent foot ulceration and amputation 
(Volmer-Thole and Lobmann, 2016).  
Diabetic peripheral neuropathy is a well-known example of peripheral neuropathy 
associated with pain, hyposensitivity or hypoesthesia and sometimes with spontaneous 
pain. Between 25% and 50% of patients with peripheral diabetic neuropathy develop 
neuropathic pain (Juster-Switlyk and Smith, 2016; Themistocleous et al., 2016). Patients 
describe a range of sensory symptoms, which may include loss of pain sensation or 
tingling, “pins and needles” sensation, burning, “electric shocks”, allodynia, or 
hyperalgesia (Juster-Switlyk and Smith, 2016). Sensory loss is a major clinical problem, 
since it may lead to ulcers, foot complications and amputations. 
The pathogenesis of diabetic peripheral neuropathy is complex and is marked by both 
metabolic and vascular factors (Cameron et al., 2001). Hyperglycemia is one of the 
metabolic events known to cause axonal and microvascular injury. Themistocleous et al. 
showed that no correlation was found between intraepidermal nerve fibre density and 
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severity of pain in the cohort of patient they studied (Themistocleous et al., 2016). The 
pathophysiological basis of neuropathic pain in diabetes is complex and poorly 
understood.  
 
Diabetic mice models have been induced in order to study the mechanisms of the disease. 
Injection of streptozotocin (STZ) to mice leads to destruction of insulin producing cells in 
the mice and to generation of diabetic mice. The sensory nerve fibre properties showed 
an impaired nociception characterized by hyposensitivity to noxious mechanical and 
thermal stimuli with impaired C-fibre and A-fibre response in single-fibre recording 
experiments (Lennertz et al., 2011). However, STZ generates peroxynitrite, which 
produces sensory abnormalities by stimulating TRPA1 directly (Andersson et al., 2015). As 
a consequence, sensory loss is established within an hour of STZ administration, 2-3 days 
before the mice become diabetic. Therefore, more refined models, like the Ins2+/Akita 
mouse should be used for studies of sensory neuropathy. The Ins2+/Akita mouse model, 
a hereditary model of diabetes, was used by Vastani et al. in order to investigate sensory 
neuropathy in diabetes. Akita mice exhibited hyposensitivity to noxious mechanical and 
heat stimulation in vivo and electrophysiological recordings of single nerve fibres showed 
a reduced activity in mechanonociceptors while low-threshold A-fibres activity were 
unaffected (Vastani et al., 2018).  
1.4.2.3 Human immunodeficiency virus (HIV)-induced neuropathy 
Distal symmetric neuropathy (DSP) characterized by axonal degeneration is one of the 
main neurologic complications in individuals living with HIV. HIV patients can experience 
pain that starts in the toes and spreads proximally; the pain frequently is described as 
burning or aching and is worse on the soles. 
HIV acts on sensory neurons in an indirect way by infecting macrophages and glial cells 
(Moss et al., 2015). Gp120 is a glycoprotein expressed on the surface of the HIV envelope. 
Application of culture media from gp120-exposed bone marrow derived macrophages 
induced a significant reduction in DRG neurite outgrowth. In addition, gp120 significantly 
increased the expression of 25 cytokine-related genes in primary bone marrow derived 
macrophages, some of which have been implicated in other painful polyneuropathies. An 
interaction between gp120 and the C-C chemokine receptor type 5 (CCR5) expressed on 
macrophages seemed to exist as inhibition of the CCR5 receptor with a pharmacological 
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antagonist (maraviroc) inhibited gp120-induced tumour necrosis factor-alpha gene 
expression (Moss et al., 2015). Gp120 has been shown to induce peripheral neuropathic 
pain when put in contact with the rat sciatic nerve (Herzberg and Sagen, 2001). Treatment 
of rat sciatic nerve with gp120 induced a persistent mechanical hypersensitivity with a 
decreased intraepidermal nerve fibre density and macrophage infiltration (Wallace et al., 
2007). Keswani et al. designed a model where a transgenic mouse expressing the HIV coat 
protein gp120 under a GFAP promoter is used. Expression of gp120 in these mice is under 
the control of GFAP promoter. As astrocytes and Schwann cells are the main cells 
expressing GFAP, gp120 is thus expressed and released by astrocytes in the CNS and 
Schwann cells in the peripheral nervous system (PNS). The rodents presented peripheral 
neuropathy characterized by distal degeneration of unmyelinated C-fibres (Keswani et al., 
2006).  
1.4.2.4 Chemotherapy induced neuropathic pain 
Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of some 
chemotherapeutic agents. Patients usually present with sensory disturbances, which 
range from mild tingling sensations to spontaneous burning pain and hypersensitivity to 
stimuli (Park, 2014). The pain induced by chemotherapeutic drugs may be severe enough 
for the patients to decline treatment or to limit the therapeutic dose that can be 
administered. The prevalence of CIPN is found to be 68.1% within the first month of 
chemotherapy treatment, 60.0% at 3 months, and 30.0% at 6 months (Seretny et al., 
2014). In the cancer cell, vincristine prevents microtubule aggregation, whereas paclitaxel 
prevents microtubule disaggregation, an effect leading to cancer cell division arrest and 
cell death. Oxaliplatin and cisplatin bind to nuclear DNA (deoxyribonucleic acid) of cancer 
cells, causing disruption of DNA replication and RNA (ribonucleic acid) transcription and 
subsequent arrest of cancer cell division (Starobova and Vetter, 2017). However, the 
mechanisms that lead to the development of neuropathic pain induced by 
chemotherapeutic drugs are unknown. Hence, chemotherapeutic drugs such as 
oxaliplatin, cisplatin, taxanes or vincristine have been used to establish translational 
rodent model of CIPN for mechanistic studies.  
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 Autoimmune pain 
For many years, pain has been broadly categorized into two main classes, neuropathic 
and nociceptive pain (Millan, 1999). However, it is becoming increasingly clear that some 
pain conditions cannot be readily placed in either of these categories (Klein et al., 2012; 
Wigerblad et al., 2016). Pain caused by autoimmune processes has recently attracted 
attention from clinicians and scientists since recent studies have demonstrated that some 
chronic pain conditions such as rheumatoid arthritis and neuromyotonia are associated 
with autoimmunity, but not with classical signs of inflammation or neuropathy (Klein et 
al., 2012; Wigerblad et al., 2016).   
The recent discovery of antibodies directed against citrullinated proteins (ACPA) in 
rheumatoid arthritis (RA) or the identification of autoantibodies targeting voltage-gated 
potassium channel (VGKC) complexes in patient with neuromyotonia lead to the 
emergence of the notion of “autoimmune pain” in the pain field. 
In rheumatoid arthritis (RA) e.g., an absence of discernible nerve injury, persistence of 
pain even when inflammation is well controlled and the chronic nature of the pain in 
certain patients indicated a distinct pathophysiological basis for pain explained by the 
presence of ACPA (Wigerblad et al., 2016).  
Some patients with neuromyotonia experience pain as a clinical feature while others 
experience myotonia or epilepsy. Recent findings identified autoantibodies to leucine rich 
glioma inactivated 1 (LGI1) and contactin‐associated protein‐like 2 (CASPR2), both 
associated with VGKC complexes, in patients with neuromyotonia. Klein et al. showed that 
CASPR2-IgG significantly associates with pain and further in vivo and in vitro studies 
demonstrated the mechanisms of pain induced by LGI1 and CASPR2 autoantibodies 
(Dawes et al., 2018; Watanabe, 2016).  
 
In this section, autoimmune pain and autoimmune conditions associated with chronic 
pain will be introduced together with autoimmune pain animal models and discussion of 
potential mechanisms responsible for pain.  
Several autoimmune diseases are reproducible in rats or mice by human patient 
autoimmune IgG administration, passive transfer, to the animal. Human autoantibodies 
recognize the mouse or rat epitope as a result of the high antigen epitope homology 
between humans and other mammalian species. Thus, the first identification of an 
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autoantibody mediated pathology using this approach, demonstrated that myasthenia 
gravis could be passively transferred from patient to mouse (Toyka et al., 1975). 
1.5.1 Autoantibody mediated pain 
1.5.1.1 Rheumatoid arthritis (RA) 
In rheumatology, assays for the detection of ACPA are commonly used for the diagnosis 
of rheumatoid arthritis (RA) (Aggarwal et al., 2009).  
One of the most dominant symptoms of RA in patients is chronic joint pain. Joint pain 
(arthralgia) regularly develops before the signs of joint inflammation (swelling joints) and 
persists during clinical treatment of RA patients using anti-inflammatory/anti-rheumatic 
drugs (Bos et al., 2010; Steenbergen et al., 2015; Wigerblad et al., 2016). Therefore, it 
seems that these patients have pain that is independent of inflammation.  
 
Wigerblad et al. suggested that ACPA are actually responsible for the induction of pain in 
RA patients (Wigerblad et al., 2016). To determine the role of ACPA in RA, mice were 
injected with human ACPA purified from RA patients, with murinised ACPA or human 
healthy donor antibodies. Both human and murinised ACPA induced long-lasting (28 days) 
pronounced pain, without signs of inflammation, whereas non-ACPA human IgG/control 
monoclonal IgG were without effect.  
In parallel, in vitro mouse osteoclast were cultured and treated with antibodies and the 
supernatant analyzed. ACPA mediated activation of osteoclasts and release of the 
nociceptive chemokine CXCL1. Protein citrullination by peptidylarginine deaminases 
(PADs) is essential for osteoclasts differentiation. Citrullination is a post-translation 
modification that involves the enzymatic conversion (deimination) of protein-contained 
arginine residues. Although citrulline is a common metabolite present throughout the 
human body, it is a non-standard amino acid, which means that it cannot be incorporated 
into proteins during protein synthesis (Vossenaar et al., 2003). Citrulline-containing 
proteins can only be generated through post-translational modification of arginine 
residues, a reaction that is catalysed by peptidylarginine deiminase (PAD) enzymes. The 
loss of a positive charge may cause structural or functional alterations and while the 
modification has been linked to several diseases including RA, its physiological or 
pathophysiological roles remain largely unclear. 
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Activated osteoclasts release the pronociceptive chemokine CXCL1 (mouse analogue of 
the human IL-8) that also promotes osteoclast activation, thereby establishing an 
autocrine positive feedback loop (Krishnamurthy et al., 2016). IL8-dependent osteoclast 
activation may constitute an early event in the initiation of the joint specific inflammation 
in ACPA-positive patients via enhanced osteoclast activity, but IL-8 also produces pain and 
hypersensitivity by acting directly on nociceptors (Krishnamurthy et al., 2016; Wigerblad 
et al., 2016). RA inflammation-independent pain is initiated by ACPA before the disease 
onset and is later followed by joint/bone destruction (Krishnamurthy et al., 2016). 
1.5.1.2 Neuromyotonia 
Patients with neuromyotonia present with clinical and electrophysiological evidence of 
excessive motor unit activity due to enhanced motor axon excitability which causes 
spontaneous muscle activity. A proportion of patients with neuromyotonia also present 
with the pathophysiological symptoms of Morvan’s syndrome, insomnia, epilepsy, 
myotonia and pain. The pathology is produced by autoantibodies that bind to VGKC or to 
associated protein that directly complex with shaker-related, voltage gated potassium 
channels (KV1) themselves, i.e. LGI1 or CASPR2 (Irani et al., 2010; Klein et al., 2012; 
Watanabe, 2016). A common feature described in patients seropositive for anti-CASPR2 
antibodies is the presence of pain. CASPR2 is required for trafficking or membrane 
insertion of fast potassium channels (KV1). Dawes et al. showed that immune or genetic 
mediated ablation of CASPR2 induces and enhances pain behavior in mice as well as 
excitability of DRG neurons through regulation of KV1 channel expression at the cell 
membrane (Dawes et al., 2018). Thus, autoantibody mediated internalization of CASPR2 
is thought to lead to hyperexcitability. Patient anti-CASPR2 autoantibodies bind in vivo 
but do not cause overt inflammation or substantial damage to the nervous system. In 
summary, anti-CASPR2 antibodies produce pain without inducing any inflammation or 
nerve damage, a novel pathophysiological mechanism responsible for pain. 
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 Introduction to Complex Regional Pain Syndrome (CRPS) 
1.6.1 CRPS – A historical view  
Complex Regional Pain Syndrome (CRPS) is a painful condition characterized by limb-
confined sensory, autonomic, motor and trophic impairment that develops after a 
traumatic event i.e. bone fracture (Goebel, 2011; Marinus et al., 2011). The hallmark of 
CRPS is regional pain, which is disproportionate to the expected clinical course of the 
original trauma or lesion (Harden et al., 2007). 
 
Alexander Denmark, a British surgeon was the first physician to describe CRPS by 
publishing a case report of a soldier wounded by a bullet in his upper arm during the siege 
of Badajoz in 1812. Denmark reports that “the wound soon healed” but also writes: “I 
always found him with the forearm bent and in supine position and supported by the firm 
grasp of the other hand” (Denmark, 1813). 
He describes in detail his observations and the type of pain the patient experiences, which 
is reported as: “It was a burning nature, […], and so violent as to cause a continual 
perspiration from his face”. 
 
A few decades later, during the American Civil War, Silas Weir Mitchell reports many other 
cases of gunshot wounds and limb nerve injuries. In 1864, George Morehouse, William 
Keen, and Weir Mitchell, wrote and published “Gunshot Wounds and Other Injuries”. The 
authors describe the signs and symptoms of causalgia (CRPS) in great detail (Mitchell et 
al., 1982). The symptoms observed in the patients led Mitchell to coin the term causalgia 
from the Greek, “Kausos” (heat) and “algos” (pain). Many individual cases were reported. 
One example is the case of a 27 year old soldier shot in his left arm. Two years after his 
injury, the wound had healed completely, but Mitchell reported that skin of the palm was 
eczematous, thin, red, and shining. The second and third phalanges of the fingers were 
flexed and stiff; whereas the first was extended. The finger nails on the hand of the 
affected arm were extraordinarily curved, laterally and longitudinally, except that of the 
thumb. Pain was still present in the median distribution, but much less prominent than in 
the ulnar tract, where it was extreme. The pain is a “burning” type of pain and can be 
described as the symptoms of what is today called CRPS (Mitchell et al., 1982).  
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Later, other clinicians such as Paul Sudeck, Rene Leriche and James A. Evans studied CRPS 
and contributed to its definition based on clinical signs and symptoms (Sudeck, 1900; 
Leriche, 1916; Evans, 1946). Evans coined the term “reflex sympathetic dystrophy (RSD)”, 
which has been the most common name to describe this medical condition during the 
late 20th century before the term was replaced by CRPS. 
 
In 1994, IASP consensus conference agreed to abandon several widely used names for the 
condition in favour of CRPS (Harden et al., 2010). Previously, CRPS was referred to as RSD, 
Sudeck's atrophy, algodystrophy, algoneurodystrophy, causalgia, shoulder-hand 
syndrome and Steinbrocker syndrome (terminology used in the 50s) (Iolascon et al., 
2015).  
 
The term RSD was considered problematic as it refers to a “reflex” impairment, which if 
involved is complicated and not fully characterized.  
The assumed “sympathetic”/autonomic changes may not be causative pain component 
and may not be physiologically involved throughout the entire course of the condition in 
every patient. Finally, the actual “dystrophy” is only present in 15% of cases (Harden et 
al., 2013).  
1.6.2 CRPS today 
1.6.2.1 Diagnostic criteria 
The pathophysiological mechanisms responsible for CRPS, and other pain syndromes, are 
not fully understood. The diagnosis of CRPS is based purely on clinical signs and 
symptoms. In 1994, IASP produced consensual agreement on the first diagnostic criteria 
of CRPS.  
CRPS is subdivided into two types, CRPS I and CRPS II. CRPS II is associated with nerve 
injury while patients with CRPS I do not exhibit demonstrable nerve lesions (Table 1-1) 
and both present similar diagnostic features. Sensory profiles suggest that CRPS I and 
CRPS II may represent one disease continuum with comparable underlying mechanisms 
(Gierthmühlen et al., 2012).   
Although, CRPS I excludes neuropathic mechanisms, Oaklander et al. tested the 
hypothesis that CRPS I was associated with distal degeneration of small-diameter axons. 
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18 adults with IASP-defined CRPS I were studied for quantitative sensory testing (QST) and 
quantification of epidermal neurite densities in skin biopsies from affected ipsilateral and 
contralateral limbs. Axonal densities were diminished at the CRPS-affected sites of 17/18 
subjects, on average by 29% (p<0.001) (Oaklander et al., 2006).  
 
 
Table 1-1 IASP CRPS Diagnostic Criteria 
 
CRPS I CRPS II 
With 2,3, and 4 being mandatory: 
1. The presence of an initiating 
noxious event, or a cause of 
immobilization. 
2. Persistent pain, allodynia, or 
hyperalgesia, which is 
disproportionate to the initial 
event. 
3. Evidence at some time of 
oedema, changes in skin blood 
flow, or abnormal sudomotor 
activity in the region of the 
pain. 
4. This diagnosis is excluded by 
the existence of conditions that 
would otherwise account for 
the degree of pain and 
dysfunction. 
All of the following: 
1. The presence of continuing pain, 
allodynia, or hyperalgesia after a 
nerve injury, not necessarily limited 
to the distribution of the injured 
nerve. 
2. Evidence at some time of oedema, 
changes in skin blood flow, or 
abnormal sudomotor activity in the 
region of the pain. 
3. This diagnosis is excluded by the 
existence of conditions that would 
otherwise account for the degree of 
pain and dysfunction. 
 
The terminology “warm” and “cold” CRPS are also used in clinics and refer to CRPS based 
on symptoms, i.e. skin temperature difference between the affected and unaffected limb 
(Bruehl et al., 2016). To classify patients into presumed warm and cold subtypes, clinicians 
only use temperature asymmetry in the limbs. Bruehl et al. studied patients with warm 
and cold CRPS in order to confirm the existence of these two CRPS subtypes and suggested 
unbiased statistical evidence in a large clinical sample for warm CRPS and cold CRPS 
subtypes (Bruehl et al., 2016). The results indicated that skin color, skin temperature, and 
edema indicated a much greater role for inflammatory mechanisms in warm CRPS. 
Overall, inflammatory characteristics were significantly elevated in the warm CRPS 
subtype only at initial assessment within approximately 5 months of CRPS onset, 
diminishing significantly over the subsequent 3 months to levels statistically 
indistinguishable from cold CRPS (Bruehl et al., 2016; Harden et al., 2010). In addition, it 
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seemed that the median pain duration was significantly (p<0.001) shorter in the warm 
CRPS (4.7 months) than in the cold CRPS subtype (20 months), with no difference in the 
pain intensity (Bruehl et al., 2016).  
Although the 1994 IASP diagnostic criteria improved the diagnosis of CRPS, they were 
extremely sensitive and lacked specificity, which was potentially leading to over-diagnosis 
(Harden et al., 2010). Hence non-CRPS neuropathic conditions were in some cases 
identified as CRPS. Therefore, another IASP consensus meeting was held in Budapest in 
2003 in order to discuss the existing issues and improve the IASP CRPS Diagnostic Criteria. 
The resulting improved diagnostic consensus criteria were adopted and referred to as the 
“Budapest Criteria” (Table 1-2) and are those currently used clinically. The Budapest 
Criteria improved diagnostic consistency between clinicians and resulted in higher 
specificity (less frequent misdiagnosis of CRPS) (Bruehl et al., 2016).  
 
Table 1-2 Current IASP clinical diagnostic criteria for CRPS also called “Budapest Criteria” 
 
1) Continuing pain, which is disproportionate to any inciting event. 
2) Must report at least one symptom in three of the four following categories: 
• Sensory: Reports of hyperalgesia and/or allodynia. 
• Vasomotor: Reports of temperature asymmetry and/or skin color changes 
and/or skin color asymmetry. 
• Sudomotor/Edema: Reports of edema and/or sweating changes and/or 
sweating asymmetry. 
• Motor/Trophic: Reports of decreased range of motion and/or motor 
dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nails, 
skin). 
3) Must display at least one sign* at time of evaluation in two or more of the following 
categories: 
• Sensory: Evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch 
and/or deep somatic pressure and/or joint movement). 
• Vasomotor: Evidence of temperature asymmetry and/or skin color changes 
and/or asymmetry. 
• Sudomotor/Edema: Evidence of edema and/or sweating changes and/or 
sweating asymmetry. 
• Motor/Trophic: Evidence of decreased range of motion and/or motor 
dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nails, 
skin). 
4) There is no other diagnosis that better explains the signs and symptoms. 
 *A sign is counted only if it is observed at time of diagnosis. 
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1.6.2.2 Sensory abnormalities in CRPS  
Quantitative sensory testing (QST) is a non-invasive method to assess and quantify 
sensory nerve function. It is used by clinicians for diagnosing peripheral nervous system 
disorders such as neuropathies and other chronic pain conditions and provides important 
clinical measures for translational mechanistic studies. This technique determines the 
perception threshold of light touch or pressure, vibration, cold and warm temperatures 
and pain (Siao and Cros, 2003). The German Research Network on Neuropathic Pain 
(DFNS) has developed a standardized QST battery that investigates different aspects of 
sensory afferent nerve fibre function. Gierthmühlen et al. conducted a study according to 
the DFNS protocol to determine the patterns of sensory signs in CRPS using QST. 
Quantitative sensory testing of CRPS patients, has identified a markedly increased 
sensitivity to noxious mechanical pressure in combination with an increased sensitivity to 
noxious cold and heat (Gierthmühlen et al., 2012). In another QST study, acute CRPS I 
patients presented warm and cold hyperalgesia with significant change in heat and cold, 
pain and detection, thresholds. Patients with chronic CRPS showed deteriorated cold and 
heat detection thresholds (Huge et al., 2008). An observational cross-sectional 
multicentre study, the Pain in Neuropathy Study (PiNS) aimed for the neurological 
examination, QST, nerve conduction studies, and skin biopsy for intraepidermal nerve 
fibre density assessment of 191 patients with diabetic neuropathic pain (Themistocleous 
et al., 2016). Also, it seems that the sensory phenotype of patient with diabetic peripheral 
neuropathy is characterised by hyposensitivity to applied stimuli that is more marked in 
the moderate/severe neuropathic pain group than in the mild neuropathic or no 
neuropathic pain groups. Loss of sensitivity in CRPS is a symptom shared with small-fibre 
neuropathies (Themistocleous et al., 2016). 
1.6.2.3 Acute versus chronic CRPS 
In most cases, CRPS is triggered by a limb injury such as fracture or surgery (Goh et al., 
2017). The injury or trauma leads to inflammation, which is part of the expected 
physiological response. In CRPS, an exaggerated inflammation induces a persistent 
oedema, vasodilation and temperature changes in the affected limb. The evolution of the 
clinical signs over time defines the chronic or acute nature of CRPS. Indeed, in most of the 
patients the clinical signs as well as the pain resolve within 6 to 13 months of onset (Bean 
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et al., 2014; Grieve et al., 2017). However, in a subset of CRPS patients (15-20%), patients 
fail to recover, and individuals will develop a long-term disability, negatively affecting 
their quality of life. It is referred as chronic or long-standing CRPS. In this case, the 
sudomotor and vasomotor symptoms associated with CRPS such as oedema and 
vasodilatations typically resolve, whereas the pain remains persistent and becomes 
chronic (Grieve et al., 2017). The reasons why CRPS manifests as an acute or chronic 
condition are not understood. The lack of clear evidence of tissue damage causing the 
activation of peripheral nociceptors or evidence for disease or lesion of the 
somatosensory system causing the pain in chronic CRPS I suggest that chronic CRPS I pain 
can be described as nociplastic pain (IASP). 
1.6.2.4 Epidemiology 
Epidemiological studies about the incidence of CRPS in the general populations are 
limited. An American population-based study quantified the prevalence of CRPS I in the 
Olmsted County, Minnesota using IASP criteria for diagnosing CRPS. The incidence was 
rated as 5.46 per 100,000 people. Females were affected four times more than males, 
with a median age of 46 years at onset (Sandroni et al., 2003).  
A European epidemiological study conducted in the Netherlands, indicated that the 
incidence of CRPS was 26 for 100,000 people. Females seemed to be affected at least 
three times more often than males (ratio: 3.4:1) (de Mos et al., 2007). 
In both American and European studies, females were more affected and 
postmenopausal woman appeared to have higher risks of developing CRPS. In addition, 
both studies showed that upper limbs were affected more frequently than lower limbs, 
and limb fracture was the most common triggering event (de Mos et al., 2007; Sandroni 
et al., 2003). 
1.6.2.5 Treatments  
The pharmacological approach used to treat CRPS patients is mainly symptomatic, 
including analgesics such as ketamine (Russo and Santarelli, 2016; Sheehy et al., 2015), 
glucocorticoids (Atalay et al., 2014; Munts et al., 2010) and bisphosphonates but there is 
not sufficient evidence to recommend their use in practice (Brunner et al., 2009). Non-
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steroidal anti-inflammatory drugs (NSAIDs), showed no value in treating patients with 
CRPS (Breuer et al., 2014). 
Physical therapy is also employed in preventing atrophy and contractures in order to 
reduce the need for analgesic therapy and to facilitate rehabilitation. Hydrotherapy pools 
seem to have a positive pain relief effect on CRPS patients (Schencking et al., 2009). Case 
reports of more invasive approaches include stimulation of the spinal cord (Crapanzano 
et al., 2017; Herschkowitz and Kubias, 2018) and insertion of peripheral nerve catheters 
with anaesthetics such as ketamine (Zhao et al., 2018). In the most severe cases and 
mostly on patient demand, as no treatment is efficient for pain relief, limb amputations 
are performed to improve patient function (Kashy et al., 2015). However, a systematic 
review conducted by Bodde et al. about amputation in CRPS I patients highlighted that 
studies did not clearly delineate the beneficial and adverse effects of an amputation 
(Bodde et al., 2011).  
Clinical outcomes are very heterogeneous and pharmacological treatments do not 
provide satisfactory relief for most patients, making CRPS pain a particularly challenging 
pain condition to manage clinically (Resmini et al., 2015). There is a critical lack of high-
quality evidence for the effectiveness of most therapies for CRPS. A study conducted on 
a population of well-established chronic CRPS patients suggested low resolution rates 
even with specialty pain care (Schwartzman RJ et al., 2009). In one large (n=102) 
retrospective longitudinal study of patients over an average six-year follow-up period, 
30% of patients reported resolution of chronic CRPS, 16% reported progressive 
deterioration, and the remaining 54% reported stable symptoms (De Mos M et al. 2009). 
1.6.2.6 CRPS an autoimmune pain condition? 
Plasma exchange (PE) therapy of CRPS patients 
 
Plasma exchange (PE) therapy (Figure 1–7) or plasmapheresis was first explored in CRPS 
patients in a retrospective study (Aradillas et al., 2015) and in a series of case reports 
(Goebel et al., 2014). Interestingly, 30 of the 33 patients demonstrated significant 
(p<0.01) median pain reduction of 64% following the initial series of PE. The success of PE 
on long standing chronic CRPS patients hints at a humoral component inducing pain in 
those patients. 
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The origin of CRPS is unknown but previous studies suggested an autoimmune 
contribution to its development. Goebel et al. hypothesised that some CRPS cases may 
have a post infectious and/or autoimmune basis (Goebel et al., 2005).  
 
Figure 1–7 Plasma exchange therapy.  
A patient blood is extracted from one arm using a blood pump and mixed with 
anticoagulant. The plasma separator separates the plasma from the whole blood. In one 
hand the plasma is pumped out (plasma pump) and on the other hand, it is replaced with 
a substitution fluid (i.e. saline solution or isotonic human albumin solution) before being 
returned to the patient. The waste contains the plasma proteins such as albumin, 
immunoglobulin, enzymes, ions, etc).  
 
 
Earlier animal studies of CRPS were based on tibial fracture of rat limb (Guo et al., 2004; 
Wei et al., 2016a). The fracture and immobilization of the injured paw induces phenotype 
changes such as hind paw allodynia, warmth, oedema, which were associated with 
expression changes in neuropeptide signalling molecule substance P (SP), SP receptor, 
inflammatory mediators TNFα, IL-1β, IL-6 and nerve growth factor (NGF) within the first 4 
weeks following the injury in hindpaw skin.  
Using the fracture/cast CRPS model, Guo et al. suggested that serum antibodies from 
fracture mice can induce regionally restricted pain behaviours in B-cell deficient fracture 
mice. Serum IgM antibodies from wild type (WT) fracture mice had pro nociceptive effects 
in the fractured limb when injected into B-cells and antibodies lacking µMT fracture mice 
(Guo et al., 2017). 
This model does not use any CRPS patient IgG and focuses on rat IgM antibodies. 
Therefore, the fracture/cast model lacks the translational value that present model of 
human IgG transfer.  
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Finally, Tékus et al. showed that some symptoms of CRPS such as mechanical 
hypersensitivity, swelling and redness on the injured limb area observed in CRPS patients 
could be passively transferred to mice (Tékus et al., 2014). However, sensitivity to noxious 
heat and cold were not different between CRPS and control groups. In their study, Tékus 
et al. purified IgGs from plasma obtained after plasma exchange of a CRPS patient (Figure 
1–7). The rest of the plasma which contained other immunoglobulins (IgA, IgM and IgE) 
and plasma proteins, but not IgG, did not induce hypersensitivity in mice (Tékus et al., 
2014). Only IgG produced a detectable pain in the mice. 
 
Intravenous immunoglobulin (IVIG) treatment  
 
IVIG treatment involves administration of a highly purified globulin preparation obtained 
from the pooled plasma of thousands of healthy donors. Although initially given as 
replacement therapy for patients with primary and secondary immunodeficiency states, 
IVIG has proven to be effective in the treatment of various autoimmune and inflammatory 
disorders (Dalakas, 2004; Lünemann et al., 2016; Sherer et al., 2002; Zuercher et al., 2016). 
Several hypotheses have been proposed to explain the underlying biological mechanism 
of the treatment.  
 
Preliminary works suggested that low-dose IVIG treatment to CRPS patients ameliorates 
their condition. Indeed, a study conducted in a small group of 12 patients sample showed 
that the average pain intensity was 1.55 units lower (95% CI, 1.29 to 1.82; P < 0.001) after 
IVIG treatment than after saline. In 3 patients, pain intensity after IVIG was less than after 
saline by 50% or more (Goebel et al., 2002, 2010).  
 
Fc region neutralization of the autoantibodies by the variable region of the injected IgGs 
is one possible explanation for this phenomenon (Figure 1–8). The Fc region can trigger 
inflammation via binding the Fc receptor on immune cells (Fridman, 1991), leading to 
sensitization/activation of intact nociceptors by inflammatory mediators (Ren and 
Dubner, 2010).  
IVIG has been shown to be effective in various autoimmune diseases such as in Guillain-
Barre polyneuropathy, an autoimmune disease where the myelin sheath that surrounds 
the axons is degraded (Arnson et al., 2009; Kaveri et al., 1991). 
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A more recent randomised placebo-controlled Phase III multicentre trial, in which patients 
with long-standing complex regional pain syndrome (the LIPS trial) received IVIG 
treatment, demonstrated that the therapy was not effective in relieving pain in patients 
with moderate to severe CRPS of 1–5 years’ duration (Goebel et al., 2017). 
 
The lack of efficacy of IVIG treatment in long-standing CRPS patients might suggest that 
the mechanism of action of CRPS autoantibody is Fc region independent. The reason that 
CRPS autoantibodies may act without causing tissue destruction is not known, but it is 
possible that they cause internalisation of target proteins, as is thought to be the case for 
CASPR2 antibodies (Dawes et al., 2018).  
 
         
Figure 1–8 Structure of immunoglobulin G (IgG) and mode of action of the IVIG. 
(A) Schematic representation of an IgG. The IgG has a non-variable region, which is the Fc 
region. The Fc region binds to its receptor once an immune-complex (IgG-antigen complex) 
is formed to initiate innate immune reaction. Fc receptors are expressed on the surface of 
immune cells, including mast cells, neutrophils and macrophages. (B) Patient IgG 
neutralisation at its Fc region by the IVIG. 
 
The specificity of pathological autoantibodies in CRPS has not yet been determined and 
the molecular targets for CRPS autoantibodies remain unknown. However, some previous 
work suggested neural surface marker specificity of the CRPS autoantigens (Kohr et al., 
2009) whereas a more recent study suggests the presence of activating autoantibodies 
against alpha1a adrenoceptors in longstanding CRPS patients (Dubuis et al., 2014). 
Nevertheless, both studies have been conducted either in in vitro cultured 
cardiomyocytes or in SH-SY5Y cells, which restrict the epitopes only to the one present on 
these cells. A more rigorous, unbiased method may be required for an accurate 
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identification of the possible epitopes recognized by the CRPS patients IgG. Indeed, 
identification of the autoantibodies responsible for the pathology would allow better 
informed, more refined strategies to be employed in the study of CRPS and would 
facilitate identification of new therapies. 
 Aims and objectives 
Despite the highly debilitating nature of CRPS, this pathology remains an enigmatic pain 
disorder with unknown neuropathophysiological mechanisms. The aim of the study was 
to identify the neurophysiological mechanisms of CRPS pain using a translational mouse 
model of CRPS.  
The first goal of this study was to establish a translational and relevant mouse model of 
CRPS. In order to do that, CRPS-IgG was transferred to a paw skin-muscle incision trauma 
mouse model (Brennan, 1999; Tékus et al., 2014). CRPS-IgG injected and control mice 
were studied for their behavioural response to various modalities (Chapter 3). We 
hypothesised that CRPS-IgG transfer from CRPS patient to mouse would induce 
sensitization of the mouse to noxious stimuli. 
Following the in vivo studies and validation of the model, the in vitro skin-saphenous 
nerve recording technique was used to determine the origin of CRPS pain at the nerve 
level. Single-unit nerve fibre properties were studied in order to identify 
neurophysiological abnormalities responsible for, or caused by, CRPS (Chapters 4 & 5). 
We hypothesised that CRPS-IgG would affect the properties of at least one class of 
nociceptor fibre. 
In addition, to determine whether IgG act by directly affecting the excitability of sensory 
















Experiments were performed on female C57Bl/6J mice (8-10 weeks old). Most of the 
experiments conducted in our laboratory and in the field are done on C57Bl/6J young 
adult (8-10 weeks old) mice. IgG donor patients (section 2.2) were mainly females we 
therefore used female mice. Mice were obtained from Envigo UK Ltd., Bicester, UK, and 
were housed in a temperature-controlled environment on a 12h light/dark cycle with 
access to food and water ad libitum. Behavioral experiments were carried out according 
to the U.K. Home Office Animal Procedures (1986) Act. All procedures were approved by 
the King’s College London Animal Welfare and Ethical Review Body and were conducted 
under the U.K. Home Office Project License PPL 70/7510. Before any nociceptive testing, 
mice were kept in their holding cages to acclimatize (10-15 min) to the experimental 
room.  Mice were randomized between cages and the experimenter blinded to their 
treatment. No animals have been excluded from analysis. n=6/group was used after an a 
priori sample size calculation. Behavioral studies described in section 2.4 (except for 2.4.3) 
were conducted by Clive Gentry.  
 Research subjects 
The main immunoglobulin donor was a 40 year old female who had CRPS of 9 years’ 
duration in a lower limb and a high average pain (9-10/10 on a 11-point numeric rating 
scale (NRS) with 10=the worst pain imaginable) and had been offered clinical plasma 
exchange treatment on compassionate grounds. She had signs in all four Budapest 
diagnostic categories (Harden et al., 2010) and alternative causes for her pain had been 
excluded by a pain specialist, a consultant rheumatologist and a consultant neurologist.  
This patient clinically exhibited strong pain to mild pressure over the painful area 
(mechanical hyperalgesia, the most common sensory abnormality in persistent CRPS 
(Huge et al., 2008; Gierthmühlen et al., 2012), whereas she had little or no pain to light 
touch; she reported that ambient temperatures below room temperature and also 
temperatures above approximately 24°C would increase her pain. Waste plasma from the 
first exchange treatment was secured with her consent and was stored frozen – the local 
Ethics committee confirmed that the use of human waste tissue did not require ethical 
permission (15/NW/0467, North West – Haydock Research Ethics Committee (see 
Appendices)). She received three plasma exchange treatments over 5 days through a 
central venous line, but unfortunately then developed line-related complications and 
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treatment was stopped. She reported no pain relief following this treatment; in line with 
earlier observations indicating that 7-8 exchange treatments over 3 weeks may be 
required before meaningful pain relief occurs in this condition (Aradillas et al., 2015; 
Goebel et al., 2014; Schwartz et al., 2016).  
 
For experiments on pooled IgG, serum samples were randomly selected, stratified 
according to either moderate (NRS 5-7) or high (NRS 7.5-9) baseline pain intensity, from 
frozen samples (-80C) available from participants in the recently-completed LIPS-trial 
(Goebel et al., 2014). A research technician (Serena Sensi) used an anonymized list of all 
patients’ sera (n=111), created by the trial statistician. The LIPS study-inclusion criteria 
were patients with persistent CRPS of between 1 and 5 years’ duration fulfilling 
international research criteria for the diagnosis of CRPS, who had an average pain 
intensity at baseline of at least 5/10. Ethical permission and individual consent for the use 
of these sera for the purpose of autoantibody research is available (12/EE/0164, East of 
England (see Appendices)). 
 
Serum does not contain human cells and is therefore not considered as “relevant 
material”, as defined by the Human Tissue Act (2004). 
 IgG purification 
Purified IgG were provided by Andreas Goebel (Liverpool, UK). As previously described  
(Tékus et al., 2014), IgG fractions were prepared using protein G beads (Sigma-Aldrich, 
Gillingham, UK). Briefly, serum was diluted 1:3 with phosphate-buffered saline (PBS), 
passed through a protein G column, and the non-bound fraction (‘flow-through’) was 
collected and retained. The bound IgG was eluted using 100 mM glycine pH 2.3, the pH 
was adjusted to 7.4 using Tris pH 8 and then dialysed overnight at 4°C in PBS using a 10 
kDa dialysis membrane (Fisher Scientific, Loughborough, UK). The concentration of IgG 
present after dialysis was determined using a modified Lowry assay (DC protein assay, 
BioRad, Hemel Hempstead, UK) and adjusted to 8–9 mg/mL, either by dilution with PBS 
or by further dialysis against a sucrose solution (Sigma-Aldrich). The purified IgG was 
sterile filtered using syringe-driven 0.2M filter units (Millipore, Watford, UK), stored at 
4°C and used within 3 months.  
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 Mouse injection and incision  
Mice were injected intraperitoneally with 0.8-16mg of IgG from healthy control subjects 
or CRPS patients on 4 consecutive days at day -1 (1 day before the incision), day 0 (the 
day of incision) and on day 1 and 2.  
Using aseptic techniques, a midline incision 0.5cm long is made through the plantar skin 
fascia starting 0.2cm from the heel and extending towards the toes. The underlying 
plantar muscle is elevated with curved forceps, leaving the muscle origin and insertion 
intact and incised longitudinally. The skin incision is then closed using sutures and the 
animals housed on paper bedding for the first 3 days post-surgery.  
 Behavioural studies  
2.5.1 Cold and heat sensitivity 
Before any nociceptive testing, the mice were kept in their holding cages to acclimatize 
(10-15 min) to the experimental room. Thermal sensitivity was assessed using a 
commercially available hot- and cold-plate (Ugo Basile, Milan). Paw withdrawal latencies 
were determined with the plate set at a chosen temperature (50°C for hot-plate and 10°C 
for cold-plate tests). The animals were lightly restrained and each hind paw in turn was 
placed onto the surface of the plate. The end point was taken as the withdrawal of the 
paw and recorded as the withdrawal latency for the ipsilateral and the contralateral paw. 
A maximum cut-off of 30 seconds was used for each paw. 
2.5.2 Mechanical sensitivity  
2.5.2.1 von Frey 
Tactile allodynia was assessed by measuring withdrawal thresholds to calibrated von Frey 
hairs (0.008–2g). Animals were placed into a Perspex chamber with a metal grid floor, 
giving access to the underside of their paws and allowed to acclimatize before the start 
of the experiment. von Frey hairs were applied perpendicular to the mid plantar surface 
of the hind paw with sufficient force to cause slight bending against the paw and held for 
a few seconds. This was repeated 5 times at intervals of 1–2s. A positive response was 
noted if the paw was sharply withdrawn or there was flinching upon removal of the hair. 
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If no response was noted a higher force hair was tested and the filament producing a 
positive response recorded as the threshold. 
2.5.2.2 Randall-Selitto/paw pressure 
Paw withdrawal thresholds (PWT) were determined in the hind paws of both ipsilateral 
and contralateral hind limbs using the Randall-Selitto paw pressure technique (Randall 
and Selitto 1957).  The analgesymeter (Ugo Basile, Italy) employs a conical shaped probe. 
Cut-off was set at 150 grams and the end point is taken as withdrawal of the hind paw. 
Data are expressed as withdrawal thresholds in grams. 
2.5.3 Advanced Dynamic Weight Bearing (ADWB) 
The distribution of body weight between the paws was monitored using the ADWB 
instrument designed by Bioseb (Vitrolles, France). The test allows the evaluation of the 
behavioural impact of CRPS-IgG on freely behaving animals. The instrument consists in a 
box with an embedded matrix at the bottom that comprises 2000 high precision force 
sensors  and a camera at the top. To acquire data, the mouse is put in the box where the 
animal is free to move as it pleases. The force sensors measure the weight distribution on 
each of the four paws of the animal in grams. The animal is filmed from above using a 
camera. The video feed is analyzed in real-time later thanks to a tracking software 
allowing a precise analysis of the animal's posture. The weight the mice put on their hind 
paws was expressed as weight ratio (ipsilateral/contralateral).  
 Assessment of post-surgical-recovery  
Photos were taken of the injured ipsilateral hind paw from CRPS-IgG injected (n=5) and 
incision-only (n=7) mice after behavioural reading (paw pressure test on ipsilateral and 
contralateral paws), using a camera. Mice were scored blindly by seven individuals for the 
healing level of the paw around the incision level. Participants were asked to use the 
following codes. 0: looks normal (the incision has healed, no redness), 1: can see the 
incision, not fully healed, 2: redness associated with a bad healing.  
The scores and the difference in the paw pressure reading (contralateral-ipsilateral) were 
correlated using a linear correlation function.  
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 Skin-nerve recording 
The mammalian skin nerve preparation was developed by Peter Reeh in the 1980’s (Reeh, 
1986) and later adapted for mice (Koltzenburg et al., 1997). In comparison to other widely 
used techniques, such as recording from single units in vivo or human microneurography, 
the technique allows experimental control over the external variables which could 
interfere with the physiology of the receptors. Using the in vitro skin nerve preparation 
allows the receptive fields of individual units to be directly stimulated by electrical, 
mechanical, thermal and chemical stimuli in a non-invasive, controlled manner. In 
addition to this, there are no obvious time related changes in respect to excitability and 
spontaneous activity and the preparation can be used for recordings up to 8 hours from 
the time of dissection. Many fibres are spontaneously active immediately after the 
dissection and therefore the preparation should be left in the organ bath for at least one 
hour before carrying out recordings, by which time no spontaneous activity remains. 
2.7.1 Skin-Saphenous nerve dissection 
Mice were sacrificed by cervical dislocation. The hind paw was shaved prior to dissection. 
The saphenous nerve and the shaved skin of the hind limb were placed in a recording 
chamber at 32°C. The chamber was perfused with a gassed (95% O2 and 5% CO2) 
prewarmed synthetic interstitial fluid (SIF buffer): 108mM NaCl, 3.5mM KCl, 0.7mM 
MgSO4.7H2O, 26.2mM NaCO3, 1.65mM NaH2PO4.2H2O, 1.53mM CaCl2, 9.6mM sodium 
gluconate, 5.55mM glucose and 7.6mM sucrose. The skin was placed inside up (corium 
side up) and pinned down using insect pins (0.2 mm diameter) in the organ bath to allow 
access to the receptive fields. The saphenous nerve was placed from the organ bath 
through a small gap to an adjacent recording chamber on a mirror platform. Desheathed 
and filamented saphenous nerve was covered with paraffin oil for electrical isolation and 





Figure 2–1 Experimental set-up. 
The skin-saphenous nerve preparation is pinned down in a bath circulated with gassed and warmed 
SIF. The nerve is passed through a little gap to an adjacent chamber where oil isolates the nerve from 
the SIF. Modified from Zimmerman et al. (2009). 
2.7.2 Determining conduction velocity of individual fibres 
Mechanically sensitive units were characterized by their conduction velocity, calculated 
by dividing the conduction distance over the electrical latency for the spike (Figure 2–2). 
According to the conduction velocity obtained from the recording, the fibre was identified 
as an Aβ (velocity>10m/s), an Aδ (1.2<velocity<10m/s) or a C-fibre (0<velocity<1.2m/s).  
Electrical latency for each single-fibre was obtained using a stimulator microelectrode 
placed perpendicularly onto the most sensitive spot of the receptive field. Once in contact 
with the receptive field of the fibre, a constant current stimulator (Digitimer DS2) 
delivered a square-wave electrical pulse of 1ms duration, every 2 or 4 seconds (depending 





Figure 2–2 Electrical stimulation of fibre.  
The fibre receives an electrical stimulus before to generate action potential. The response time is 
defined as latency and measured in millisecond (ms). 
2.7.3 Mechanical stimulation 
The stimulating probe, equipped with a force transducer, was placed onto the most 
sensitive spot within the receptive field. The stimulator was controlled by Spike2 program 
from Cambridge Electronic Design (CED), the force was entered in mV in Spike2, which 
was automatically delivered by the stimulator. Stimulus response function for the fibre 
was obtained by following a mechanical stimulation protocol. 
2.7.3.1 Mechanical threshold 
The mechanical threshold for each unit was determined by applying a 2s mechanical 
stimulation with a step waveform onto the most sensitive spot of the receptive field. 
Increasing and decreasing levels of force (g) were applied iteratively until the mechanical 
threshold could be identified. The threshold was determined as that force required to 
evoke at least two action potentials.  
2.7.3.2 Step protocol 
A 10s long mechanical stimulation comprised between 0 and 20g of amplitude was 
applied in order to characterize more precisely the type of fibre according to the 
adaptation property stimulation response shape. Increasing force levels of 0.5g, 1g, 2g, 
4g, 5g, 10g, 15g and 20g were applied with a 2 minute gap before each new step to let 
the fibre recover with minimal tachyphylaxis. Forces between 0.5g-20g cover a range of 
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forces that are innocuous and noxious, i.e. forces capable of stimulating low threshold 
mechanoreceptors (LTMRs) and high threshold mechanoreceptors (HTMRs).  
2.7.3.3 Ramp protocol 
Unlike LTMRs, AM- (A-) and CM-HTMRs fibres encode the applied force with a linear 
increase in the evoked impulse rate. Therefore, ramp stimuli were also applied on AM and 
CM fibres after the series of step stimuli. 0.5g, 1g, 2g, 4g, 5g, 10g, 15g and 20g ramps of 
15s were applied. The number of action potentials and the temporal profile were analysed 
in order to characterize the fibre adaptation and discharge properties to increasing force 
stimulus.  
All the recordings and analysis were performed using the Spike2 CED. 
2.7.4 Data acquisition  
Action potentials were recorded using a WPI (World Precision Instrument) low-noise head 
stage DAM80 AC differential amplifier with a ground connection which amplified the 
signal (gain of 104). The signal was filtered with a low pass (300Hz) and a high pass (10kHz) 
filter. The differential amplifier was connected to a CED 1401 data acquisition board. The 
output of the signal was visualised on an oscilloscope, recorded on a PC and made audible 
via a speaker. All recordings were performed using the Spike2 software from Cambridge 
Electronic Design. 
2.7.5 Data analysis  
Raw data were analysed using Spike2, which was also used during the data acquisition 
phase. A template was defined manually by choosing one single spike among all the 
recorded spikes. The entire recording was scanned with the template to identify and 
select matching waveforms.  The identified waveforms were displayed simultaneously in 
a separate event-viewer window (Figure 2–3). To finish, results were displayed in in a 




Figure 2–3 Template settings. 
A spike is defined as a template and helps spikes discrimination.  
 
To determine and visualise discharge rates, the channel was duplicated, and the channel 
draw mode was changed for number of event/second (Hertz) to visualize discharge rates 
as histogram (Figure 2–4). 
 
Figure 2–4 Force steps and responses. 
In green are the fibre responses to the applied forces, shown as action potentials. In blue are the spikes 
corresponding to the action potentials matching to the template after screening. Histograms 
represent fibre impulse frequency (events/sec or Hertz). 
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2.7.6 Analysis of mechanical response 
To identify action potentials, the period during which mechanical stimuli were applied 
was scanned for events. To do so, two vertical cursors were placed to determine the time 
frame of the recording to analyse. Cursor (1) was placed a few seconds before the start of 
the mechanical stimulus and the other cursor (2) was placed a few seconds after the end 
of the stimulus (Figure 2–5). The selected period was scanned for events matching the 
templated defined for the select unit. The force output was exported as numerical text 
data into an Excel spreadsheet. Cursor (1) corresponded to the start time and cursor (2) 
to the end time (seconds). The output sample rate was set as 10Hz and the waveform 
interpolation method was “as drawn”.  
Using an existing script, Spike2 generated an output window, which indicated the number 
of impulses occurring during each second as 1-second bins (Figure 2–5). The duration of 
a step stimulus was 10s and of ramp stimulus 15s but respectively 11s- and 16s-time 
windows were selected in order to include action potentials occurring just at the end of a 
stimulus. 
The output was exported to a Microsoft Excel spread sheet for basic analysis, and graphs 
were plotted using PRISM GraphPad. Statistics were done using GraphPad and SPSS. Data 
were tested for normality and analysed accordingly with Mann-Whitney or two-sided t-





Figure 2–5 Analysis of mechanical responses using Spike2. 
The first upper channel shows the spikes of interest (in blue). The second channel is a representation 
of spikes as events/s. The first channel shows the force applied onto the receptive field of the fibre. 
The last channel shows the original fibre activity recording. The right window indicates the number of 
impulses occurring during each second as 1-second bins. The cursors (1) and (2) on the left window 
determine the period scanned for events. 
 
 Human-IgG staining 
Mouse hind paw glabrous skin was removed and immersion-fixed with paraformaldehyde 
for 24h. The tissue was then processed to paraffin wax; 6µm thick sections were cut and 
mounted onto Superfrost Plus slides. Sections were deparaffinised and rehydrated to 
water before blocking endogenous peroxidases. After rinsing in buffer, sections were 
incubated overnight at room temperature with biotinylated goat polyclonal antibody to 
human IgG (dilution 1:5000, Abcam, ab98561). One slide was incubated in buffer 
containing no antibody, as negative control. After further buffer rinses, sections were 
incubated with streptavidin Biotin- HRP Complex (VectorlabsPK6100). Sites of Antigen-
antibody interaction were visualised using in-house DAB preparations. Nuclei were 
counterstained using Gill's No. 1 Haemalum before slides were dehydrated, cleared in 
xylene and coverslipped using DPX mountant. 




Human IgG ELISA Kit ab195215 (Abcam) was used to measure mouse plasma IgG 
concentration. Plasma was prepared from whole blood of mice that had been injected 
intraperitoneally with 8mg human IgG daily on four consecutive days, using heparin 
treated tubes. The collected plasma was frozen at -20°C before use according to the 
provided instructions from the manufacturer. 
 Dorsal root ganglion (DRG) neuron culture and imaging 
Dorsal root ganglion neurons were prepared from adult C57Bl/6J mice. Animals were 
killed by cervical dislocation, as approved by the United Kingdom Home Office, and DRGs 
were removed from all levels of the spinal cord using aseptic methods. DRGs were 
incubated in 0.25% collagenase in serum-free MEM (Invitrogen, Paisley, UK) containing 
1% penicillin and streptomycin for 3 hours at 37°C in a humidified incubator gassed with 
5% CO2 in air. This was followed by 20-minute incubation with 0.25% trypsin in MEM. The 
DRGs were then dissociated mechanically via trituration with flame polished Pasteur 
pipettes to obtain a suspension of single cells. Trypsin was removed by addition of 10ml 
MEM (containing 10% FBS) followed by centrifugation at ~168 x g (1000 revolutions min-
1) for 10 minutes. The pellet, containing the DRGs, was re-suspended in MEM containing 
1% penicillin and streptomycin, 10% FBS and 0.05% DNase. The cell suspension was then 
centrifuged through a 2ml cushion of sterile 15% bovine albumin in MEM at ~168 x g (1000 
revolutions/min) for 10 minutes. The pellet, containing the neurons, was then re-
suspended in an appropriate volume of MEM containing 10% FBS, 50ng/ml NGF and 
10μM cytosine arabinoside to prevent/reduce the growth of non-neuronal cells. The 
neurons were then plated at a high density, ~80% of confluency, onto the centre of sterile 
13mm glass coverslips previously coated with 10μg/ml poly-D-lysine. Cultures were 
maintained at 37°C in a humidified incubator gassed with 5% CO2 and cells were studied 
12 to 24 hours after dissociation. 
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 Calcium imaging 
2.11.1 Imaging of intracellular calcium ion levels 
2.11.1.1 Fura-2 
Fura-2 (Invitrogen), a UV excitable ratiometric calcium indicator dye was used to measure 
changes in [Ca2+]i. The excitation spectrum for Fura-2 changes upon binding calcium ions, 
emission measured at >510nm increases when the dye is excited at 340nm and decreases 
at 380nm excitation. 
Cells were loaded with the acetoxymethyl (AM) ester version of the dye which allows 
Fura-2 to pass across cell membranes by passive diffusion. Intracellular esterases then 
cleave the ester bonds once the dye is inside the cell, yielding a relatively membrane-
impermeant acidic form of the dye. For all calcium imaging experiments the cells or 
neurons were loaded with Fura-2 for 1-2h prior to experimentation. Fura-2 was loaded in 
physiological extracellular solution supplemented with 0.01% pluronic acid and 1mM 
probenecid. Pluronic acid is included to promote solubilization of Fura-2, and probenecid 
prevents Fura-2 being extruded from the cell by inhibiting organic-anion transporters in 
the plasma membrane. 
2.11.1.2 Microscope-based imaging of intracellular calcium ion levels 
Neurons were plated onto 13mm glass cover slips which formed the base of the perfusion 
chamber (volume~0.5ml). The chamber was mounted on to the stage of an inverted 
microscope (Nikon Diaphot) and cells were visualized using a 10x Fluor objective with a 
numerical aperture of 0.5. 
Test solutions were applied to cells by local microperfusion of solution through a fine tube 
placed very close to the cells being studied. The temperature of the superfusate was 
controlled using a Peltier device connected to a feedback regulated power supply 
(Marlow Industries, model SE5010) with the temperature measured at the orifice of the 
inflow tube. Neurons were perfused with solutions (gravity fed) supplied from one of 8 
reservoirs. Neurons were distinguished from non-neuronal cells by a final depolarising 
challenge with a solution containing 50mM KCl, which evoked a calcium ion influx through 
voltage gated calcium channels. 
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Fura-2 signals were measured using RatioMaster Fluorescence Microscopy System (PTI). 
Cells were excited by light generated by a xenon-arc lamp which was passed alternately 
through one of two monochromonators (DeltaRam high speed monochromator, PTI) to 
transmit light of the pre-selected wavelengths (340nm and 380nm, ± 2nm). The emitted 
light was filtered by a long pass optical filter (>510nm) and captured by a cooled CCD 
camera (PTI CoolOne). Exposure length was equal for each excitation wavelength and 
determined by the user to ensure adequate signal without saturation of the camera 
(typically 100-400msec). 
PTI ImageMaster software served as the user interface during the experiments to monitor 
the fluorescence emission intensity ratios at 340nm/380nm excitation and was also used 
to select individual neurons of interest for analysis. The ratio time-base data was exported 
to Microsoft Excel (Microsoft) for further analysis and then into Origin (Origin Pro, version 
9.1) for graphical representation of the results. 
2.11.1.3 Extracellular solution (ECS)  
ECS was prepared with 140mM NaCl, 5mM KCl, 10mM glucose, 10mM HEPES, 2mM CaCl2, 
and 1mM MgCl2 and buffered to a pH of 7.4 using (NaOH).  
2.11.1.4 Statistical tests 
Chi2 (2) test were performed in Microsoft Excel. Kruskal-Wallis test (comparison of non-
normally distributed multiple groups) was followed by Dunn’s multiple comparison test 
using GraphPad.  
 Statistical tests 
Data are expressed as mean ± SEM of the number of animals (Chapter 3), nerve fibres 
indicated (n) (Chapter 4 & 5) or number of neurons (n) (Chapter 6). Behavioural data were 
analysed using unpaired t-test or ANOVA (followed by Tukey’s) as appropriate.  
Electrophysiological data (Chapter 5) were analysed by Mann-Whitney U test, since the 
mechanical response thresholds and impulse frequencies are not normally distributed.  
Intracellular calcium imaging data were analysed by Mann-Whitney U test, since neuronal 
responses are not normally distributed and by Dunn’s multiple comparison test when 
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more than two groups (non-normally distributed) were tested. A χ2 test was used to test 
the number of cold responders. Statistical tests were performed in SPSS 24 (IBM).  
 
An a priori sample size calculation has been done to determine the number of animals 
required for the behavioural study. Data from previous experiments using the paw 
pressure test in other experimental pain models, indicate that the minimum reduction in 
paw pressure test required for meaningful results is 15g. Assuming that naïve mice 
respond to paw-pressure with an average threshold of 105g and an SD of 6.6, a minimum 
of 5 mice is required to detect a reduction of 15g with a statistical power of 0.9 and 

























CHAPTER 3 PASSIVE TRANSFER OF CRPS 
















CRPS is a chronic disease condition with unknown cause and pathophysiological basis. 
There are no well-established experimental models of CRPS, but a small number of studies 
have explored the mechanisms responsible for a CRPS-like condition in a tibial-fracture 
model. In these studies, the rat right distal tibial bone was fractured and the hind limb 
fixed in a cast for 4 weeks before subjecting mice to behavioural nociceptive tests (Guo et 
al., 2004). Although in this model mice developed painful hypersensitivities in their 
injured limb, it is unclear whether the fracture model shares a mechanistic basis with CRPS 
I in patients, only a small proportion of patients that have suffered a fracture develop 
CRPS (Beerthuizen et al., 2012). Tékus et al. demonstrated for the first time the 
transferability of CRPS from human to mice via IgG administration to incised mice (Tékus 
et al., 2014).  
 Aim 
The aim of this chapter was to establish and characterize the passive-trauma-IgG-transfer 
model of CRPS in our laboratory. Furthermore, the behavioural phenotype observed in 
this model was compared with sensory abnormalities observed in quantitative sensory 
testing of CRPS patients, to determine whether symptoms were faithfully translated into 
a behavioural phenotype. 
 Methods 
Female C57BL/6J mice were used throughout the entire study, since we worked with 
female patient/donors. Mice with a hind paw skin-muscle incision (Brennan, 1999) were 
either injected with IgG purified from CRPS patients or IgG purified from healthy control 
(HC) subjects. A third group of control mice received no IgG, but were subjected to paw 
incision alone. Mice were tested by Clive Gentry for tactile allodynia with von Frey 
filaments, for mechanical hyperalgesia with the Randall-Selitto paw-pressure test and for 
thermal hyperalgesia with a plate set at 50°C for hot-plate and 10°C for cold-plate tests. 
Weight distribution on the mice hind paw was assessed with the dynamic weight-bearing 
instrument as described in the Chapter 2. The severity of the incision was correlated with 
the healing phenotype of the paw. Immunostaining on the mouse paw skin tissues was 
performed in order to investigate the distribution of human IgG on both ipsilateral and 
contralateral paws of both CRPS and HC mice.  
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 Results 
Three groups of mice (n=6/group) were used in this experiment. Groups of mice were 
injected on four consecutive days (day -1, 0, 1 and 2) with either IgG from healthy control 
subjects (HC) or with IgG from a CRPS patient. All the groups were subjected to incision 
on their ipsilateral paw either alone or in combination with intraperitoneal IgG injection 
and the threshold of the paw withdrawal was measured on both paws, ipsilateral and 
contralateral, using either von Frey hairs or the Randall-Selitto test (as described in the 
methods).  
3.4.1 CRPS-IgG transfer to mice exacerbated and prolongs mechanical 
hypersensitivity produced by paw incision 
All groups displayed a significant hypersensitivity to stimulation with von Frey filaments 
on day 1 after the incision in the ipsilateral paw when compared to baseline (day -1) 
(Figure 3–1, Dunnett’s test). Three days after the paw incision, all groups displayed a 
reduced hypersensitivity to von Frey stimulation, but had not yet recovered fully to the 
naïve level. We observed no significant difference between the CRPS-IgG versus HC-IgG 
injected mice and the incision-only mice (one-way ANOVA test). No difference was 
observed in the mechanical sensitivity in the mice contralateral paw, which is in good 
agreement with earlier studies of paw incision as a model of post-surgical pain (Brennan, 
1999) (Figure 3–1B).  
Similar to the observations with the von Frey test, all treatment groups developed 
hypersensitivity to paw pressure on the day following the incision. The mean paw 
withdrawal threshold was reduced from about 105g to around 80g in the HC-IgG injected 
mice, the CRPS-IgG injected mice and the incision only mice groups (Figure 3–1C). A slight 
but significant difference between the two groups was detectable already on day 1 after 
the incision (Figure 3–1C). While on day 2 post-incision, the control group’s paw 
withdrawal threshold to mechanical pressure started to recover; the CRPS-IgG injected 
mice maintained mechanical hypersensitivity, which was statistically significant. On day 3 
after the incision, the HC-IgG injected mice and incision-only groups recovered whereas 
the CRPS group showed a significant and statistically reduced threshold, with no sign of 
recovery (Figure 3–1C).  
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The uninjured contralateral paw showed no change over time in mice injected with HC-
IgG or incision-only mice, while the CRPS mice group displayed a slight, but significant 
increased sensitivity to mechanical pressure in this experiment (Figure 3–1D).  
This first behavioural study suggested that administration of CRPS patient IgG, but not HC-
IgG, exacerbates the hypersensitivity to mechanical pressure in the incised ipsilateral paw. 
In addition, these results indicated a slight systemic sensitising effect of CRPS-IgG, since 






Figure 3–1 Serum IgG from CRPS patient, but not healthy control subject, exacerbates 
and prolongs the mechanical hypersensitivity produced by a paw incision. 
Mice were injected intraperitoneally with 8mg of healthy control (HC)- IgG or CRPS-IgG (8 mg daily) 
on 4 consecutive days. von Frey ipsilateral (A) and contralateral paw (B). Randall-Selitto ipsilateral (C) 
and contralateral paw (D). n=6/group. One-way ANOVA, comparison with HC-IgG group using 
Tukey’s HSD test. *p < 0.05, ** p < 0.01, ***p < 0.001. †p<0.05, ††p<0.01, †††p<0.001, One-way 




3.4.2 CRPS-IgG transfer to mice exacerbated and prolongs thermal hypersensitivity 
produced by paw incision 
In addition to exhibiting mechanical hypersensitivity, CRPS patients regularly display 
hypersensitivity to heat and cold temperatures (Gierthmühlen et al., 2012; Huge et al., 
2008). Therefore, we wanted to assess mouse sensitivity to cold and heat. We examined 
the influence of IgG on thermal nociception using a modified 10°C cold plate (Figure 3–
2A-B) and a 50°C hot plate assays (Andersson et al., 2009; Gentry et al., 2010) (Figure 3–
2C-D).  
Both groups, CRPS-IgG and HC-IgG treated mice, displayed a slight non-significant 
increased sensitivity to both cold and heat stimulation 1 day after the incision in the 
ipsilateral paw (Figure 3–2A; C). However, on the following days, while the postsurgical 
hypersensitivities to cold and heat were progressively lost in control groups, mice treated 
with CRPS-IgG showed a significantly increased hypersensitivity to cold and noxious heat 
stimulus (Figure 3–2A; C). A significant increase of contralateral cold hypersensitivity was 
also observed in the CRPS mice group on day 2 and 3 post-incision (Figure 3–2B). In 
addition, CRPS mice developed sensitivity to heat on their contralateral paw, but only on 






Figure 3–2 Serum IgG from CRPS patient, but not healthy control subject, elicits cold and 
heat hypersensitivity following a paw incision.  
Mice were injected intraperitoneally with IgG from healthy control subject (8mg) or CRPS patient 
(8mg on 4 consecutive days). Ipsilateral (A) and contralateral (B) paw withdrawal latencies to a cold 
(10°C) stimulus. Ipsilateral (C) and contralateral (D) paw withdrawal latencies to a heat (50°C) 
stimulus. n=6/group. One-way ANOVA, comparison with HC-IgG group using Tukey’s HSD test. *p < 
0.05, ** p < 0.01, ***p < 0.001. †p<0.05, ††p<0.01, †††p<0.001, One-way ANOVA, compared to 




3.4.3 CRPS patient IgG administration to mice induces sustained hypersensitivity to 
mechanical stimuli 
The previous behavioural results raised several questions; we wanted to evaluate the IgG 
dose regimen required to induce behavioural hypersensitivity, and to establish a dose-
response relationship for CRPS-IgG (Figure 3–3). We also sought to determine the time 
course of the exacerbated hypersensitivity produced by IgG from CRPS patients. 
To do so, three different doses (0.8mg, 4mg and 8mg) of IgG from the same CRPS patient- 
were administered to three groups of mice (n=6/group). As in the previous study, IgG was 
injected on four consecutive days, and mice were subjected to a paw incision on the day 
of the second injection. The paw withdrawal threshold to mechanical pressure was 
monitored for 2 weeks (Figure 3–3A-B). A separate group of mice received only two 
injections of 8 mg (Figure 3–3A-B). 
The group that received four injections of 8mg CRPS-IgG displayed a sustained reduction 
of the paw withdrawal threshold to mechanical pressure (Figure 3–3A). In fact, the 
increased sensitivity of these mice remained throughout the whole experiment and for 
mice treated with 4x8mg of CRPS-IgG this phenotype persisted throughout the 2-week 
time course when compared to the HC-IgG injected mice. In contrast, injection of two 
doses instead of four, one on the day before the incision and one on the day of incision, 
was not sufficient to produce the behavioural changes observed in the reference group 
(Figure 3–3A). In addition, injections of lower doses of CRPS-IgG (4mg/day or 0.8mg/day) 
induced no, or markedly reduced behavioural abnormalities compared to the group 
receiving 8mg/day (Figure 3–3A).  
Unlike the injured side, the modest behavioural sensitization to noxious cold or 






Figure 3–3 CRPS-IgG administration induced sustained hypersensitivity to paw pressure 
and noxious cold in correlation with the dose of administered IgG.  
(A) Effect of serum IgG from CRPS patient and HC on ipsilateral and (B) contralateral paw withdrawal 
thresholds to mechanical pressure. (C) Ipsilateral and (D) contralateral paw withdrawal latencies to 
noxious cold (10°C). n=6/group. ANOVA with Tukey’s post-hoc analysis: *p < 0.05, **p < 0.01, ***p < 
0.001, vs HC-IgG group. 
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3.4.4 CRPS patient IgG administration to mice induces sustained hypersensitivity to 
noxious cold  
We also examined mice for their sensitivity to noxious cold (+10°C) using a modified cold 
plate assay, in which a hind paw is placed in contact with plate surface and the latency to 
paw withdrawal is measured in seconds (Andersson et al., 2009; Gentry et al., 2010). Cold 
allodynia and hyperalgesia are characteristic symptoms of chronic CRPS patients 
(Grothusen et al., 2014; Finch et al., 2009). In good agreement with the clinical situation, 
mice treated with 8mg of CRPS-IgG/day displayed a significantly increased sensitivity to 
cold stimulation, which was maintained for at least 2 weeks (Figure 3–3C). Interestingly, 
the group that received half the dose of CRPS-IgG (4mg/day) had a relatively long and 
persistent hypersensitivity to cold from day 1 to day 13 post-incision (Figure 3–3C). 
Indeed, although this group response to mechanical stimulus was not significantly 
different from the control group, it shows here a significant sensitivity to cold stimulus, 
suggesting that IgG from CRPS patients is particularly associated with cold allodynia or 
paraesthesia.  
As seen in Figure 3–3A, a very slight, transient sensitization to mechanical stimulus could 
be detected in the contralateral paw. Similarly, the contralateral paw of the mice injected 
with the highest dose of CRPS-IgG displayed a modest, but significant sensitivity to cold 
stimulus on day 3 post-incision (Figure 3–3D). However, this sensitivity was later lost, after 
day 6 post-incision. The contralateral phenotype indicates that IgG from this patient may 
produce sensitization of nociceptors in the absence of an initiating trauma or injury.  
Alternatively, it is possible that the heightened hypersensitivity from the injured paw, 
sensitized the contralateral side through a central, spinal mechanism, as it has been 
described in neuropathic conditions (Hatashita et al., 2008).  
Interestingly, the mechanical and cold hypersensitivity observed in mice treated with IgG 
from CRPS patients were maintained even 10 days after the last IgG injection and 13 days 
post-incision.  
To determine whether the circulating human IgG concentration correlated with the 
observed behavioural phenotype, we measured the plasma concentration of human IgG 
in mice treated with HC-IgG or CRPS-IgG on days 3, 8 and 13 after incision with a human 
IgG ELISA (Figure 3–4). 
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Perhaps not surprisingly, the concentration of human IgG at day 3 was high, similar to that 
seen in human subjects (19±9 mg/ml). In contrast, the concentrations of circulating 




Figure 3–4 Anti-human IgG ELISA results in human-IgG injected mice plasma at day 3, 8 
and 13.  
Mice were injected intraperitoneally with HC or CRPS-IgG on 4 consecutive days (day -1, 0, 1 and 2). 
Circulating human IgG concentration was measured with an ELISA kit using mice plasma from 
different time course (day 3, 8 and 13). 
 
3.4.5 Hypersensitivity to paw pressure in CRPS-IgG treated mice is correlated with the 
patient pain score 
To determine whether the sensory phenotype observed in mice correlated with the 
donor-patients’ pain intensities, we next examined the activity of IgG pooled from 
randomly selected patients with either high or moderate baseline pain from the LIPS trial 
(Goebel et al., 2017) (high: n=27, mean pain intensity 8.3±0.4 (SD), range 7.3-9.5 on a 11-
point numerical rating scale (NRS); moderate: n=26, 6.0±0.8 (SD), range 5.0-7.0NRS). IgG 
(4x8mg) from patients with severe pain, but not from patients with moderate pain, 
produced significant mechanical hypersensitivity (Figure 3–5A), indicating that the degree 
of sensory abnormalities in CRPS mice reflect the donor patients’ spontaneous pain 
intensities.   
The discrepant results observed with IgG from patients with high or moderate pain, may 
suggest that target heterogeneity or autoantibody titre influences symptom severity, as 
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it is the case in patients with autoantibodies against the voltage-gated potassium channel 
complex constituents LGI1 and CASPR2 (Klein et al., 2012).  
Next, we therefore examined whether larger doses of IgG (16mg/day) from patients with 
moderate pain intensity influenced mechanical nociception. This larger dose of IgG (from 
patients with moderate pain) produced a significant hypersensitivity compared to HC, 
which was more transient than that observed in mice treated with IgG (8mg) from 
patients with higher pain intensity (Figure 3–5B). Our results thus strongly suggest that 




Figure 3–5 Hypersensitivity to paw pressure in CRPS-IgG treated mice is correlated with 
patient pain score.  
(A) Ipsilateral paw withdrawal thresholds to paw pressure before and 7 days after paw incision (4 
days after the last IgG injection), in mice injected with IgG (8mg) pooled from either healthy control 
subjects (HC), CRPS patients with moderate pain intensities, or CRPS patients with high 
pain intensities. (B) Paw withdrawal threshold of mice treated with 4x16mg of IgG from HC-IgG 
or CRPS patients with moderate pain intensities, or 4x8mg of IgG from patients with high pain 
intensities. n=5-6. ANOVA with Tukey’s post-hoc (A, B): *p < 0.05, **p < 0.01, ***p < 0.001, vs HC-IgG 














3.4.6 CRPS-IgG is responsible for the mechanical hypersensitivity independently of 
the incision  
CRPS-IgG injected (n=5) and incision-only (n=7) mice ipsilateral paws were pictured after 
the behavioural reading, using a camera. Both groups of mice were scored blindly by 
seven individuals for the healing level of the paw around the incision. 0: looks normal (the 
incision is healed, no redness), 1: can see the incision, not fully healed, 2: redness 
associated with a bad healing. Both CRPS-IgG injected (R2=0.4816) and incision only 
(R2=0.1866) mice did not show a strong correlation between the mechanical sensitivity of 
the animal to paw pressure (Δ paw pressure vs healing score) and the healing level of the 




Figure 3–6 CRPS mice hypersensitivity to mechanical pressure did not strongly correlate 
with impaired healing of the incision.  
Correlation between mechanical sensitivity and healing in CRPS (A) versus HC mice (B).  paw 
pressure is the difference between contralateral and ipsilateral mouse paw withdrawal to mechanical 
pressure (g). Healing was assessed visually by different subjects and averaged. CRPS n=5 mice, 
Incision-only n=7 mice. 
 
  
Since the healing did not differ between the groups, it is not likely that the rate of healing 
is directly responsible for pain. Since the healing was scored similarly in the two groups of 
mice, it is unlikely that the hypersensitivity observed is caused by the incision per se. 
Instead, the CRPS-IgG seems to be responsible for all of the mechanical hypersensitivity 
(Figure 3–6). In addition, the n number for both groups is too low to conclude about 
potential correlation between an impaired or delayed healing and the mechanical 
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hypersensitivity to paw pressure induced by CRPS-IgG however a trend is observed for 
CRPS group. 
3.4.7 CRPS-IgG did not affect mice ipsilateral vs. contralateral weight distribution         
A last behavioural experiment was conducted in order to assess the behavioural impact 
of passively transferred CRPS. A device that measures in a dynamic setting where mice 
could move freely, the weight distribution on both hind paws of CRPS and control mice 
was used in these experiments. The weight distribution a mouse uses on its paws to move 
is considered a measure that integrates hypersensitivity, spontaneous pain and impaired 
movement due to injury (Figure 3–7).  
Mice were injected with HC or CRPS with 8mg/day during 4 consecutive days as described 
in the previous sections.  
No difference was observed at the baseline measurement (on the day preceding the paw 
incision). Both groups had a very similar weight distribution. Day 1 after the incision, CRPS-
IgG injected mice seemed to put less weight on their ipsilateral, incised, paw. However, 
no significant difference was observed (Figure 3–7, t-test). Mice treated with CRPS-IgG 
spared their ipsilateral (incised) paw modestly more than control mice, but not 
significantly.  
Similarly, on day 3 post-incision, CRPS-IgG injected mice seemed to be more sensitive on 
their ipsilateral paw in comparison to the HC-IgG injected group, again, without any 
significant difference.  
These data suggested that CRPS-IgG or HC-IgG did not have an effect on the mice weight 
distribution on their hind paws although a slight non-significant effect was observed for 





Figure 3–7 CRPS-IgG did not affect mice weight distribution   
Weight (g) mice put on their ipsilateral and contralateral paw was measured using the dynamic 
weight bearing instrument and presented as weight ratio (ipsilateral weight/contralateral weight) on 
day before incision (day -1), one day after incision (day 1) and on day 3 post-incision.  n=6 mice/group. 
Tested with t-test.  
3.4.8 Human IgG localizes in the mice paw skin 
Since CRPS pain seems to be confined to the injured paw, we wanted to stain mouse 
glabrous skin for the presence of human IgG. CRPS-IgG injected mice and control mice 
were both assessed for human IgG distribution in the glabrous skin (Figure 3–8). 
CRPS-IgG was present around the site of the incision (Figure 3–8A-B). It seemed that more 
IgG was present in the direct vicinity of the incision, which might be due to blood vessel 
dilatation and inflammation following paw injury. Mouse paw skin is a highly irrigated 
tissues (Nebuloni et al., 2014) and IgG was also present in the contralateral paw skin of 
CRPS mice, suggesting that human IgG are infiltrating surrounding tissues in the mice paw 
(Figure 3–8C). Patient IgG was found mostly in the very superficial epidermis of the 
contralateral paw skin (Figure 3–8C). Although, human IgG was found in both ipsilateral 
and contralateral paw of HC-IgG injected mice, donors IgG seemed to be confined to the 
dermis area of the skin with less staining on the epidermis (Figure 3–8D-E). No positive 
staining was observed for incision only mice skin (Figure 3–8F). In contrast, human IgG 
could not be detected in the control mouse spleen, demonstrating that the human IgG 
antibody was specific (Figure 3–8G). Human lymph node was also used as a positive 
control. B cells were positively stained (Figure 3–8H). 
Injury and IgG are both required to produce the persistent postsurgical hypersensitivities 
reported above. The profuse IgG deposits seen in the mouse skin, particularly around the 
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incision, demonstrate that serum IgG have access to peripheral nerve endings and all 
dermal layers. The presence of both, CRPS-IgG and an incision, are necessary to induce a 
pronounced mechanical and temperature hypersensitivity. The link between these two 




Figure 3–8 Human-IgG localizes in the mouse ipsilateral and contralateral glabrous skin 
of CRPS and HC-IgG treated mice.  
(A-B) CRPS-IgG treated mouse ipsilateral each representative of n=5 CRPS mice and (C) contralateral 
hind paw glabrous skin stained for human-IgG (representative of n=2 mice) (brown staining). (D) HC-
IgG treated mouse ipsilateral and (E) contralateral hind paw glabrous skin stained for human-IgG 
(brown staining). (F) Incision-only mouse hind paw glabrous skin was negative for human-IgG. (G) 
Human-IgG was also tested on mouse spleen as negative control. (H) Finally, human lymph node was 




The results presented in this Chapter, indicate that mice injected with CRPS-IgG exhibited 
persistent post-traumatic hypersensitivity to stimulation with mechanical pressure, cold 
and heat, but normal sensitivity to tactile stimulation with calibrated von Frey filaments.  
Our results thus demonstrate that administration of CRPS-IgG in combination with paw 
incision, recapitulate sensory abnormalities observed in patient with CRPS (Gierthmühlen 
et al., 2012). The behavioural study presented in Chapter 3 was conducted on mice 
injected with IgG from a single CRPS patient (described Chapter 2 section 2.2) except for 
the pooled IgG study where mice were injected with IgG from different CRPS patients 
(also described Chapter 2 section 2.2). Using a single CRPS IgG donor allowed us to 
compare and correlate the mice behaviour directly to the donor patient clinical 
observation. Additional experiment with additional CRPS IgG donor would allow us to 
demonstrate biological reproducibility of the transfer model. However, the sensory 
abnormalities generated in CRPS mice are correlated with the pain intensity experienced 
by the donor patients. These experiments demonstrated that IgG from different CRPS 
patients have additive effects. 
Donor IgGs were found to be present in the glabrous skin in both groups at the site of 
incision but also in the non-incised paw.  
Mice injected with donor IgGs demonstrated IgG deposit in both ipsilateral and 
contralateral paws but with an enriched deposit around the incision. 
This strong presence of IgG in the mouse paws can be explained by the doses of IgG we 
administered and can be due to the highly vascularised nature of the paws. The presence 
of IgG in both injured (ipsilateral) and non-injured (contralateral) paw when compared 
with the behavioural findings indicates that neither patient IgG, nor injury is sufficient to 
induce behavioural change in the mice. Therefore, the incision and the autoantibody 
present in CRPS serum are required to transfer the sensory abnormalities from patient to 
mouse. Indeed, since HC-IgG is without any discernible effect compared to paw incision 
alone, human IgG per se has no effect on nociception, only CRPS-IgG does. 
One hypothesis to explain the observed results, is that the skin-muscle incision induces 
an inflammatory response in the mice with leads to an increased expression of antigens 
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or to the expression of novel epitopes. Citrullination is a post-translational modification 
of arginine to citrulline by the enzyme peptidyl arginine deiminase (PAD). Inflammation 
in the joints induces citrullination of proteins which are targeted by autoantibodies 
against citrullinated proteins (ACPA). In the ACPA transfer model of RA, Wigerblad et al., 
found that ACPA targets osteoclasts which release the CXCL1 nociceptor factor in the mice 
joint (Wigerblad et al., 2016). Hence, the authors described an example of passive transfer 
model of pain induced by transfer of patient autoantibodies. In our model a similar 
mechanism can explain the pain behaviour of CRPS mice. CPRS IgGs might target novel 
epitopes, which are generated after the paw incision. Autoantibodies might as well target 
existing antigens which expression is increased after the incision. Indeed, gene expression 
profiling of cutaneous nociceptors in SNI mouse model of neuropathic pain showed an 
increase of some gene expression in the injured DRG neurons (Berta et al., 2017). 
Additionally, a recent study revealed 63 differentially expressed genes in the rat dorsal 
horn between chronic constriction injury (CCI) and control groups (Du et al., 2018). Finally, 
an increased gene expression of pronociceptive interleukins as well as nerve growth 
factor genes was also found in a model of post-surgical pain (plantar incision) in the rat. 
The study showed that there were few changes in gene expression in DRGs while greater 
changes occurred in muscle and skin tissues (Spofford and Brennan, 2012). 
Neuromyotonia with pain, a rare condition, can be associated with other symptoms such 
as insomnia, epilepsy and myotonia, and is caused by antibodies to voltage-gated K+ 
channel complexes, CASPR2 and LGI1 (Irani et al., 2010; Klein et al., 2012; Watanabe, 
2016). To study the mechanisms of action of these antibodies, human CASPR2 
autoantibodies, were transferred to mice, which induced mechanical hypersensitivity in 
the absence of neural injury (Dawes et al., 2018). In this model, pain is induced indirectly 
via the action of CASPR2 on the Kv1 channel expression. A similar mechanism of action is 
possible with CRPS antibodies.  
Interestingly, our study showed that CRPS mice were not different from the control 
groups when tested with von Frey for tactile sensitivity but were hypersensitive to 
mechanical paw pressure. von Frey and Randall-Selitto (paw pressure) test are used to 
assay different modes of mechanosensation. Indeed, von Frey filaments apply a very local 
light pressure on the skin. It can therefore be considered as a test for tactile sensory 
changes. The Randall-Selitto assay is a paw pressure test that utilizes a more intense 
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noxious mechanical stimulus. The instruments exert a force increasing at a constant rate 
on the animal paw, which is placed on a small plinth under a cone-shaped pusher with a 
rounded tip. When painful the animal withdraws its paw. The weights applied on the 
animal paws are considerably higher (over 100g) than what is applied with calibrated von 
Frey filaments (0.008–2g). The Randall-Selitto test is therefore a more complex type of 
stimulation on the mouse paw. Hairy skin, muscles, joints and glabrous skin are all 
stimulated. We consider here the paw pressure test as a way of measuring mechanical 
nociception that undoubtedly integrates input from nociceptive and non-nociceptive 
fibres (Hogan et al., 2004).  
Furthermore, we also showed that the hypersensitivity of the incised mouse paw was 
long-lasting. Comparing CRPS mice tissues from later stages to CRPS mice tissues prepared 
on day 3 post-incision might give us a more detailed idea of the changes that occurs over 
time in the animal. As shown in the results, a slight but significant contralateral effect was 
observed in CRPS-mice. Regarding this contralateral effect, our hypothesis is that the 
postsurgical inflammatory environment leads to sensitisation and pain, which is 
accentuated by CRPS-IgG. It is possible that the high level of nociceptive input to the spinal 
cord leads to a sensitisation of the contralateral side of the spinal cord via the system of 
commissural interneurons as in neuropathic pain (Won and Lee, 2015). A study conducted 
in a rat model of hemi lateral nerve injury outlined the induced contralateral neuropathic 
pain and neuropathology in dorsal root ganglion and in spinal cord (Hatashita et al., 2008). 
Another study suggested that activation of spinal microglia in a mouse model of 
peripheral inflammation-induced a long-lasting contralateral allodynia (Schreiber et al., 
2008). This contralateral effect is lost after a brief time, perhaps because of the modest 
level of input coming from the contralateral paw. It is also possible that a continuous 
supply of patient IgG is required to generate and maintain the modest sensitisation in the 
contralateral side, and it is possible that IgG from different patients do not produce 
identical phenotypic changes. The experiments in the current Chapter have all been 
produced with IgG from a single patient with very severe CRPS. In addition, injection of 
CRPS-IgG in the absence of paw injury has been tested in early studies of CRPS-IgG transfer 
by Goebel et al. The study showed that CRPS-IgG did not induce stimulus-evoked pain or 
autonomic signs in injected mice (Goebel et al., 2011).  
The concentration of human-IgG in injected mice plasma was at negligible levels on day 8 
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and 13 after incision although behaviourally animals maintained mechanical and cold 
hypersensitivity. It is possible that the injected IgG are no longer present in the blood 
circulation, but localized in specific tissues in the mouse. Tissue lysate of various mouse 
tissue for immunoblotting with anti-human IgG would test this hypothesis. Finally, 



















CHAPTER 4 SINGLE FIBRE RECORDING FROM 
NAIVE MOUSE SKIN-NERVE PREPARATIONS 
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 Introduction  
The aim of this research project was to investigate the neurophysiological mechanisms of 
CRPS using a translational mouse model. As described in Chapter 3, CRPS-IgG transfer to 
mice with paw skin-muscle incision elicited hypersensitivity in the mice ipsilateral paw to 
mechanical pressure and noxious temperatures. The paw-skin incision model is widely 
used as a model of post-surgical pain (Brennan, 1999). The skin-muscle incision sensitizes 
plantar nociceptors in the glabrous skin (Banik and Brennan, 2008). In this Chapter as well 
as in the following Chapter, we are studying the activity of fibres terminating in the hairy, 
dorsal paw skin, not immediately juxtaposed to the incision injury. Recording fibres 
activity from the hairy skin circumvents the potential bias of the incision-induced 
sensitization of the nerve fibres. Before starting experiments on preparations from 
incision-only mice and CRPS mice, we examined the properties of saphenous nerve fibres 
in C57BL/6J female mice to build a control group of the different fibre types (A-SA, -RA; 
A-DH, -AM and C-fibres). The fibre properties of the hind paw hairy skin have been 
investigated by Koltzenburg and his team (Koltzenburg et al., 1997) in early studies in mice 
of both sexes. Recent studies indicate that pain mechanisms differ significantly between 
male and female mice (Mogil, 2012; Sorge et al., 2015). Since CRPS mostly occurs in female 
individuals, all studies have therefore been performed in female mice. 
 Aim  
The aim of the present study was to determine the properties of mechanically sensitive 
afferent nerve fibre classes in naïve C57BL/6J female mice. The conduction velocity, 
mechanical activation threshold and the evoked patterns of impulse activity in different 
fibre types were analysed. 
 Methods 
Adult female C57BL/6J mice were used for the in vitro electrophysiological analysis, since 
the results from these studies will primarily serve as a reference for the 
neurophysiological basis of CRPS, which predominantly affects women. To investigate the 
properties of fibres innervating the hairy skin, the saphenous-nerve was dissected, and 
the fibres were characterized using electrical and mechanical stimuli as described in 
Chapter 2-2.6. Finally, the data were analysed as described in Chapter 2-2.6.4 & 2.6.5. 
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 Results 
A total of n=216 fibres, 75 from naïve C57BL/6J adult female mice, 71 from incision group 
and 70 from CRPS mice group mechanically sensitive saphenous fibres from the hairy hind 
paw skin were recorded and classified according to their conduction velocity, mechanical 
threshold and impulse discharge properties (Zimmermann et al., 2009).  
4.4.1 Types of mechanically sensitive fibres in the hairy skin 












RA 14 0.21 0.03 14.13 1.02 
SA 12 0.2 0.03 17.01 0.91 
Aδ 
DH 12 0.22 0.07 5.73 0.66 
AM 20 2.57 0.35 6.28 0.61 
C CM 17 4.04 1.21 0.65 0.09 
 
Fibres in preparations from naïve female C57BL/6J mice were studied as a control group 
for their properties. Here, we wanted to study the fibre properties in preparations from 
female mice. Indeed, the overall aim of the study was to assess the effect of CRPS-IgG on 
the response of the mechanically sensitive fibres. Since CRPS-IgG was from a female 
patient, we decided to use female mice throughout the study. In addition, previous 
studies with skin-nerve recordings used male mice whereas our study requires female 
mice.  
 
N=75 fibres were analysed for their conduction velocity and mechanical threshold in order 
to establish a reference group for further comparisons. The saphenous nerve from the 
isolated skin-nerve preparation was dissected into progressively thinner filaments and the 
receptive field of the fibre innervating the skin spotted mechanically. Once the receptive 
field was identified, the conduction velocity of the fibre and its mechanical threshold were 
identified. 
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Mechanosensitive fibres were categorized into five different classes. Groups of fibres 
were established according to the conduction velocity of the fibres (Koltzenburg et al., 
1997). The fibres were either Aβ fibres (conduction velocity>10m/s), Aδ fibres 
(1.2<conduction velocity<10m/s) or C-fibres (conduction velocity<1.2m/s). Aβ fibres were 
then separated into two types, rapidly adapting (RA) and slowly adapting (SA) fibres, 
according to their response to sustained mechanical stimuli.  
Aβ fibres that discharged briefly at the beginning and at the end to a constant force 
stimulus were classified as RA fibres, whereas Aβ fibres that responded with a more 
sustained pattern of impulses were classified as SA fibres (Table 4-1). Both, RA and SA 
fibres discharge impulses for very low forces (Table 4-1). The findings were in agreement 
with previous findings (Koltzenburg et al., 1997; Smith et al., 2013).  
 
Fibres with a conduction velocity between 1.2m/s and 10m/s were classified as Aδ fibres 
and two distinctly different types were encountered. Aδ fibres with low force threshold 
for activation were classified as D-hair (DH) and ones with high force threshold for 
activation were classified as Aδ-mechanoreceptor (AM) fibre (Table 4-1). DH fibres 
impulse discharge and activation threshold (0.22±0.07g) was very similar to that of RA 
fibres (0.21±0.03g). DH fibres discharged brief impulses at the very beginning and the end 
to a constant force stimulus application (Table 4-1). In contrast, AM fibres had a higher 
mechanical threshold than other classes of A-fibres (2.57±0.35g) (Table 4-1). 
AM fibres responded throughout the full duration of a constant force application. When 
the force was increased gradually (ramp stimulation) the fibres displayed increasing firing 
to increasing force, thereby encoding the stimulus intensity (Figure 4–2). This is in contrast 
with DH- and Aβ fibres, which do not encode force with a linear increase in the impulse 
frequency.  
Mechanically sensitive C (CM) fibres were also recorded. They had a very low conduction 
velocity and a high activation threshold in response to mechanical stimulation (Table 4-1). 
Mechanosensitive C (CM) fibres generally displayed a similar impulse discharge pattern 
to AM fibres in response to mechanical pressure, faithfully encoding increasing force with 





Figure 4–1 Example traces of naive low-mechanical threshold fibres response to step 
stimulus. 
(A) Example of an A- rapidly adapting (RA) fibre that discharges impulses at the beginning and at 
the end of the mechanical stimulation without discharging during the duration of the stimulation. (B) 
Example of an A- slowly adapting (SA) fibre, which sustains impulses throughout the whole duration 
of the mechanical stimulation. (C) Example of an A-D-Hair (DH) fibre that discharges action 
potentials at the beginning and the end of the mechanical stimulation like RA fibres. DH and RA fibres 





Figure 4–2 AM and CM-fibre impulse discharge response.  
(A) AM and (C) CM fibres discharge throughout the entire duration of the constant mechanical 
stimulation (step). Both (B) AM and (D) CM fibres encode an increasing force by discharging more 
action potentials for higher forces. 
4.4.2 Conduction velocity of mechanically sensitive fibres 
The conduction velocity of each fibre was determined by electrically stimulating the 
receptive field with a square-wave electrical pulse (duration 1ms, with inter-stimulus 
intervals of 2 or 4 seconds) as described in Chapter 2. Fibres with a conduction velocity 
above 10m/s were classified as thickly myelinated Aβ fibres. Fibres that had a conduction 
velocity between 1.2 and 10m/s were classified as thinly myelinated Aδ fibres. If the 
conduction velocity of the fibre was below 1.2m/s, the fibre was considered an 
unmyelinated C-fibre. The mean conduction velocity of Aβ fibres recorded from naïve 
mice was 15.5±0.74m/s (n=26). The mean conduction velocity of Aδ fibres was 
6.1±0.47m/s (n=29) and the mean conduction velocity of C-fibres was 0.65±0.09m/s 
(n=17).  
The distribution of conduction velocities does not appear normally distributed, which is 
explained by the diverse populations of fibres (Figure 4–3) (Koltzenburg et al., 1997). The 
distribution of conduction velocities from all fibres, suggested a relatively clear distinction 
between A and C-fibres, but not between Aβ and Aδ fibres. Conduction velocity is a first 
good indication of which class of fibre the recorded fibre belongs to but is not enough in 
itself to distinguish between the two Aβ and Aδ fibres. Therefore, the fibre response 
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properties were further analysed for a clear classification of the fibre, based on their 
impulse discharge pattern.  
 
 
Figure 4–3 Bin distribution of the fibres conduction velocity (m/s). 
Fibre conduction velocity (CV) varies according to the fibre class. CM fibre are the slowest with a CV 
between 0.2 and 1.2m/s. A  fibres have an intermediate CV between 2 and 10m/s and A fibres 
have the highest CV (>10m/s). The dotted bars indicate a delimitation of the different fibres class 
according to their CV (Koltzenburg et al., 1997).  
4.4.3 Analysis of mechanically sensitive fibres impulse discharge properties  
RA, SA and DH fibres are low threshold mechanosensitive fibres (LTMRs), they require 
lower forces than mechano-nociceptors to be activated. After recording the fibre 
conduction velocity, fibres were stimulated with mechanical force for 2s and their 
activation threshold identified iteratively (Chapter 2).  
RA fibres had a mean mechanical force threshold of 0.21±0.03g, SA fibres of 0.20±0.03g 
and DH fibres 0.22±0.07g (Table 4-1 and Figure 4–4A). 
In contrast, AM and CM fibres are high threshold mechanosensitive fibre (HTMRs) and 
require more intense stimulation to evoke action potential discharge. AM fibres had a 
mean mechanical activation threshold of 2.57±0.35g. CM fibres had a mean mechanical 
threshold of 4.04±1.21g (Table 4-1 and Figure 4–4B). The HTMRs are nociceptive and need 
higher forces than the LTMRs to give a response.  
The conduction velocity itself might not be enough to identify the fibre class and type with 
confidence; the activation force threshold is then required to distinguish the different 
fibres classes and types. Hence, AM and DH fibres have similar conduction velocities but 







Figure 4–4 Activation threshold of mechanically sensitive hairy-skin nerve fibres in naive 
mice. 
(A) Low threshold mechanical receptors (LTMRs), SA, RA and DH fibres had similar activation 
threshold. (B) High threshold mechanical receptors (HTMRs), AM and CM fibres, required higher 








A feedback-controlled mechanical stimulator was used to investigate single unit 
responses evoked by stimulation of different intensities. Sustained steps of constant force 
ranging from 0.5-20g were used to study the mechanical adaptation properties of RA, SA, 
DH, AM and CM-fibres.  
Since AM and CM fibres encode force with the rate of impulse discharge, these fibres 
were also stimulated with a mechanical ramp stimulus ranging from 0.5-20g and the 
evoked impulse discharge pattern and encoding properties analysed. 
 
A typical recording from an SA fibre is displayed Figure 4–5A. As shown in the example 
(Figure 4–5), low forces (0.5-1g) evoked responses in SA fibres (10-20 imp/s) but forces in 
the range of 2-5g produced a higher impulse rate (25-50 imp/s). The number of impulse 
discharges decreased for higher forces (10-20g), suggesting that the adaptation rate is 
markedly increased by forces in the noxious range. The mean response of SA fibres to 
steps of increasing intensities showed that SA fibres respond to all the forces by 
discharging impulses throughout the stimulus duration but to a lesser extent for higher 
forces (Figure 4–6).The discharge rate was higher at the onset of the force application 
between 0 and 5s of the total 10s stimulation. The average total number of action 
potentials generated for different step stimuli varied from 25 for the lowest force (0.5g) 
to around 100 for the highest force (20g) (Figure 4–7A). However, SA fibres generated a 
number of action potentials that was proportional to forces ranging from 0.5-5g. 
Observations show that SA fibres can sustain very high impulse rates, with the highest 
action potential rate recorded for 5g, exceeding 160 total number of action potential 
(165±30). Higher forces did not induce a higher number of action potential but instead 
seemed to have an inhibitory effect on the discharge rate of the SA fibre (Figure 4–5A).  
 
RA fibres also belong to the Aβ fibre class but exhibit a different discharge pattern from 
SA fibres. As shown by the example RA recording (Figure 4–5B), these fibres mostly 
generate action potentials at the very beginning and end of the step stimulus, which is 
very characteristic of RA fibres. The mean response rates of RA fibres challenged with 
stimuli of different intensities revealed a lower peak impulse discharge rate (<20 imp/s) 
compared to SA fibres (>40 imp/s) (Figure 4–6). In addition, the total number of action 
potential generated in RA fibres in response to different stimulus intensities is much lower 
as a consequence of its rapid mechanical adaptation properties (Figure 4–7B). With similar 
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conduction velocity, these two types of Aβ fibres were distinguished from each other by 
the distinct adaptation properties of their responses to sustained applications of 
mechanical force.  
 
Although DH fibres belong to the Aδ fibre class, they display discharge patterns that are 
reminiscent of RA fibres (Figure 4–6). They responded at high frequencies at the beginning 
and at the end of the stimulus, but are essentially silent during the remainder of the 
mechanical challenges. There is no clear correlation between force and the number of 





Figure 4–5 Mechanical response profile of slowly adapting (SA) and rapidly adapting 
(RA) Aβ fibres to different constant force stimuli.  
(A) SA fibre and (B) RA fibre response to increasing constant force stimuli shown as impulse/s (imp/s) 
and raw recording (in blue).  
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Figure 4–6 Mean response of slowly adapting (SA), rapidly adapting (RA) and D-hair (DH) 
fibres from naïve mice to step stimuli.  
(A) SA fibres were more responsive to constant force stimulus than (B) RA and (C) DH fibres. SA fibres 
discharged impulses throughout the stimulation while RA and DH fibres did discharge impulses at the 





                          
Figure 4–7 Low mechanical threshold fibre response to mechanical stimulus.  
(A) Slowly adapting (SA) fibres discharged in average more action potentials (AP) than (B) rapidly 
adapting (RA) and (C) D-hair (DH) fibres in response to mechanical stimulus. The mean number of AP 
increased for increasing forces from 0.5 to 5g. The generated number of AP reached its maximum for 
5g in SA and RA fibres, and 10g for DH fibres. SA n=12, RA n=12 and DH n=10. Data are mean  SEM.   
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Table 4-2 Correlation between force (g) and number of action potential 
 
Fibre Stimulus R P value 
SA Step 0.3282 0.4274 
RA Step 0.5864 0.1266 
DH Step 0.7508 0.0318 
AM 
Step 0.994 <0.0001 
Ramp 0.9956 <0.0001 
CM 
Step 0.9911 <0.0001 
Ramp 0.9956 <0.0001 
 
In contrast to Aβ- and Aδ-LTMRs, AM fibres did not respond to low force stimuli such as 
0.5g and 1g (Figure 4–8). They instead responded to higher forces, above 2g. HTMRs, AM 
and CM fibres, were both stimulated with step stimuli of increasing intensities, which 
were followed by ramp stimuli as shown on the example Figure 4–8. The mean response 
of AM fibres shows that they discharged impulses for step stimuli exceeding 4g (Figure 4–
9A). AM fibres maintained a constant impulse frequency throughout the step stimulation, 
in contrast to what was observed for Aβ and DH fibres. In addition, the total number of 
action potentials and the impulse rate generated were positively correlated with the 
intensity of the step stimulus (Figure 4–10A). The highest total number of action 
potentials generated was recorded for the highest force, 20g. Stimulation of AM fibres 
with a ramp stimulus generated an increasing impulse discharge rate throughout the 
stimulation period. A maximal impulse discharge rate was reached towards the end of the 
ramp stimulus (Figure 4–9B). The force intensities applied during ramps were also 
correlated with the total number of action potentials generated during the stimulation 
period (Table 4-2). 
CM fibres had a similar firing pattern to AM fibres in response to step and ramp stimuli 
(Figure 4–9). In comparison to AM fibres, CM fibres displayed a lower peak discharge and 
a lower total number of action potentials for step stimuli, but a similar number of impulses 
were evoked by ramps. For forces in the range of 10-20g, CM fibres discharged a similar 
number of action potentials to AM fibres stimulated with a ramp shaped stimulus, 
indicating that CM fibres for high forces are able to maintain a high impulse discharge 
frequency even after long series of stimulations (Figure 4–10). In summary, our 
observation demonstrates that mechano-nociceptors, both A- and C-type, faithfully 






Figure 4–8 Example AM fibre encoding force intensity. 
(A) Aδ-mechanonociceptive (AM) fibre responses evoked by stimulation with constant force-steps 





Figure 4–9 Response evoked by step and ramp stimuli in AM and CM fibres in 
preparations from naïve mice. 
(A) AM and CM fibres both discharged continuously during constant step force application and (B) 
encoded the intensity of the ramp force. Data are mean  SEM. AM step n=17, AM ramp n=15; CM 






Figure 4–10 Force-response relationships of AM and CM fibres in preparations from 
naïve mice.  
(A) AM and (C) CM fibres displayed higher number of action potentials (AP) in response to higher 
forces (g) for both step and (B-D) ramp stimulus. Step stimulus triggered a higher impulse discharge 
compared to ramp stimulus. AM step n=17, AM ramp n=15; CM step n=13, CM ramp n=12. Data are 












 Discussion   
In this chapter, the properties of myelinated A-fibres and unmyelinated CM fibres from 
the hairy skin of naïve C57BL/6J female mice were established.  
4.5.1 LTMRs 
Aβ fibres from hairy skin displayed rapidly adapting (RA) or slowly adapting (SA) properties 
in response to constant force stimulation of their receptive fields. Both are activated by 
light touch (LTMRs). Early work conducted in the monkey and human glabrous skin 
identified the role of these fibres and their properties. These two types of fibres are more 
abundant in the finger tips when compared to the hand palm and convey very fine spatial 
information as they have very small receptive fields (Johansson and Vallbo, 1979a, 1979b; 
LaMotte and Whitehouse, 1986). RA fibres are important for signalling when an object 
slips from the hand for instance, in the grip of objects (Park et al., 2016). The properties 
of SA and RA fibres in hairy skin of C57BL/6J female mice were similar to those reported 
by Koltzenburg and colleagues, who first examined the properties of sensory fibres in skin-
nerve preparations from mice (Koltzenburg et al., 1997). Two types of afferents with 
conduction velocities in the Aδ range; D-hair receptors (DH) and high threshold Aδ 
mechanoreceptors (AM), were found in the mouse hairy skin.  
Zotterman showed that gently stroking the fur of a cat evokes several types of action 
potentials that travel at different speeds and that strokes of different intensities activate 
distinct fibre types (Zotterman, 1939). Using single-unit recordings, Brown and Iggo 
(Brown and Iggo, 1967) confirmed and extended these findings and showed that in cats 
and rabbits movement of guard hairs preferentially activates thickly myelinated fibres, 
whereas thinly myelinated A fibres are activated by movement of the smaller zigzag hairs, 
the D-hair (down hair receptors). Thirty years later, mouse DH properties were studied by 
Koltzenburg et al. (Koltzenburg et al., 1997) whose findings are in accordance with those 
presented in this chapter.  
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4.5.2 HTMRs 
4.5.2.1 Aδ-mechanonociceptors (AM) 
Myelinated high threshold mechanical receptors (HTMR) that responded to noxious 
stimuli were first described in cats, monkey and humans (Adriaensen et al., 1983; Burgess 
and Perl, 1967; Perl, 1968b). Burgess and Perl showed that noxious heat, noxious cold or 
acid applied to the receptive field and bradykinin injected into the skin did not evoke 
discharges from these myelinated high threshold mechanical receptors (Burgess and Perl, 
1967). The receptive fields of these fibres were described as responsive spots which were 
separated by unresponsive areas. In 1968, Perl further identified myelinated HTMR in the 
primate hairy and glabrous skin. Those receptors required strong mechanical stimuli for 
activation and had thresholds that ranged from moderate to damaging pressures (noxious 
stimuli) (Perl, 1968a). Due to their thinly myelinated characteristics, intermediate 
conduction velocities and high threshold for mechanical activation, these HTMRs were 
referred to as Aδ-mechanonociceptors (AM). In this present study the mechanical 
threshold and number of action potentials generated for various mechanical stimuli in 
naive female AM fibres have been described and were in accordance with previous 
studies conducted in male mice (Koltzenburg et al., 1997; Smith et al., 2013). As described 
in early rat and mouse studies, AM fibres had a higher activation threshold in comparison 
to myelinated Aβ fibres and were able to accurately encode the intensity of force stimuli 
(Koltzenburg et al., 1997; Smith et al., 2013). 
4.5.2.2 C-mechanonociceptors (CM) 
Unmyelinated C-fibres are divided into two main groups; mechanically sensitive C-fibres 
(CM) and mechanically insensitive C-fibres. Mechanically sensitive C-fibres are further 
divided into those with low mechanical thresholds (C-LTMRs) which may primarily have a 
non-nociceptive function and those with high mechanical thresholds (C-HTMR), thought 
to be nociceptors. C-LTMRs were first described in the cat (Zotterman, 1939) and were 
subsequently found in the hairy skin of many species including mouse, rat, primates and 
humans. C-LTMRs are activated by innocuous mechanical stimuli (Johansson et al., 1988; 
Kumazawa and Perl, 1977; Leem et al., 1993; Seal et al., 2009; Vallbo et al., 1999). Like 
DHs (Aδ-LTMRs), C-LTMRs are activated by stimuli that move slowly across their receptive 
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field and are thus known as ‘caress detectors’. Their role in nociception is controversial 
although they may play a role for injury induced mechanical hypersensitivity (Seal et al., 
2009). Recently, Moqrich and colleagues have defined C-LTMRs using single-cell 
transcriptomics, and demonstrated a central role for this class of afferents for mechanical 
allodynia (Reynders et al., 2015). In the present study C-LTMRs have not been 
encountered due to their anatomical distribution. In the mouse, C-LTMRs are located in 
the hairy back skin and have not been described as innervating the mouse paw hairy skin 
(Li et al., 2011).  
The present studies on C-fibres have exclusively examined the activity of C-HTMRs. CM 
fibres exhibited the slowest conduction velocities (CV<1.2m/s) and, similar to AM fibres, 
had a high mechanical thresholds (>2g) and they encoded the intensity of the mechanical 
stimulus (Koltzenburg et al., 1997). 
 
AM and CM fibres were stimulated both with constant force stimuli (step) and increasing 
force stimuli (ramp). AM fibres exhibited a closer correlation between the intensity of the 
stimulus and the number of action potential in response to mechanical ramp stimulus in 
comparison with CM fibres. The mean number of action potentials generated by ramp 
stimuli were lower than for step stimuli in AM fibres. Interestingly, in CM fibres, the mean 
number of action potential generated was similar for both step and ramp stimuli 
especially for forces >5g.  
 
Fibre properties of female WT mice hind paw hairy skin were described in this Chapter. 












By administering purified CRPS patient IgG to mice subjected to a minor experimental 
trauma, such as paw incision, we have been able to transfer pain from human to mice 
(Chapter 3) 
However, the neurophysiological mechanisms and the types of sensory afferents targeted 
by CRPS patient IgG are unknown. The in vitro skin nerve preparation technique allows 
the receptive fields of individual units to be directly stimulated by electrical, mechanical 
and thermal stimuli in a precise, controlled manner. This technique allows the 
experimenter to study the function of sensory afferents in their anatomical context 
independently of the CNS (spinal cord and brain).  
 
 Aim 
In this chapter the aim was to study spontaneous impulse activity of the desheathed 
whole saphenous nerve and the evoked activity of single nerve fibres properties from 
CRPS and control incision-only mice skin-nerve preparations to understand whether or 
not CRPS-IgG affect the saphenous nerve activity. 
 
 Methods 
Preparations from CRPS and incision-only mice ipsilateral hairy paw skin were dissected, 
and electrophysiological recordings compared. CRPS mice used in this chapter were 
injected four time (8mg) with IgG from one CRPS patient (described Chapter 2 in section 
2.2). Before starting the saphenous-nerve dissection which was required for the single-
unit recordings (Chapter 2), the whole skin-nerve activity was recorded in order to assess 
the spontaneous ectopic impulse discharge activity and quality of the preparation. Ectopic 
sensory afferent impulse discharge generates spontaneous pain and paraesthesia in both 
rodents and human patients (Seltzer et al., 1989; Wall et al., 1979). 
Single-unit activity was then recorded as described in Chapter 2. Different types of 
mechanosensitive sensory afferent fibres were characterized using electrical and 




Table 5-1 CRPS and incision mice fibres details. 
 
Class Type Mouse n 
Mechanical 










CRPS 12 0.22 0.04 15.44 1.81 
SA 




CRPS 13 0.18 0.03 13.42 1.03 
Aδ 
DH 




CRPS 9 0.18  0.05 7.16 0.78 
AM 




CRPS 23 1.32 0.13 6.18 0.56 
C CM 




CRPS 13 1.87 0.23 0.78 0.10 
5.4.1 Comparison of incision group and CRPS group fibres discharge properties 
5.4.1.1 Mechanical threshold 
The discharge properties of preparations from both incision and CRPS mice (Table 5-1), as 
it was done for fibres from naïve mice preparations (Chapter 4).  
The mechanical threshold of SA fibres was not different between the incision group (n=14) 
and mice treated with CRPS-IgG (n=13) (Figure 5–1A). 
RA fibres from the incision group (n=16) and from mice treated with CRPS-IgG (n=12) were 
compared for their mechanical threshold and no difference was observed (Figure 5–1B).  
Similarly, DH fibres from the incision group (n=10) and from mice treated with CRPS-IgG 
(n=9) were compared for their mechanical threshold and no difference was observed 
(Figure 5–1C). Conduction velocities of LTMRs were also unaffected (Table 5-1). CRPS-IgG 





Figure 5–1 Mechanical threshold of LTMRs in incision versus CRPS groups. 
 (A) SA and (B) RA fibre mechanical threshold was similar in both incision and CRPS groups. (C) DH 
activation threshold seemed to be reduced in CRPS group, but not different from incision group. 
Mann-Whitney test. Data are mean  SEM. 
 
The mechanical threshold of HTMRs (AM and CM) was determined in the same manner 
as previously done in preparations from naive mice (Chapter 3). The mean activation 
thresholds were not different in preparations from incision mice compared to 
preparations from CRPS-IgG injected mice (p=0.056, Mann-Whitney) (Figure 5–2). 
C-mechano-sensitive nociceptors (CM) in preparations from mice treated with a paw 
incision in combination with CRPS patient IgG responded to mechanical stimulation with 
a reduced force threshold, compared to CM units in preparations from mice with incision 
only (p=0.035, t-test) (Figure 5–2). 
The conduction velocity of both AM and CM fibres did not differ significantly between 





Figure 5–2 Mechanical threshold of AM was not different between preparations from 
CRPS-IgG treated and incision only mice but was significantly different for CM fibres. 
(A) HTMR-AM fibre activation threshold is on average lower in CRPS-IgG treated mice (p=0.056, 
Mann-Whitney test). (B) HTMR-CM fibre activation threshold is lower than incision-only mice 
(*p<0.05, t-test). Data are mean   SEM. 
5.4.1.2 Mean number of action potentials (AP) 
After identifying individual fibres activation threshold, fibres were stimulated with 
constant forces for a duration of 10s with a 2-minute recovery period before each force 
application to avoid tachyphylaxis and allow full recovery from the previous challenge 
(Figure 5–3).  
The observed impulse pattern in SA fibres in preparations from the two treatment groups 
was similar and their response thresholds and impulse rate were indistinguishable (Figure 
5–3A). SA fibres in both groups maintained a sustained and persistent impulse pattern 
throughout the stimulation (as described in Chapter 4). SA fibres in preparations from 
CRPS-IgG treated and incision-only mice generated a minimum mean number of action 
potential for 0.5g, around 50 impulses. The number of impulses generated gradually 
increased with the increase of the force. Hence, the number of impulses generated for 5g 
was around 180 in SA fibres from both preparations. The mean number of action 
potentials generated for 10g, 15g and the highest force 20g, was higher than the mean 
number of impulses generated for forces between 0.5g and 3g (~120 impulses). However, 
as described in Chapter 4 for SA fibres in preparations from naïve mice, the SA fibres reach 
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a plateau and do not generate higher number of impulses for higher forces. Also, the 
properties of SA fibres are not altered by CRPS-IgG administration to the mice. 
 
Similarly, the observed impulse pattern in RA fibres from the two treatment groups was 
similar. As observed for SA fibres, the impulse rate was minimal for minimal force 
application and forces between 5g and 20g induced similar impulse rate. RA fibres impulse 
rate also plateaued for forces >4g (Figure 5–3B). Both response threshold and impulse 
rate were indistinguishable for RA fibres in preparations from CRPS-IgG treated and 
incision-only mice (Figure 5–3B). DH fibres (A-LTMRs) were also identified and their 
response threshold, as well as their impulse discharge rate, were similar in both treatment 
groups (Figure 5–3C).  
 
In summary, LTMRs displayed similar responses to mechanical stimulations in both 
preparation from CRPS-IgG treated mice and incision-only mice groups. Their activation 
threshold but also their discharge rate in response to forces ranging from low to high 
(0.5g-20g) were indistinguishable.  
Therefore, CRPS-IgG seem to have no particular effect on LTMRs. These observations are 
also consistent with the lack of effect of CRPS-IgG on tactile sensitivity (Chapter 3). An 
alteration in LTMRs functions can induce painful sensation (Yu et al., 2015), but it appears 
that saphenous LTMR function is unaffected by CRPS-IgG and plantar incision in mice. 
Since, we have not studied the plantar mechano-nociceptors, we were unlikely to detect 







Figure 5–3 LTMRs discharge rate in response to different forces in incision versus CRPS 
mice.  
(A) SA fibres discharged similar number of action potential (AP) in incision and CRPS mice. (B) RA and 
(C) DH fibres number of AP generated for different forces was also similar between the two groups. 
Mann-Whitney test. Data are mean  SEM.  
 
AM fibres displayed an increased discharge rate in preparations from CRPS-IgG treated 
mice when compared to mice that had been subjected to a paw incision alone (Figure 5–
4). Application of step shaped mechanical stimuli of constant force (from 0.5 to 20g, each 
stimulus applied for a duration of 10s) demonstrated that AM fibres in preparations from 
CRPS-IgG treated mice responded with a higher impulse rate throughout the range of 
forces used (Figure 5–6A, p<0.05, 4 and 5g, Mann Whitney).  
Analysis of the impulse pattern evoked by a 5g force step challenge, revealed that AM 
fibres in preparations from CRPS-IgG treated mice responded with a markedly increased 
impulse rate, but with a very similar temporal profile compared to that observed in 
preparations from mice that were not treated with IgG (Figure 5–6C). 
Stimulation of the receptive fields with force ramps evoked significantly higher impulse 
rates in preparations from CRPS-IgG treated mice throughout the range of forces used 
(p<0.01, Mann-Whitney, Figure 5–6B). 
As described in Chapter 4, AM fibres encode increasing mechanical force with a 
corresponding linear increase in impulse frequency.  
In AM fibres in preparations from CRPS-IgG treated mice this force-impulse relationship 
is significantly steeper in comparison with non-IgG treated mice. The minor reduced 
response threshold may indicate sensitized transduction mechanisms and the steeper 
force-impulse rate relationship may indicate that these fibres are hyperexcitable or 
exhibit a sensitized conduction/transmission in preparations from CRPS-IgG treated mice 
AM fibres. 
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In addition, the maximal impulse discharge rates evoked by either a 20g force step (Figure 
5–6E) or a force ramp to 20g (Figure 5–6F) were increased significantly in preparations 
from CRPS-IgG treated mice, compared to AM fibres in preparations from mice that were 
only subjected to a paw incision, hence affirming the change in fibre properties in CRPS-





Figure 5–4 Example traces of AM fibres response to step and ramp stimulations in 
incision and CRPS mice.  
(A) Response evoked by a constant 5g mechanical stimulation in in an AM fibre from a mouse treated 
with CRPS-IgG (red) in combination with a paw incision, or a paw incision alone (black). (B) Response 
evoked by an increasing 10g ramp stimulus in incision versus CRPS mouse AM fibre. In these examples 




Figure 5–5 IgG from CRPS patients sensitizes AM fibres. 
(A) Mean number of action potentials (AP) evoked by step or (B) ramp stimulation of AM fibres in 
preparations from mice only subjected to a paw incision (black) and an incision in combination with 
CRPS-IgG. (C) The mean impulse pattern of AM fibres during 10s constant force applications (5g) and 
(D) 15s ascending force of 10g (means calculated from all fibres presented in A, B). (E) Peak firing 
frequency (events/s) in incision compared to CRPS groups for 5g ramp stimulation and (F) 10g ramp 
stimulation. *p<0.05, **p<0.001, Mann-Whitney test. Data are mean  SEM. *P<0.05, **P<0.01; 
Mann Whitney U-test. 
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C-fibres constitute a diverse class of fibres. Some C-fibres are only thermosensitive (cold 
and/or heat sensitive) and other C-fibres are mechanosensitive only. Some C-fibres are 
both thermosensitive and mechanosensitive (Zimmermann et al., 2009). 
Mechanosensitive C-fibres are either sensitive to light touch (C-LTMR) (Li et al., 2011) or 
to mechanical stimuli in the noxious range (C-HTMR). We have not encountered C-LTMR 
fibres in our preparations and only recorded the activity of mechanosensitive C-HTMR 
fibres and characterized their response to mechanical stimuli but not to thermal stimuli. 
Mechanosensitive C-fibres (CM) in preparations from mice treated with CRPS-IgG were 
analysed with the same testing strategy that was used above for AM fibres and the results 
compared to CM activities in preparations from incision mice. A series of force steps and 
force ramps (0.5-20g) were applied. 
Both type of stimulus, step and ramp, induced an increased discharge rate in preparations 
from CRPS-IgG treated mice in comparison to the incision-only group, in good agreement 
with earlier observations that demonstrate that CM fibres encode an increasing force with 
an increasing impulse rate (Koltzenburg et al., 1997; Smith et al., 2013). 
 
Analysis of the response pattern evoked by a series of force steps identified a significantly 
increased impulse rate in CRPS CM fibres at the highest forces used (15g and 20g, Figure 
5–6A, p<0.05, Mann-Whitney). For the ramp stimulus, the 20g force also induced a 
significantly increased impulse rate (Figure 5–6B). The temporal distribution of action 




Figure 5–6 CRPS-IgG sensitized CM fibres.  
(A) Mean number of action potentials (AP) evoked by step stimulus and (B) by ramp stimulus in CM 
fibres in preparations from incision and CRPS-IgG treated mice. (C) The mean impulse pattern of CM 
fibres during 10s constant 20g force simulation and (D) 15s ascending force of 20g (means calculated 
from all fibres presented in A, B). (E) Peak firing frequency (events/s) in CM fibres in preparations from 
incision mice compared to CM fibres in preparations from CRPS-IgG treated mice for 20g ramp 
stimulation and (F) 20g ramp stimulation. *p<0.05, **p<0.001, Mann-Whitney test. Data are mean 




5.4.2 CRPS-IgG induces spontaneous impulse generation in skin-saphenous nerve 
preparations 
Persistent spontaneous pain is a hallmark of CRPS and we therefore recorded the activity 
of the intact saphenous nerve, before splitting the nerve into thin filaments for studies of 
single-units described above. The intact saphenous nerve activity recording in 
preparations from CRPS-IgG treated mice demonstrated a significantly increased ongoing 
impulse rate (7.1±2.4Hz) compared to preparations from naïve (0.9±0.4Hz), incision only 
(1.4±0.4Hz) and HC-IgG (1.4±0.5Hz) treated mice (p<0.01, Kruskal-Wallis test, Figure 5–7). 
Although, whole nerve recording in preparations from CRPS-IgG demonstrated an 
enhanced ectopic activity, it is not possible to identify which types of units contribute to 
the spontaneous activity. In contrast with the single-unit recording, the whole nerve 
recording, does not allow the identification of single fibres which is done by conduction 
velocity identification and fibres firing properties in response to mechanical stimulus as 
described above and in Chapter 4.  
Nevertheless, the demonstration of enhanced ectopic activity in an in vitro preparation 
isolated from the central nervous system suggests that CRPS-IgG exerts a peripheral 
pathogenic effect.  The observed heightened spontaneous activity may be consistent with 







Figure 5–7 CRPS-IgG increases the spontaneous impulse rate in skin-saphenous nerve 
preparations.  
(A) Typical examples of spontaneous activity recorded in skin-nerve preparations from naïve mice, 
mice only subjected to a paw incision, or subjected to a paw incision in combination with IgG from 
HC or CRPS patient. (B) Spontaneous activity recorded in the intact saphenous nerve. Each data point 

















Electrophysiological investigations of skin-saphenous nerve preparations from incision-
mice model transferred with IgG from a patient-donor with severe, persistent CRPS, 
demonstrate an increased spontaneous impulse rate in the intact saphenous nerve and a 
markedly increased stimulus-evoked discharge rate in A- and C-mechanonociceptor single 
units in combination with a reduced mechanical threshold.  
Low-threshold mechanoreceptors (A and A-DH fibres) were unaffected, reflecting both 
the patient’s clinical experience, and the transferred behavioural phenotype in mice, 
which lasted for at least 2 weeks (see Chapter 3).  
 
Quantitative sensory testing of CRPS patients, has identified a markedly increased 
sensitivity to noxious mechanical pressure associated with an increased sensitivity to 
noxious cold and heat in long standing CRPS patients (Gierthmühlen et al., 2012). Similar 
sensory changes were observed in our CRPS model after the paw incision and IgG 
injection. Hence the faithful transfer of symptoms from patient to mice constitute an 
opening for mechanistic studies of the human pathogen in an experimental setting. 
 
In agreement with patient QST data and our behavioural results, LTMRs were not affected 
whereas nociceptor HTMRs were hypersensitive. However, clinical signs in CRPS patients 
may vary. In the QST study conducted by Gierthmühlen et al., CRPS patient exhibited a 
loss of sensitivity as assessed by mechanical detection threshold, which was measured 
with von Frey hairs. Painful mechanical allodynia or pain in response to light touch 
(dynamic mechanical allodynia) tested by gentle/light stroking with a cotton wisp (~3mN), 
a cotton wool tip fixed to an elastic strip (~100mN), and a brush (~200–400mN) was 
observed in some CRPS patient as frequently as in patient with peripheral nerve injury 
(Gierthmühlen et al., 2012). Mice treated with CRPS-IgG did not exhibit hypersensitivity 
to punctate stimulation with calibrated von Frey filaments, which are likely to activate 
LTMRs or fibres with an activation threshold <1g (since the normal paw withdrawal 
threshold in the mouse is in the range 0.4-1g). von Frey hairs were applied on the plantar 
skin whereas LTMRs were recorded from the hairy skin.    
 
In contrast, CRPS mice had hyperalgesia in the injured paw when challenged with the paw 
pressure (Randall-Selitto) test. A conical probe was used to apply an increasing 
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mechanical force (g) in the noxious range on the mouse paw (0-150g). In the present 
study, recordings on CRPS mice hairy skin have shown increased excitability in nociceptive 
HT-AM and CM fibres in response to high mechanical forces (>4g for AM and >15g for 
CM). Behavioural and electrophysiological recordings are therefore consistent.  
 
Since thermal pain in CRPS patient is not a very distinct sign (Grothusen et al., 2014) and 
since the population of fibres that is responsive to thermal stimulation is of low frequency, 
we focused on mechanosensitive AM and CM fibres in the present study. 
 
In this study, saphenous nerve fibres receptive fields were characterized in the uninjured 
hind paw hairy skin, rather than the incised plantar skin. The functional abnormalities 
observed in these nociceptors are thus not directly explained by the postsurgical 
hypersensitivity seen in sural and tibial single units in the paw-incision model (Banik and 
Brennan, 2008; Brennan, 1999), but are consistent with the more generalized regional 
pain seen in patients who develop CRPS after injury.  
Although, nociceptors are clearly modified functionally by CRPS-IgG it is yet unclear how 
CRPS-IgG sensitizes nociceptors, and whether the autoantibodies responsible for pain 
bind directly to sensory neurons.  
One possibility is the direct action of CRPS antibodies on nociceptive AM and CM fibres. 
In this case, CRPS-IgG may act via binding to epitopes expressed on the nerve terminals 
or be internalized by the nerve endings via endocytosis. CRPS-IgG might act via antibody-
epitope interaction extracellularly or intracellularly and affect the signal transduction. 
This would suggest a Fab- epitope type of interaction and could explain why pain is not 
sensitive to treatment with steroids or other anti-inflammatory strategies (Barbalinardo 
et al., 2016).  
 
It is possible that pathological autoantibodies are directed against ion channels expressed 
on sensory neurons and in this way alter neuronal function independently of 
inflammation. Hence, antibodies directed against CASPR2 have been associated with pain 
in seropositive patients (Irani et al., 2012; Klein et al., 2012; Watanabe, 2016). Passive 
transfer of CASPR2 IgG to mice induced tactile hypersensitivity. Electrophysiological 
studies of skin-nerve preparations from Cntnap2-/- mice identified an increased 
excitability to mechanical stimulation of DH fibres (Dawes et al., 2018). In their study, 
 120 
Dawes and colleagues did not use the IgG transfer model for the electrophysiological 
recordings, possibly because of the limited availability of patient IgG. Cntnap2-/- originally 
served as a model for autism spectrum disorder (ASD) as the KO mice exhibited many of 
its characteristics. They display epileptic seizures as well as some core autism related 
deficits including stereotypic motor movements, behavioural inflexibility, and 
communication and social abnormalities (Gordon et al., 2016). Gordon et al. using a 
Caspr2:tau-LacZ knock-in reporter line (Cntnap2tlacz/tlacz), showed that CASPR2 is actually 
expressed in many brain region in the mouse including brain regions involved in different 
sensory processing (Gordon et al., 2016).  
In this Chapter skin-nerve recording data were acquired from a highly translational mouse 
model of CRPS, transferred with patient IgG. The findings are therefore thought to reflect 
with higher similarities what occurs in the patient.  
 
Another possibility is sensitization of the neurons via an Fc-FcR type of interaction where 
the constant region of the antibody, the Fc region, binds to Fc receptors (FcRs), previously 
shown to be expressed on sensory neurons (Qu, 2012). This type of interaction requires 
immune-complex (IC) formation with soluble antigen. Qu and co-workers showed that 
IgG-IC directly excites the primary sensory neurons through neuronal FcγRI. The incision 
is likely to trigger release of proteins from injured tissues, and it is possible that this may 
be associated with elevated levels of IgG-IC formation and nociceptor sensitization is 
possible. A lack of specific expression of the FcγRs would reject the present hypothesis. 
However, Andoh and Kuraishi have shown that the high affinity IgG receptor FcγRI, but 
not the low affinity receptors FcγRII and FcγRIII, was expressed especially on small- or 
medium-sized mouse DRG neurons (Andoh and Kuraishi, 2004). FcγRs expression on the 
peripheral fibres might however differ.  
To determine to what extent the Fab or Fc region of the CRPS autoantibody is crucial in 
the sensitization of nociceptive nerve fibres, fragmenting the IgG into soluble Fab and Fc 
fractions would be required. Instead of injecting the mice with intact IgG, they would be 
injected with either the Fab region or with the Fc region of the IgG. Behavioural 
investigations would bring a first answer about the role of each antibody region.  
 
The second possible mode of action of CRPS-IgG on nociceptors is via indirect activation 
of the nociceptors. CRPS-IgG would then not target nerves directly but bind to non-
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neuronal cells which would sensitize nociceptors instead. Wigerbald et al. have suggested 
a mechanism for pain in rheumatoid arthritis (RA) via the activation of osteoclasts by anti-
citrullinated protein antibodies (ACPA), which by release of nociceptive CXLC1 
chemokines sensitizes nociceptors. Patients with RA have elevated levels of ACPA 
associated with joint pain that persist even after when inflammation is suppressed with 
anti-rheumatic drugs (Wigerblad et al., 2016). A similar mechanism of action is possible in 
CRPS-IgG mediated pain where pain persists after resorption of the initial clinical signs of 
inflammation especially in long standing chronic CRPS patients.  
Taken together, these observations indicate that circulating autoantibodies maintain pain 




CHAPTER 6 INCUBATION OF CULTURED DRG 





Analysis of skin-nerve recordings from CRPS-IgG treated mice showed an increased 
impulse frequency in response to mechanical stimulation in AM and CM fibres. To 
determine whether this functional abnormality is maintained in vitro, isolated DRG 
neurons were studied using the intracellular calcium ([Ca2+]i)-sensitive dye fura-2. Using 
[Ca2+]i-measurements at modest magnification (10x objective) allows for rapid analysis of 
large numbers of neurons. Using an imaging technique, we wanted to investigate the 
effect of patient IgG on isolated DRG neurons. A simple way to measure neuron’s 
response to various modalities, i.e. chemical or temperature, in cultured neurons, is to 
measure change in their [Ca2+]i.  
 Aim 
The aim of the present study was to determine the effect of CRPS patient IgG on neuronal 
excitability. Specifically, these studies were designed to determine whether CRPS-IgG 
caused hyperexcitability (assayed as an increased sensitivity to challenges with K+) and 
cold hypersensitivity in cultured DRG neurons.  
 Method 
In an effort to assess the excitability of isolated DRG neurons, we used challenges with 
KCl. Mouse DRGs (all the DRGs) were dissected and DRG neurons cultured as described 
Chapter 2 (section 2.10). If patient IgG enhances the neuronal excitability, challenges with 
submaximally effective increases in [K+] would be expected to elicit potentiated [Ca2+]i-
responses.  
We used two approaches in order to assess patient IgG effect on neuronal excitability; 
acute applications of IgG (30min) and extended (overnight ~12h to 24h) incubation in the 
presence of IgG to examine whether IgG were inducing direct activation/depolarisation 
or sensitisation of neurons. IgGs were diluted 1:10 for a final concentration of 0.8mg/ml 
in ECS for the acute application or in MEM when applied for overnight (12h to 24h) 
incubation with the neurons. IgG treated neurons were stimulated with capsaicin (1µM) 
before the end of each experiment and followed by 50mM KCl application to identify all 
viable neurons. DRG neurons were cultured and imaged as described in Chapter 2.  
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 Results  
6.4.1 Acute application of CRPS-IgG had no effect on [Ca2+]i in naive DRG neurons   
Initially, DRG neurons were challenged with acute application of CRPS or HC-IgG to 
determine whether IgG could depolarise neurons directly. The [Ca2+]i response of DRG 
neurons to direct incubation with either CRPS or HC-IgG was examined. The neurons were 
in extracellular solution (ECS) for a minute, followed by addition of CRPS or HC-IgG 
(concentration of 0.8mg/ml). The [Ca2+]i was monitored continuously for 30 minutes, 
followed by application of capsaicin (1µM) to identify TRPV1 expressing nociceptors and 
50mM KCl to identify all viable neurons.  
After 30 minutes incubation with HC or CRPS-IgG the [Ca2+]i had increased in a 
subpopulation  of DRG neurons (Figure 6–1). After incubation with CRPS-IgG, [Ca2+]i had 
increased in 17% of neurons (56 of 327) and in about 24% of neurons incubated with HC-
IgG (56 of 236). The proportion of DRG neurons responding with a [Ca2+]i-increase was 




Figure 6–1 Example traces of naive mouse DRG neurons incubated with HC or CRPS-IgG 
for 30 min. 
Example traces of DRG neurons incubated for 30 min with either HC (A) or CRPS-IgG (B). Neurons 




6.4.2 EC50 for KCl in IgG incubated neurons  






) where R is the universal gas constant and is equal to 8.314 J.K-1.mol-1 
(Joules per Kelvin per mole), T is the temperature in Kelvin (K=25 °C + 273.15), z is the 
valence (+1 for potassium), F is Faraday's constant and is equal to 96485 C.mol-1 
(Coulombs per mole), [K+]out is the concentration of K+ in the extracellular fluid, [K+]in is the 
concentration of K+ in the intracellular fluid, which we assumed to be 130mM (Molleman, 
2002). 
Veq was calculated for [K+]out=5mM and [K+]out=25mM, which respectively gave Veq of -
83.7mV and -42.4mV. 5mM is the concentration of potassium in the ECS (see chapter 2).  
Increasing the [K+]out depolarizes neurons by reducing the electrochemical gradient for K+ 
and thereby the K+ conductance/currents that are responsible for keeping the resting 
membrane potential at ~-70mV. A depolarization of about 30-40mV (as indicated by the 
calculations of the impact of increasing [K+]out by 20mM) will open voltage gated sodium 
(NaVs) and calcium channels (CaVs). Different neurons will vary with respect to the types 
of voltage-gated channels expressed, resting membrane potential and therefore also in 
their response amplitudes. 
 
[K+]out =25mM would, in contrast with [K+]out=5mM, induce a substantial membrane 
depolarisation (ΔVeq=-41.3mV), thereby activate NaVs and CaVs. The consequent Ca2+ 







Figure 6–2 Neuronal response to different concentrations of KCl.  
(A) Naive mouse DRG neurons were incubated with HC or (B) CRPS-IgG before being stimulated with 
increasing concentrations of KCl of 5mM, 10mM, 15mM and 20mM. Neurons were then stimulated 
with capsaicin (1M) followed by KCl (50mM) stimulation. 
 
The effect of different [K+]out-increases were tested on DRG neurons in order to identify 
the half-maximal effective concentration (EC50) that would be amenable for detection of 
positive and negative modulation of the cellular activity and therefore provide a sensitive 
assay (Figure 6–3). 
[K+]out of 5mM, 10mM, 15mM and 20mM were first used to stimulate the neurons, which 
were then stimulated with capsaicin (1μM) to identify nociceptive neurons and with a 
final challenge of 50mM KCl to identify all viable neurons and to determine their maximal 
[Ca2+]i-response amplitude. The Δratio (340/380) response was plotted for the different 
used KCl concentrations. The EC50 was essentially identical for DRG neurons incubated 
with IgG from HC and CRPS, respectively 18.6±0.06mM (n=529) and 18.9±0.6mM (n=677). 
We therefore chose a [K+]out of 20mM as an ideal concentration for the following 
experiments. Next, we examined the effect of incubation with HC- or CRPS-IgG on [Ca2+]i-




Figure 6–3 Dose response curve of DRG neurons incubated overnight with HC or CRPS-
IgG to increasing concentration of KCl.  
(A) Naive mouse DRG neurons were incubated with HC or (B) CRPS-IgG and stimulated with 
increasing concentration of KCl. n=3 coverslips for each condition. HC, EC50 18.6mM 0.06, n 
cells=529; CRPS, EC50 18.9mM   0.6, n cells=677. Data are mean   SEM. 
6.4.3 CRPS-IgG increased [Ca2+]i in response to 20mM KCl stimulation  
A brief 30 second application of 20mM KCl increased [Ca2+]i response in both HC and CRPS-
IgG incubated cells (Figure 6–4A-B,D).  
Stimulation with 20mM KCl evoked significantly larger [Ca2+]i-responses in a subset of 
neurons incubated with IgG from CRPS patients compared to HC-IgG (p<0.001, Mann-
Whitney test) (Figure 6–4C). Interestingly, neurons incubated with CRPS-IgG displayed an 
increased [Ca2+]i response (Figure 6–4A) that did not come back to baseline level as 
observed for neurons incubated with HC-IgG (Figure 6–4B). This observation indicates 
that the larger [Ca2+]i-transients evoked by 20mM KCl in a subset of CRPS-IgG treated DRG 
neurons may be more persistent. 
Behavioural experiments demonstrate that passive transfer of CRPS-IgG in combination 
with a paw incision predominantly, or exclusively affects the ipsilateral, injured paw 
(Chapter 3). Additionally, analysis of the major classes of mechanosensitive sensory 
afferent fibres (Chapter 5), showed that low threshold fibres were unaffected by CRPS-
IgG and mechano-insensitive fibres were not studied. A large proportion of isolated DRG 
neurons are thus likely to be unaffected by CRPS patient IgG. To determine whether the 
[Ca2+]i-response amplitude was increased in a subset of DRG neurons treated with CRPS-
IgG, we compared the distribution of response amplitudes in neurons following IgG 
treatment. Most of the HC-IgG treated neurons had a relatively low amplitude response, 
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between 0 and 0.5, whereas CRPS-IgG treated neurons mostly had a response amplitude 
that was above 0.5 (Figure 6–4E). The distribution of the neuronal response amplitudes 
indicated that a population of cells became responsive to low potassium stimulation 
following an overnight (12h-24h) incubation with CRPS-IgG but not with HC-IgG (Figure 6–
4E). Neurons with a response amplitude >0.8 (Figure 6–4E) were analysed for their 
response to capsaicin, in CRPS-IgG treated neurons 79% (total capsaicin responders 
47.5%) were capsaicin responders and in HC-IgG treated neurons 82% were capsaicin 
responders (total capsaicin responders 47.6%). These results indicate that neurons with 
enhanced sensitivity to low potassium stimulation occurs mostly in capsaicin responders 
and that CRPS-IgG mostly sensitizes nociceptive neurons. It is also possible that IgG from 
different patients contain antibodies against a repertoire of targets, not all of which are 
central for the clinical presentation of CRPS. It is currently unclear whether the effect of 
the preparation used in Figure 6–4 is representative for patients broadly, or whether the 
hyperexcitability produced is unique to this patient. A second patient IgG preparation 





Figure 6–4 Cells response to 20mM KCl after overnight incubation with HC-IgG or CRPS-
IgG 
(A) Example traces of neurons incubated with HC and (B) CRPS-IgG that were stimulated 
with 20mM KCl, capsaicin and 50mM KCl. (C) CRPS-IgG incubated neurons had an 
increased Δratio (340/380) in comparison with HC-IgG treated neurons (Mann-Whitney, 
p<0.001). (D) The average cell response curve showed that CRPS-IgG increased [Ca2+]i 
response in the neurons at least two fold. (E) Bin distribution of CRPS and HC-IgG incubated 
neurons response amplitude to 20mM KCl. HC-IgG (n=332); CRPS-IgG (n=257); Mann-
Whitney test, ***p<0.001. 
 
 130 
6.4.4 Reproducibility of KCl-evoked [Ca2+]i responses  
Next, the neuronal responsiveness to repeated challenges with 20mM KCl following 
incubation with HC or CRPS-IgG was examined. Reproducible responses to repeated 
challenges would facilitate pharmacological investigations aimed at identifying the ion 
channels involved. An altered desensitization to repeated depolarizing challenges may 
further indicate that IgG from CRPS patients alters the neuronal excitability, or the cellular 
handling of, or metabolic response to increased Ca2+. 
Neurons incubated in the presence of either HC or CRPS-IgG were stimulated twice with 
20mM KCl for 30 seconds each, with a 2 min recovery in between, followed by challenges 
with capsaicin 1µM and 50mM KCl (Figure 6–5).  
 
 
Figure 6–5 Neuronal responses to repeated challenges with 20mM KCl.  
Repeated challenges with 20mM KCl evoked [Ca2+]i-responses  of similar amplitudes, but 
substantially smaller than responses evoked by capsaicin and 50mM KCl. 
 
Two consecutive challenges with 20mM KCl evoked [Ca2+]i-responses of similar amplitude 
in DRG neurons treated with HC-IgG (p>0.05, Dunn’s test). In contrast, CRPS-IgG treated 
neurons exhibited larger [Ca2+]i amplitudes (p<0.001, Dunn’s multiple comparison test) in 
response to the first 20mM KCl stimulation compared to the second application (Figure 
6–6).  The amplitude observed in response to the first KCl challenge in CRPS-IgG treated 
cells, was significantly higher compared to HC-IgG treated cells (p<0.001, Dunn’s test), 
whereas the second KCl challenge evoked [Ca2+]i-response of similar amplitudes (Figure 
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6–6). These results indicate that the hypersensitivity observed in vivo and the 
hyperexcitability seen in ex vivo tissue preparations can be recapitulated by incubating 




Figure 6–6 CRPS-IgG increased the KCl-evoked [Ca2+]i-response amplitudes. 









6.4.5 Effect of mibefradil on KCl-evoked [Ca2+]i-responses in IgG treated DRG neurons  
DRG neurons express a range of voltage-gated Ca2+ channels (Li et al., 2017; Murali et al., 
2015; Watanabe et al., 2015). Earlier studies have demonstrated a surprisingly marked 
effect of the selective T-type Ca2+ channel inhibitor mibefradil on CGRP release evoked by 
KCl (40mM) in synaptosomes from the mouse dorsal horn (Quallo et al., 2015). These 
results prompted an investigation of the effect of mibefradil on KCl-evoked [Ca2+]I in DRG 
neurons incubated with HC and CRPS-IgG. 
Incubation with CRPS-IgG enhanced the [Ca2+]i-response amplitude evoked by 20mM KCl 
stimulation. The distribution of [Ca2+]i-response amplitudes (Figure 6–7C) demonstrates 
the increased responsiveness of DRG neurons incubated with CRPS-IgG compared to HC-
IgG (Figure 6–7C).  
Responses were not maximal since 20mM is about EC50, which indicated that KCl did not 
fully activate CaV or did not activate all CaVs. Under conditions that cause a submaximal 
voltage-gated Ca2+-entry, low-voltage activated calcium channels (LVAs) such as T-Type 
Ca2+-channels play an important role, and previous work from the lab identified a marked 
inhibition of KCl-evoked CGRP release by mibefradil (Quallo et al., 2015). To determine 
the importance of T-type Ca2+-channels for the increased [Ca2+]i-responses in CRPS-IgG 
treated neurons, we therefore examined the selective CaV inhibitor mibefradil (10μM). 
Neurons were pre-treated with 10µM mibefradil and then stimulated with 20mM KCl in 






Figure 6–7 Response amplitude and relative amplitude of cells incubated with HC or 
CRPS-IgG stimulated with 20mM KCl pre-treated or not with mibefradil.  
(A) Naive mouse DRG neurons were incubated with HC-IgG or (B) CRPS-IgG. Mean response 
amplitude of naive neurons (mean  SEM; n total): No IgG (24.4  1.2; n=386), HC-IgG only (33,1   
0.7; n=1330), HC-IgG + mibefradil (23.3  1.1; n=412), CRPS-IgG only (44  0.8; n=1414), CRPS-IgG + 
mibefradil (19.5  0.8; n=670). Data are shown as dot plot and box plot (percentile 25-75%). 
Percentage frequency distribution of [Ca2+]i-responses amplitudes evoked by 20mM KCl. (C) 
Incubation of the neurons with CRPS-IgG increased the [Ca2+]i-response amplitudes in a subset of 




Figure 6–8 Example traces of mibefradil treated neurons.  
Neurons were pre-treated with mibefradil 10M, a T-type CaV blocker, for 1 minute before to be 
challenged a first time with mibefradil and KCl (20mM), and a second time with KCl (20mM) only. 
Capsaicin and KCl (50mM) were applied at the end of the experiment.  
 
The amplitude of responses evoked by 20mM KCl in mibefradil treated neurons was 
compared to non-mibefradil treated neurons and to control neurons that have not been 
in contact with any IgG (Figure 6–7).  
Neurons incubated with HC-IgG exhibited a larger response amplitude to 20mM KCl when 
compared to naïve neurons (no IgG incubation) (n=386) (p<0.001, Dunn’s multiple 
comparison test, Figure 6–7A).  Furthermore, mibefradil treatment of HC-IgG incubated 
neurons reduced the neurons response amplitude to 20mM KCl (n=1330 and n=412, 
p<0.001, Dunn’s multiple comparison test, Figure 6–7A).  
Challenges with KCl (20mM) produced responses of significantly larger amplitudes in 
CRPS-IgG incubated neurons (n=1414) when compared to untreated (no IgG) DRG 
neurons (n=368) (p<0.001, Dunn’s multiple comparison test, Figure 6–7B). 
Mibefradil treatment of CRPS-IgG incubated neurons (n=670) significantly decreased the 
response amplitude of the highly responsive neurons (p<0.001, Dunn’s multiple 
comparison test, Figure 6–7B and D). In addition, mibefradil treated neurons displayed a 
similar response amplitude to non-treated neurons, demonstrating that mibefradil 
sensitive ion channels are important for the neuronal responsiveness to moderate 
depolarisations. Mibefradil successfully reversed the increased responsiveness to KCl 
(20mM) of CRPS-IgG incubated neurons. 
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6.4.6 CRPS-IgG increased the number of cold sensitive DRG neurons 
Cold ramps (from 32 to 10°C), stimulated [Ca2+]i-responses in 4.7% of control naïve DRG 
neurons, incubation with CRPS-IgG increased the proportion of neurons activated by 
cooling to 10.2% and incubation with HC-IgG increased the proportion of neurons 
activated by cooling to 7% (Figure 6–9). 
A significantly higher number of neurons responded to cold in CRPS-IgG incubated 
neurons when compared to naïve neurons (χ2 test, p<0.001) and to HC-IgG incubated 
neurons (χ2 test, p<0.01). Surprisingly, incubation with HC-IgG significantly increased the 
proportion of cold responders (χ2 test, p<0.05) (Figure 6–9). The percentage of capsaicin 
responders among the cold sensitive neuronal population was also analysed (Figure 6–
9A). 33% (9/27) of the non-treated cold sensitive neurons, 36% (32/89) of the HC-IgG 
incubated cold sensitive neurons and 40% (35/89) of the CRPS-IgG treated cold sensitive 
neurons were sensitive to capsaicin. There was no statistical difference between the 
groups (χ2 test). These data suggest that CRPS-IgG incubation of DRG neurons induces a 
marked increase in the number of cold responders among the whole population of 
neurons. 
 
          
 
Figure 6–9 Population of cold sensitive neurons in naive DRG neurons and in neurons 
incubated with HC or CRPS-IgG.  
(A) Example traces of cold sensitive neurons. A cold ramp was applied on the neurons (cooling from 
32°C to 10°C) before to be stimulated with capsaicin and KCl. (B) Cold ramps were applied on control 
naive neurons, HC-IgG or CRPS-IgG incubated neurons. Neurons with [Ca2+]i-responses were 
considered as cold sensitive neurons. *p<0.05, **p<0.01, ***p<0.001, χ2 test.; HC vs CRPS.  
A B 
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An altered temperature sensitivity in vivo, may be generated either by recruiting novel 
temperature sensitive neurons or by changing the activation threshold or response 
amplitude of thermosensitive neurons. Analysis of naïve, untreated DRG neurons 
demonstrate a wide range of cold activation thresholds, in good agreement with previous 
work (Viana et al., 2002). Incubation of DRG neurons with CRPS-IgG (19.8±0.52°C, n=87 
cells) did not change their activation temperature threshold compared to HC-IgG 
incubated neurons (18.8±0.53°C, n=89 cells) and naïve neurons (22±0.97°C, n=27 cells) 
(Figure 6–10A, ns, Dunn’s test). The number of naive neurons was lower than for IgG 
treated neurons. A higher number of neurons would perhaps give more accurate results. 
In contrast to our behavioural investigations in vivo, HC-IgG appeared to reduce the 
average cold activation temperature threshold (Figure 6–10A, p<0.01, Dunn’s test), in 









Figure 6–10 Temperature activation threshold of DRG neurons.  
(A) Naive (no IgG), and HC and CRPS-IgG incubated neuronal response threshold to temperature 
change. CRPS average temperature threshold 19.8±0.52°C (n=87 cells), HC average temperature 
threshold 18.8±0.53°C (n=89 cells), No IgG average temperature threshold 22±0.97 (n=27 cells). (B) 
Data are shown as bin distribution (2°C bin) for naive DRG neurons, (C) HC-IgG incubated neurons and 





For a closer inspection of these results (Figure 6–10A), the data were also plotted as a bin 
distribution for each group (Figure 6–10B-D). In non-treated naïve neurons, many neurons 
responded to cold around 26°C (Figure 6–10B) and the rest responded mainly to 
temperature between 14°C and 24°C.  
In contrast, in HC and CRPS-IgG incubated neurons, cold responder neurons seemed to 
cluster in two groups (Figure 6–10C-D). For HC-IgG incubated neurons, two peak number 
of responders were observed for 16°C and 24°C (Figure 6–10C). The other responders 
were distributed in a Gaussian-like fashion.  
CRPS-IgG incubated neurons showed a slightly different pattern to HC group with two 
peaks but one at 20°C and another at 24°C (Figure 6–10D). A less marked scission and a 
more spread distribution was observed among CRPS-IgG treated cold responders. This 
observation would be consistent with the novel cold-sensitive neurons, after treatment 
with IgG, responding at lower temperatures. 
The observed increase in the population of cold-sensitive DRG neurons and a reduced 
mean temperature threshold for activation, suggests that CRPS-IgG may confer cold 
sensitivity to normally temperature-insensitive neurons. Surprisingly, HC-IgG also 
increased the proportion of DRG neurons that respond to cooling with a [Ca2+]i-increase. 
Future investigations will determine whether these effects were specific to IgG from the 
donating individuals, or whether the observations hold true for IgG from other patients 









 Discussion  
The results presented in this chapter demonstrate that an acute 30-minute incubation of 
the neurons with IgG, did not induce significant change in the number of responders in 
response to acute application of IgG. In contrast, overnight incubation of freshly 
dissociated neurons with IgG from CRPS patient increased the neurons excitability to low 
concentration of KCl (20mM) challenge and doubled the proportion of DRG neurons that 
respond to cooling. Incubation with CRPS-IgG greatly enhanced the [Ca2+]i-response 
amplitude evoked by 20mM KCl stimulation. 
These findings strongly suggest that longer incubations with CRPS-IgG sensitize DRG 
neurons directly. The KCl-evoked [Ca2+]i-responses were inhibited by application of the 
selective T-type CaV blocker, mibefradil. This pharmacological tool is relatively selective 
for T-type CaV compared to other CaV isoforms, but it does effectively inhibit NaV1.8 and 
NaV1.9 at the same concentrations as T-type channels (Coste et al., 2007). Mibefradil may 
thus inhibit KCl evoked [Ca2+]i-responses by acting on these three channels, which are all 
thought to be important in chronic pain conditions and which may facilitate repetitive 
firing in DRG neurons.   
Although the average activation thresholds of cold sensitive neurons were not different 
between CRPS and HC-IgG incubated neurons, the fact that a larger population of neurons 
responded strongly, indicate that CRPS-IgG recruits novel, abnormal cold sensitivity in 
some neurons. In the present study, neurons were tested for their response to cold 
ramps. Since the presence of TRPA1 does not influence cold sensitivity of DRG neurons 
(Bautista et al., 2007) and since the most specific TRPM8 agonist available, icilin, is 
particularly susceptible to desensitisation (Kühn et al., 2009) and may not identify all 
TRPM8 expressing neurons in culture, we did not use TRPM8 agonist (e.g. icilin) or TRPA1 
agonist (e.g. AITC). 
In the present study, a single CRPS patient and healthy donor (HC) were used for IgG 
purification, the same used for behavioural and skin-nerve preparations presented in the 
previous chapters. Future investigations using different patients and control subjects IgG 
are required to determine whether or not the observed effects are representative of the 
wider patient population. 
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In the present study, dissociated DRG neurons from naïve mice were exposed to human 
IgG in an ex vivo setting. In the previous chapters, behavioural and skin-nerve recordings 
were performed on the CRPS-trauma-transfer model. Mice were subjected to a paw 
incision and injected intraperitoneally with CRPS patient or control subject IgG. CRPS-IgG 
induced hypersensitivity to noxious mechanical and cold stimuli in the mice ipsilateral 
paw. DRG neurons could be harvested from these treated mice in order to study the 
functional properties of the very neurons responsible for the painful hypersensitivity 
Retrograde labelling, the local injection of a dye that is internalised by the peripheral 
terminals or axons of sensory neurons, followed by transport to the cell soma, can be used 
to study the functional properties of neurons innervating particular tissues (Rigaud et al., 
2008; Schmidt and Rathjen, 2011; da Silva Serra et al., 2016). Neurons that innervate the 
hind mouse paw have their soma located within the DRGs situated at L3, L4 and L5 levels 
in C57BL/6 mice (Rigaud et al., 2008). In a study conducted by da Silva Serra and 
colleagues., it has been shown that only 6% of the neurons (mostly L3 and L4 neurons) 
innervate the hind paw skin (da Silva Serra et al., 2016).   
The percentage of neurons innervating the hind paw skin constitute a limitation as 
ipsilateral and contralateral L3-L5 DRGs need to be separated. Indeed, several mice need 
to be injected with IgG (limited amount) and incised in order to have a sufficient number 
of retrogradely labelled neurons. 5% of the neurons were cold responders in our naïve 
mice. Only 0.3% of ipsilateral L3-L5 neurons would be expected to form hind paw cold 
receptive afferents in this situation.  
Retrograde labelling of the neurons innervating the mouse hind paw would be more 
suitable for patch-clamp experiments. The neuronal excitability could be investigated 
using the current-clamp configuration in retrogradely labelled neurons. The ionic basis for 
any hyperexcitability, could thereafter be investigated using voltage-clamp and 
pharmacological tools in order to identify the type of current and ion channels 
responsible.  
It is yet unclear whether the direct effect of patient IgG on DRG neurons is prevalent 
among CRPS patients, or a particular feature of the patient IgG we used for this study. It 
is also unclear whether IgG from CRPS patients in general produce functional 
modifications of DRG neurons directly, or whether they do so indirectly.  
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Studies conducted on rat and mouse DRG neurons suggest that neurons express IgG 
receptors on their membrane, the FcγRs (Andoh and Kuraishi, 2004; Qu et al., 2011). Both 
studies suggested the direct action of IgG-antigen immune-complex (IC) on FcγRI. Both 
showed using the calcium imaging technique that the IC, but neither of the antibody (IgG) 
or antigen alone, produced an increase in intracellular calcium. IC, in addition, induced 
release of substance P of DRG neurons (Andoh and Kuraishi, 2004) and increased the 
number of action potentials evoked by a depolarizing current during current-clamp 
recordings (Qu et al., 2011). IgG need to form immune complex with the antigen and act 
through its Fc region by binding to the FcγRI on DRG neurons. In our study, the purified 
IgG that we use does not contain IC, but it is possible that some may be formed after 
administration in vivo. However, CRPS is not a destructive condition and is unlikely to be 
caused by conventional Fc-IgG dependant activities. Furthermore, acute applications of 
IgG did not elicit [Ca2+]i-responses in the current study. It then appears highly unlikely that 
FcgR are involved. 
It is more likely that in the present study, CRPS-IgG act via binding to antigens expressed 
either on the neuron extracellular membrane or to intracellular targets, which is possible 
when the IgG is internalized by the neurons.  
Geis et al., showed that intrathecal application of purified patient anti-amphiphysin IgG 
induces stiff person syndrome-like symptoms in rats, including stiffness and muscle 
spasms. They further showed that anti-amphiphysin IgG was internalized into neurons by 
an epitope-specific mechanism and colocalized in vivo with presynaptic vesicular proteins 
(Geis et al., 2010).  
In contrast, Congdon et al. study showed that antibody uptake into neurons occurs 
primarily via clathrin-dependant FcR endocytosis. Excessive Tau aggregates are found in 
brain neurons of patient with neurodegenerative diseases i.e. Alzheimer disease or 
Parkinson. Tau immunotherapy can clear Tau in the neurons. Their results showed that 
Tau antibody uptake correlates with Tau levels, the uptake primarily takes place via 
clathrin-dependent FcII/III endocytosis and is required for acute Tau clearance  (Congdon 
et al., 2013).  
Dawes and colleagues similarly showed that CASPR2 antibody treatment of mouse DRG 
neurons induces a reduction in Kv1 channel surface expression by its internalisation 
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(Dawes et al., 2018). In that case, CASPR2 antibody contributed to clinical pain by directly 
targeting neuronal molecules that regulate cell excitability. 
The exact mechanism of action of CRPS-IgG on neurons is not fully understood and it is 
possible that the in vivo mechanism of action of CRPS-IgG might be separate from the in 
vitro activities described in this chapter. Further investigations will clarify if IgG from other 
patients with persistent CRPS also causes nociceptor hyperexcitability.  
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CRPS is an extremely painful condition and was reported for the very first time during the 
19th century (Iolascon et al., 2015). Acceptance of the pathology as a physiological 
condition rather than a psychological condition took a long time and it still remains a 
difficult condition to diagnose (Bruehl et al., 2016; Harden et al., 2010, 2013). Patients 
with chronic long-standing CRPS experience extreme pain, although the initial injury, 
autonomic dysfunction and inflammation have resolved. A lack of mechanistic 
understanding of the disease makes it particularly difficult to treat and therapies mostly 
fail in alleviating the pain. In most chronic pain conditions, pain deeply affects patient 
quality of life and mental health (Torrance et al., 2014). Chronic pain patients in general, 
and CRPS patients in particular, are affected by a larger number of depressions compared 
to the normal population (Torrance et al., 2014; Brinkers et al., 2018). In the most severe 
cases CRPS patient ask for limb amputation (Kashy et al., 2015). 
 
Compared to other neurological conditions, our understanding of the mechanisms 
responsible for chronic pain of different aetiologies is incomplete.  Over the last few years, 
an interest in pain caused by autoantibodies is emerging. Perhaps the two best examples 
are rheumatoid arthritis (RA) and neuromyotonia. In RA, antibodies directed against 
citrullinated proteins (ACPA) are thought to induce pain (Wigerblad et al., 2016). In 
patients with a rare form of neuromyotonia the pain is caused by autoantibodies directed 
against VGKC complex (CASPR2) (Dawes et al., 2018; Klein et al., 2012). In both cases, the 
pathogenic antibody has been identified, and has been used for passive transfer to mice, 
which resulted in pain behaviour. Passive transfer of human pathology to mice offers very 
important advantages over other forms of mechanistic, translational models. Unlike other 
translational approaches, passive transfer enables investigators to examine the 
pathophysiological consequences of the human pathogen in experimental animals. The 
translational predictive value of passive transfer models is thus almost unique, because 
of their excellent face and construct validity.  
 
Using passive transfer of human IgG to mice, we have reproduced the sensory 
abnormalities observed in CRPS patients in the mouse. In CRPS patients, pain develops 
after an initial trauma/injury in the affected limb and is confined to the affected limb. 
Unlike other autoimmune pain condition such as RA, lupus or Sjögren’s syndrome, CRPS 
pain is in general unilateral. 
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Here, CRPS patient IgG was transferred to mice that were subjected to a plantar skin-
muscle incision in one hind paw. Importantly, this approach accurately reproduced the 
sensory symptoms presented by CRPS patients. The mice exhibited hypersensitivity to 
mechanical, cold and heat stimuli, in the injured paw, but not in the uninjured 
contralateral paw.  
We showed that the initial amount of injected IgG was crucial in obtaining a lasting pain 
behaviour. A dose regimen of 8mg IgG from patients with severe pain on four consecutive 
days was necessary in inducing significant mechanical and cold hypersensitivity. The 
transferred painful hypersensitivities appeared persistent and persisted for at least two 
weeks, in good agreement with the time course of other passively transferred 
neurological disorders (Wigerblad et al., 2016).  
Interestingly, the pain score of CRPS-IgG donors correlated with the hypersensitivity 
observed in mice injected with IgG pooled from patients with either high pain score or 
with low/intermediate pain score. Our findings strongly suggest a role for the 
autoantibody titre in the pain intensity observed in mice, but it is also possible that 
different CRPS patients have autoantibodies targeting different epitopes or proteins. This 
would be consistent with findings in other neurological autoantibody mediated 
conditions, such as those caused by anti-VGKC. Irani et al. measured VGKC-antibody levels 
in 96 patients and 70 control individuals. The level of VGKC-antibody varied according to 
the clinical condition and varied among patients with the same pathology. In addition, 
two distinct proteins complexed with VGKC were found to be targeted by VGKC-antibody, 
CASPR and LGI1 (Irani et al., 2010). Thereby, two distinct antibodies, CASPR2 and LGI1 
were identified. Patients with CASPR2 or LGI1 antibodies shared some similar clinical 
features such as amnesia, confusion and neuropsychiatric symptoms. However, in 
patients with CASPR2 autoantibodies, seizures were less common, neuromyotonia, 
neuropathic pain, insomnia, dysautonomia and weight loss were more frequent than in 
patients positive for LGI1-autoantibodies (Irani et al., 2010).  
 
Skin-nerve preparations from mice treated with CRPS-IgG exhibited a significantly higher 
rate of spontaneous activity, which may be consistent with the presence of paraesthesias 
and spontaneous pain (Chapter 5). However, the dynamic weight bearing assay did not 
reveal a significant behavioural difference between the two treatment groups. It is 
possible that the absence of tactile hypersensitivity in these mice (Chapter 3) means that 
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normal movement is not painful. Future immunohistochemical studies focused on the 
presence of activity markers such as c-fos, arc, pERK and p38 in DRGs and the dorsal horn 
may reveal whether mice treated with CRPS-IgG experience spontaneous pain associated 
with spontaneous input to the dorsal horn (Hunt et al., 1987; Tsuji et al., 2000; Häring et 
al., 2018).  
 
The goal of this study was to elucidate some of the physiological mechanisms responsible 
for CRPS pain using a translationally valid mouse model of CRPS. Early animal models of 
CRPS consisted in tibial fracture and limb immobilization of the hind leg in rats or mice 
(Guo et al., 2004; Wei et al., 2016). However, it is unclear whether these models share a 
pathophysiological basis with CRPS. Here we have demonstrated that the passive 
transfer/trauma mouse model, recapitulates the main sensory signs of CRPS in vivo, and 
we have examined its impact on the functional properties of all the major classes of 
mechanosensitive primary afferent neurons, using the ex vivo skin-nerve recording 
technique.  
CRPS-IgG sensitized nociceptors in the injured paw, which displayed an increased 
discharge rate evoked by mechanical stimuli. In contrast, the properties of low threshold 
Aβ and Aδ DH fibres were unchanged. Both findings were consistent with QST studies of 
CRPS patients, which report spontaneous pain, mechanical, cold and heat 
hypersensitivities, but not tactile hypersensitivity (Gierthmühlen et al., 2012; Huge et al., 
2008). 
[Ca2+]i imaging of CRPS-IgG incubated naive mouse neurons suggested a sensitization of a 
population of neurons that were hyperexcitable after incubation with CRPS-IgG, 
consistent with the electrophysiological findings. Most of the neurons that became 
hyperexcitable after incubation with CRPS-IgG were TRPV1 positive nociceptor neurons. 
Together, these results strongly suggest that CRPS pain is caused by IgG autoantibodies, 
which act by sensitizing nociceptors, at least in part directly. 
 
The results presented in this study were performed with IgG from patients with long 
standing chronic CRPS. The mice behaviour was monitored for a maximum of 13 days 
post-incision and in most cases for 3 days post-incision, on which day the skin-saphenous 
nerve was dissected for fibre activity recording. Although CRPS-IgG treated animals were 
hypersensitive to mechanical pressure on day 3 post-incision, measuring the fibres activity 
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at a later stage (e.g. day 13 post-incision) might be more representative of the chronic 
phase of CRPS in the mice. In addition, repeated administration of patient IgG may mimic 
persistent CRPS, which would allow more valid investigations of anatomical changes (such 
as loss of IENFs).   
 
In vitro skin nerve recordings and [Ca2+]i imaging experiments were performed with IgG 
from a single CRPS patient IgG. Although, this approach ensures reproducibility and 
consistency throughout the series of experiments by limiting differences between IgG 
preparations from different patients, it may mean that heterogeneity in the activity of 
patients IgG preparations is overlooked. Repeating the experiments with IgG from other 
CRPS patients with perhaps distinct clinical features would validate the highly 
translational characteristic of CRPS. Treating the mice with IgG from patient with a more 
acute form of CRPS or an early stage CRPS patient might provide some insight regarding 
the pathophysiological mechanisms of CRPS in more acute and early phases versus 
chronic stages of CRPS. This approach would allow us to assess whether or not sensory 
abnormalities observed in CRPS patient in early stages is also caused by autoantibodies. 
However, skin-nerve investigations are time-consuming and laborious compared to 
behavioural studies. We have therefore examined the activity of IgG from 2 additional 
individual patients and IgG pooled from a cohort in behavioural experiments to establish 
whether our findings apply to the wider population of patients. Electrophysiological 
investigations are suitable for detailed mechanistic studies, but not for repeated 
characterization of samples. 
 
Additional investigations of the cold and heat sensitivity of Aδ and C-fibres (Zimmermann 
et al., 2009) could enhance our understanding of the actions of CRPS IgG and may be an 
interesting avenue for future investigations. Nerve fibres were identified in the first place 
based on the fibre response to mechanical stimulus. However, mechanically insensitive 
fibres do exist in the mouse skin and could be identified and characterized when searched 
with electrical stimulus. Identification of mechanically insensitive-cold sensitive fibres can 
be also achieved using cold stimulus and fibres responses analysed. In our study, we 
focused exclusively on mechano-sensitive fibres, since mechanical hypersensitivity is the 
most prominent sensory abnormality observed in patients (Gierthmühlen et al., 2012). 
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Therefore, many other types of fibres were not studied and characterized. To include 
other these remaining classes of fibres would require more time than was available. 
 
In the present study we used the in vitro intracellular [Ca2+]i-imaging technique to 
measure dissociated DRG neurons response to various stimuli following their direct 
incubation with patient IgG. This technique consists in dissecting DRGs, dissociating the 
neurons and culturing them in an in vitro setting to measure the neurons sensitivity to 
various stimuli (e.g. cold). Neuronal properties and quality may vary from experiment to 
experiment and bias the results. This needs to be taken into consideration although we 
reduced the risks of variations by treating the neurons which were from the same animal 
with both control and CRPS IgG on the same day. Some population of neurons especially 
the large diameter neurons may be underrepresented because of their fragility and low 
survival rate throughout the culturing process.  
An alternative approach to tackle the bias induced by in vitro experiments would be to 
use the in vivo imaging approach which uses the genetically encoded fluorescent calcium 
indicator GCaMP to study the activity of DRG neurons in live mice that can be challenged 
with both noxious and innocuous stimuli (Chisholm et al., 2018; Emery et al., 2016). 
 
In the present study, our findings demonstrate an autoimmune basis of CRPS. However, 
the proteins targeted by the pathological autoantibodies have not yet been identified. In 
contrast with previous studies of autoimmune pain conditions, the mice were injected 
with total IgG as the autoantibody is not yet known. Future efforts should be focused on 
the identification of target proteins and epitopes. 
 
To improve our understanding of the role of IgG in CRPS, a depletion or fractionation of 
IgG into subclasses IgG1, IgG2, IgG3 and IgG4 may be useful (Bird at al., 1984). Different 
subclasses can be administered to mice and behavioural changes studied (Beenhouwer et 
al., 2007; Dekkers et al., 2017). Identification of the subclass to which the pathogenic IgG 
of CRPS patients belongs, may bring additional information on the mechanisms involved. 
Clinical observation of CRPS patients, as well as results from our experimental animal 
model, indicate that CRPS is a non-inflammatory autoimmune pathology, since pain is 
typically unaffected by resolution of inflammation. Indeed, there is no tissue damage 
induced as seen in lupus disease for instance (Nowling and Gilkeson, 2011). CRPS is 
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associated with exacerbated swelling, but since pain remains after swelling has been 
resolved, it does not appear to be critical for pain (Goebel, 2011). Importantly, different 
IgG subclasses are known to be more or less inflammatory (Dekkers et al., 2017). In 
particular, the IgG4 subclass does not activate the complement system, unlike the other 
subclasses of IgG and therefore does not induce inflammatory response (Bindon et al., 
1988; Bruhns et al., 2009). The lack of effector function of IgG4 antibodies and the 
absence of inflammatory damage in CRPS patients suggests that an autoimmune IgG4 
may be involved in the aetiology of CRPS. Alternatively, it is possible that pathogenic IgG 
exert their effects by promoting internalisation of its target protein(s), similar to what has 
been found with anti-CASPR2 IgG (Dawes et al., 2018; Irani et al., 2010). 
Identification of the antibodies involved in CRPS pain will facilitate diagnosis of CRPS and 
may enable prognostic testing before elective surgery. Beyond diagnostic applications, 
identification of the targeted proteins and epitopes would identify novel therapeutic 
rationales and development of targeted and specialised treatments to inhibit pain in CRPS 
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